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Summarv 
This thesis investigates the effects of various inflammatory stimuli, including 
cytokines and air pollution particles, on the expression and secretion of various pro- 
inflammatory proteins in the lung epithelial cell line A549. The pro-inflammatory 
proteins investigated were C-reactive protein (CRP), fibrinogen, and heat shock 
protein 70 (Hsp70), all of which are known to be produced during inflammation and 
are also known risk factors for cardiovascular disease. These proteins were 
investigated because inhalation of particulate air pollution has been associated with 
increased cardiovascular disease and mortality. The production of these proteins in the 
lung may be involved in a systemic inflammatory response which increases the 
plasma levels of these proteins and other cardiovascular risk factors therefore 
increasing the susceptibility for cardiovascular events. Alternatively, localised CRP 
functions as an opsonin, while fibrinogen and its degradation products are involved in 
the recruitment of neutrophils and leukocytes to the lung. 
Both CRP and fibrinogen are known to be produced in hepatocytes in response to 
cytokines. Chapter 3 investigates the effect of cytokine treatment of the A549 cells 
which shows that CRP and fibrinogen can be induced in this cell line by various 
cytokines. CRP was found to be induced by the cytokines ILI P, EL6, IL8, TNF(x and 
IFN7 with increased effects shown by simultaneous treatment with two cytokines. 
Fibrinogen was found to be induced mainly by IL6, but fibrinogen levels were also 
slightly increased by ILlp; simultaneous treatments of IL6 with either ILlP or 
TNF(x reduced the effect of IL6 treatment. Treatment of A549 cells with IL6 and IL8 
simultaneously induced a synergistic effect. 
After establishing that cytokines induce the expression of CRP in A549 cells, the 
effects of particulate air pollution on pro-inflammatory protein expression were then 
investigated (chapter 4). The cells were treated with carbon black (CB), ultrafine CB 
(ufCB), and iron chloride (FeC13) to find out what effect these air pollution 
components and PM10 would have on the expression of CRP, fibrinogen, Hsp70 and 
the transcription factor NFKB and its inhibitor IKB. NFKB is known be activated by 
PM10 and is involved in the signalling of pro-inflammatory responses. All the 
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particulate treatments induced a pro-inflammatory response with expression and 
secretion of CRP, fibrinogen, and Hsp70, whereas the soluble metal treatment had 
little effect. The metal salt FeC13 was used to treat the cells since it has been suggested 
that PM10 may mediate its effect through the presence of transition metals which are 
implicated in oxidant generation. The particulate exposures were also associated with 
the activation and nuclear translocation of NFKB indicating the involvement of NFKB 
and IxB in the induction of the pro-inflammatory response. 
Investigations into the mechanisms by which the particles induced the pro- 
inflammatory response are discussed in chapter 5. Firstly, investigations into the 
effect of particles on the secretion of the pro-inflammatory proteins were carried out; 
these indicated that particles were capable of inducing the secretion of CRP, 
flbrinogen and Hsp70. Investigations into the transcriptional mechanisms of pro- 
inflammatory protein expression were carried out using specific inhibitors. CRP and 
fibrinogen were induced in an NFKB dependent manner, while Hsp70 was produced 
as a result of activation of the JAK/STAT pathway. The effect of oxidative stress 
being induced as a result of particle exposure was investigated using antioxidants. 
This showed a reduction in the amount of intracellular and secreted CRP, fibrinogen 
and Hsp70 in the presence of antioxidants, indicating that oxidative stress was 
involved. This correlated with a reduction in the levels of intracellular ATP. 
Finally in chapter 6 the effects of proteins secreted from A549 cells on the monocyte- 
like cell line MM6 were examined. This was carried out as a model of the effects of 
secreted pro-inflammatory proteins from the lung epithelium on other cells. It was 
found that CRP and fibrinogen were able to induce the activation of NFkB in MM6 
cells, indicating that secretion of these proteins during lung inflammation could have 
an effect on other'resident lung cells. Conditioned medium from A549 cells was also 
found to induce the expression of pro-inflammatory proteins including CRP, 
fibrinogen, Hsp70, IL6, IL8 and TNFcc. The A549 conditioned medium also appeared 
to induce a stress response and cellular damage in MM6 cells, thereby potentially 
exacerbating the inflammatory response. 
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These results indicate that pro-inflammatory proteins can be produced in lung 
epithelial cells in response to particle exposure as a result of oxidative stress. They 
may be involved in the progression of localised lung inflammation and in the systemic 
response to particulate air pollution. 
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Chapter 1 
Introduction. 
1.1.0 The lung 
The main function of the lung is to supply oxygen to the body and to remove the 
waste product carbon dioxide. The airways consist of branching tubes which become 
shorter, narrower and more numerous as they penetrate deeper into the lung. The 
upper areas of the lung known as the conducting zone, consist of the trachea, bronchi 
and tenninal bronchioles. The function of these is to draw the inhaled air into the 
respiratory region of the lung. The respiratory zone consists of the respiratory 
bronchioles and the alveolar region where gas exchange occurs. The alveoli wall 
contains a dense network of capillaries (with a diameter of around 10 microns) and a 
thin blood-gas barrier (0.5 microns) which allow efficient gas exchange (West, 1985). 
The lung is constantly exposed to foreign particles and invading organisms. This can 
result in lung inflammation and can cause tissue injury. To deal with this problem the 
cells of the lung and respiratory tract have developed several defence mechanisms. 
The upper respiratory tract removes the vast majority of the foreign particles and 
invading organisms deposited on the thin mucous coating of the nasopharynx which is 
then removed by ciliated epithelial cells to the epiglottis where it is swallowed. Some 
of these particles can reach the lower airways where they require processing by the 
immune system. Every day infectious agents can enter the alveolar region of the lung 
and yet do not normally cause a threat to health. The alveolar region consists of 5x1 08 
alveoli which have a total surface area Of 10OM2 (Stone et. aL, 1992). The alveolar 
epithelium lines the alveoli and is the first point of contact for inhaled agents. The 
epithelium is capable of playing an active role in airway inflammation by the 
production and release of cytokines (Adler et. aL, 1997). The alveolar epithelium is 
composed of many different cell types including type I epithelial cells, type II 
epithelial cells, ciliated epithelial cells, Clara cells, fibroblasts and alveolar 
macrophages. In this study the type 11-like cell line A549 cells and the monocyte- like 
cell line MM6 were used. 
1.1.1 A549 cells. 
The A549 epithelial cell line has been used in many studies as an experimental model 
of alveolar type II epithelial cells. The major advantage of these cells is that large 
numbers of the cells can be grown and controlled in reproducible conditions. There 
has been some controversy over the similarity of A549 cells to type 11 epithelial cells 
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(Mason and Williams, 1980). Type II cells represent 60% of the alveolar cells by 
number and like A549 cells are spherical in shape and approximately 9 [Lm in 
diameter. There are several major functions of type 11 cells including synthesis and 
secretion of surfactant, xenobiotic metabolism, transepithelial movement of water and 
regeneration of the alveolar epithelium following lung injury (Reviewed by 
Castranova et. A, 1988). 
1.1.2 MM6 cells 
Many studies have used blood derived monocytes to represent the alveolar 
macrophage. In this study we have used a monocyte-like cell line, MM6, to represent 
alveolar macrophages (AM). AM are the first cells to encounter foreign material due 
to their situation at the air-tissue interface in the alveoli. AM have an important role 
in phagocytic, microbicidal and secretory functions, and play a role in lung immunity 
by regulating immune and inflammatory processes. Failure of the AM to clear 
potentially hazardous inhaled matter can represent the first step in the initiation of 
lung disease (Reviewed by Thepen et. aL, 1994; Twigg, 1998) 
1.2.0 Lung inflammation 
When foreign particles and invading organisms breach the defence mechanisms of the 
lungs inflammation can occur. The lung epithelium is involved in the inflammatory 
process either directly by contact with the foreign material or indirectly by interaction 
with various species released from AM. These can include cytokines and ROS 
produced by the AM during phagocytosis of the foreign material (reviewed by Adler 
et. al., 1997; Twigg, 1998). This results in the signalling of an inflammatory response 
in the epithelial cells which is often via the activation of transcription factors (review 
on cytokines and inflammation by Hanada et. al., 2002). This can lead to the 
production of many pro-inflammatory proteins by epithelial cells, including cytokines 
and acute phase proteins which can interact with other cells in the lung or may be 
involved in a systemic inflammatory response. Many of these proteins produced in the 
lung during inflammation have important effects on the body as a whole and will now 
be discussed. 
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1.3.0 Fibrinogen 
Fibrinogen is involved in the coagulation cascade and is produced rapidly during 
tissue injury and is therefore termed an acute phase protein. Acute phase proteins are 
produced in the acute phase response (APR) which occurs within the first 24 - 48 
hours of inflammatory stimulation. The APR is the innate response to tissue damage 
or infection and is described as a "large number of systemic changes, distant from the 
site or sites of inflammation and involving many organ systems, which may 
accompany inflammation" (Gabay and Kushner, 1999). Physiological responses to the 
APR include the activation of monocytes and macrophages, and the induction of the 
release of pro-inflammatory cytokines from damaged and activated cells. 
The coagulation cascade is usually initiated upon damage or inflammation of the 
tissue endothelium. Products of damaged cells can then stimulate endothelial cell 
retraction and the release of fibrinogen and other plasma constituents from the 
vasculature. Fibrinogen is the precursor of fibrin, an insoluble polymer which forms 
the basis of the blood clot. The primary function of fibrinogen is to control blood loss 
by platelet aggregation and the formation of fibrin clots. As well as its role in 
haemostasis, fibrin also provides a matrix for adhesion, migration and proliferation of 
cells during repair processes after tissue damage. 
1.3.1 Fibrinogen in the liver. 
Fibrinogen is a 340kDa glycoprotein produced constitutively by hepatocytes. The 
protein is produced as three separate polypeptide chains A(X, BP, and y (Herrick et. 
al., 1999). The constitutive production of fibrinogen results in secretion into the 
plasma and therefore a basal level of fibrinogen exists in all individuals. During 
inflammation the plasma levels of fibrinogen dramatically rise due to the function of 
fibrinogen as an acute phase protein. Extrahepatic synthesis of fibrinogen has been 
found in several tissues. Molmenti et. al. (1993) found that intestinal cells could 
produce fibrinogen and proposed that it functioned as part of a repair mechanism. 
Simpson-Haidaris (1997) reported that the human lung epithelial cell line A549, was 
able to synthesise and secrete fibrinogen, and that this secreted fibrinogen in response 
to inflammation plays a role in wound repair. 
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1.3.2 Fibrinogen transcription 
The three human fibrinogen genes are clustered within a 65kb region on chromosome 
4 and are transcribed in a coordinated manner allowing all three subunits to be 
increased to the same extent in response to an upregulation signal (reviewed by Fuller 
and Zhang, 2001). The promoters for each fibrinogen gene contain IL6 responsive 
elements which enable IL6 to be the major inducer for fibrinogen transcription. 
Signalling by IL6 requires the transcription factors STAT3 (signal transducer and 
activator of transcription) and C/EBP (CCAAT- enhancer binding proteins). In 
hepatocytes the hepatic nuclear factor -1 (HNFI) is also required for the expression of 
Aa and BP proteins. The cytokines TNF a and IL10 have also been found to inhibit 
the IL6 response in hepatocytes and in animals when co-administered (Zhang and 
Fuller, 2000; Nguyen and Simpson-Haidaris, 2000). ILlP and TNF a activate 
fibrinogen production by NFicB signalling (Siebenlist et. al., 1994) and in the 
fibrinogen gene the binding sites of STAT3 and NFKB overlap. Therefore if ILIP is 
present it induces NFKB, which when bound to the DNA prevents the binding of 
STAT3. 
1.3.3 Function of fibrinogen. 
One of the main functions of fibrinogen is in the coagulation cascade. Circulatory 
fibrinogen also can act as an acute phase protein and is involved in the inflammatory 
response. In particular fibrinogen has been found to promote leukocyte adhesion and 
cytokine secretion at inflammatory sites. Leukocyte and neutrophil migration is an 
important event during an immune or inflammatory response. 
Fibrinogen participates in leukocyte and neutrophil movement and adherence to 
endothelium by binding to the leukocyte integrin OWN (CD I lb/CD 18) (Altier et. al., 
1993). This allows the leukocyte (Forsyth et. al., 2001) or neutrophil (Gross et. al., 
1997) to migrate across the endothelium to the site of inflammation. Fibrinogen can 
also stimulate the production of cytokines in leukocytes and neutrophils. Degraded 
fibrinogen molecules known as fibrin degradation products are also able to influence 
neutrophil movement indicating that the fibrinogen molecule is not required to be 
intact for these effects to occur (Leavell et. al., 1996). 
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Fibrinogen has been shown to induce the activation of NFKB in monocytic U937 cells 
(Sitrin et. al., 1998) which could result in the production of cytokines. Fibrinogen can 
also stimulate chemokine secretion through Toll-like receptor 4 (TLR4) in U937 and 
THPI. cells (Smiley et. al., 2001). Fibrinogen was also found to increase cytokine 
gene expression in neutrophils when bound to the P2 integrin (CD1 l/CDI 8). 
1.3.4 Fibrinogen in the lung. 
Fibrinogen has been found to be produced in many extrahepatic locations including 
the lung. Fibrinogen can be induced in A549 lung epithelial cells when treated with 
IL6 and dexamethasone suggesting that fibrinogen could induce a local response to 
lung inflammation (Simpson-Haidaris, 1997; Anderson et. al., 2003). Fibrinogen was 
found to be secreted from these cells in a polarised manner with 80% being secreted 
basolaterally, toward the basement membrane in a microtubule dependent manner 
(Gaudiz et. al., 1997). 
Fibrinogen was also found to be induced in response to parasitic infection by 
Pneumonocystis carnii in an animal model (Simpson-Haidaris et. al., 1998). 
Fibrinogen was found associated with the parasites aggregated along the alveolar 
membrane suggesting that it played a role in the adherence of the parasite to the lung 
epithelium similarly to the adhesive glycoproteins fibronectin and vitronectin. 
Recently fibrinogen was found to be endocytosed by A549 cells in an integrin, (43, 
dependent manner (Odr1jin et. al., 2001). It was suggested that the endocytosis of 
matrix-associated fibrinogen may be involved in the process of alveolar tissue repair 
and matrix remodelling. 
1.4.0. C-reactive protein 
C-reactive protein (CRP) is the prototypic human acute phase protein (APP) and is a 
member of the pentraxin family of proteins. This is a highly conserved protein family 
and has evolved since the horseshoe crab (Dinulus polyphemus), (Shrive et. al., 1999) 
and is thought to have been present before the evolution of immunoglobulins. The 
pentraxins are characterised by a ring-like structure consisting of 5 identical 
monomers (Szalai et. al., 1999). CRP was originally thought to be produced only in 
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the liver in response to cytokine induction (Tonatti et. al., 1990). Synthesis in 
hepatocytes occurs at low rates and CRP is retained in the endoplasmaic reticulurn via 
interaction with two carboxylesterases (gp60a and gp60b) until the APR occurs, at 
which time the CRP is released into the circulation (Yue et. al., 1996). Normal serum 
levels of CRP are <Iýtg/ml and during and APR there can be up to a 1000 fold 
increase within several hours of stimulus (Dowton and Colton, 1988). In recent years 
there have been reports of extrahepatic synthesis of CRP in many areas of the body 
including the brain (Yasojima et. al., 2000), atherosclerotic plaques (Yasojima et. al., 
2001), respiratory tract (Gould and Weiser, 2001), blood lymphocytes (Murphy et. al., 
1991; Kuta and Baum, 1986), and alveolar macrophages (Dong and Wright 1996). 
CRP in the respiratory tract was found to be expressed and the epithelial cells and 
secreted from these cells which was detectable in sputum and nasal airway surface 
fluid. 
1.4.1 CRP transcription 
Transcription of CRP in hepatocytes during the APR is known to be induced by 
cytokines. The main translational activator of CRP is interleukin 6 (IL6) which is 
produced by T-cells, macrophages and endothelial cells (Baumann and Gauldie, 
1994). However, although IL6 is essential for CRP transcription it is not sufficient for 
the induction of the CRP gene in vivo (Weinhold and Ruther, 1997). In the liver ILI P 
must also be present for the transcription of CRP (Weinhold et. al., 1997; Zhang et. 
al., 1995). However in human cell lines IL6 is able to induce CRP transcription 
without the need for ILIP to be present, although the presence of both cytokines 
increases the rate of CRP production. This occurs because the cytokines interact with 
the CRP gene at loci known as acute phase response elements (APRE) and induce the 
production of CRP (Zhang et. al., 1996). Each APRE is thought to increase the 
production of CRP by 10-fold, and the CRP gene contains many of these APRE 
allowing more than one cytokine to induce the transcription of CRP (Tonatti et. al., 
1990). Other cytokines known to increase the production of CRP during inflammation 
include tumour necrosis factor a (TNF cc), interferon y (IFN y), and transforming 
growth factor P (TGF P). 
1.4.2 CRP function 
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The function of CRP is still not fully understood although CRP was discovered in the 
1930s and has been widely studied since. It is known that CRP is dramatically 
increased during APR and has been highly conserved throughout evolution suggesting 
that it performs an important biological role. Unlike antibodies, CRP is present at the 
onset of infection and is rapidly reduced in expression when infection subsides (Du 
Clos, 2000). CRP is found at most sites of inflammation associated with neutrophils 
and other inflammatory cells (Heuertz et. al., 1993). The main biological function of 
CRP is determined by its ability to bind to pathogens and damaged cells and mediate 
their elimination by recruitment of the complement system and phagocytic cells 
(Volanakis, 2001). 
CRP acts as an opsonin by binding to C-polysaccharide on bacteria and 
phosphatidy1choline on damaged cell membranes and signals for their removal by 
phagocytosis. Phagocytosis occurs by the binding of CRP to receptors on neutrophils, 
monocytes and macrophages similar to the IgG receptor Fcy (Marnell et. al., 
1995; Bharadwaj et. al., 1999; Mold et. al., 2001). 
CRP can also activate the early classical complement cascade (Kaplan and Volanakis, 
1974). CRP has also been shown to inhibit the alternative pathway activation from C3 
(Heurtz, 1993,1994). Complement is an important factor in clearance of soluble 
immune complexes, damaged, transformed and apoptotic cells (Jarva et. al., 1999). 
Complement allows these complexes to bind to erythrocytes (Mold, 1996) so that they 
can be transported to the liver and spleen to be degraded, thus minimising 
inflammation. 
CRP is also known to enter the nucleus of apoptotic and necrotic cells. This is 
dependent on a nuclear localisation sequence (NILS) within the CRP gene (Du Clos et. 
al., 1990). Once in the nucleus CRP can bind to chromatin (Robey et. al., 1984; Du 
Clos, 1991; Pepys et. al., 1994) and the small nuclear ribonuclear proteins (snRNPs), 
(Du Clos et. al., 1989; Jewell et. al., 1993; Pepys et. al., 1994). It is believed that this 
facilitates phagocytosis of the nuclear material and reduces the chances of developing 
autoirnmuninty (Du Clos, 1996). Shepherd et. al. (1986) also suggested that CRP 
binding to chromatin promotes its degradation by endogenous nucleases. 
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1.5.0 Heat shock protein 70. 
The heat shock response is one of the most primitive and highly conserved cellular 
defence systems known in biology. Heat shock proteins (Hsps) are consititutively 
expressed in all cells and are essential in many cellular processes including protein 
folding, protection of proteins from denaturation and aggregation and in the 
facilitation of protein transport through membrane channels (Hartl, 1996). A wide 
variety of stressful stimuli including heat, radiation, and infection can induce 
increases in intracellular heat shock proteins. Heat shock proteins are a family of 
stress proteins which are divided in to subfamilies according to molecular weight and 
are generally classified as HsplOO, Hsp90, Hsp70, Hsp60, Hsp40, and small heat 
shock proteins. Hsp70 is found in the nucleus and cytoplasm of mammalian cells 
whereas Hsp60 is located in the cell mitochondria and membrane and Hsp27 is found 
only in the cytoplasm of cells (reviewed by Garrido et. aL, 2001). 
1.5.1 Transcriptional regulation of Hsp70. 
The heat shock response is regulated by a transcription factor known as heat shock 
factor -1 (HSFI). In unstressed cells HSFI is present in the nucleus and cytoplasm of 
cells in a monomeric form bound to Hsp70 and other chaperones. During stress the 
monomers trimerise and undergo conformational changes which allow HSFI to bind 
to the responsive elements in the promoters of stress inducible genes. During this 
process HSFI becomes phosphorylated which correlates with DNA binding (Kim et. 
al., 1995). Hsp70 and Hsp90 belong to a subset of HSPs which can be transactivated 
by signal transducers and activators of transcription (STATS) (Stephanou et. al., 
1999). This occurs in the presence of IFNy which induces STATI. STATI. can then 
bind to the DNA which is in an area around the Hsp70 and Hsp90 promoters. This 
region of the DNA also contains binding sites for NF-IL6, STAT3 and HSF1. STATI. 
and HSF1 can also interact with each other and produce strong activation of 
transcription, while STAT3 and HSF1 antagonise each other (Stephanou et. al., 1999). 
1.5.2 Function of Hsp70 under 'normal' conditions. 
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During normal (unstressed) conditions Hsp70 functions as an ATP-dependent 
molecular chaperone assisting the folding of newly synthesised polypeptides. Hsp70 
is an ATP binding protein and has ATPase activity. The ATP-bound form of the 
protein has a low binding affinity for substrate whereas the ADP-bound form can bind 
substrate. Inhibitors of the Hsp70 ATPase have been found which can inhibit Hsp70 
chaperone activity (Raynes and Guerriero, 1998). Hsp70 also assists in the assembly 
of multi-protein complexes and the transport of proteins across cellular membranes 
(Beckmann et. al., 1990; Shi et. al., 1992; Murakami et. al., 1988). 
1.5.3 Function of Hsp70 during stressed conditions. 
Cellular stress arises from many sources including heavy metals, inflammation, 
oxidative damage, ischernic stresses all of which can stimulate the expression of HSP 
genes. Hsp70 is produced rapidly in response to cellular stress and has been shown to 
protect against reperfasion lung injury, stress- and TNF(x-induced apoptosis, 
radiation-induced apoptosis, and necrosis (Stuhlheimer, 2000). Hsp70 has also been 
shown to block the activation of the transcription factor, nuclear factor -icB (NFKB), 
therefore blocking the inflammatory process (Feinstein et. al., 1996; Yoo et. al., 2000; 
Malhotra and Wong, 2002). During a stress response Hsp70 is removed from the 
HSFI allowing HSF1 to enter the nucleus and induce production of HSPs. The Hsp70 
proteins then are involved in ensuring the correct folding of polypeptides in response 
to stress stimuli. Once the level of Hsp70 in the cells is high enough Hsp70 travels to 
the nucleus and can bind to the HSFI and repress HSP gene transcription. Hsp70 is 
known to be involved in inhibition of apoptosis and therefore increasing the ability of 
cells to survive when exposed to lethal stimuli. Overexpression of Hsp70 protects 
cells from stress-induced apoptosis both upstream and downstream of the caspase 
cascade. Hsp70 can reduce or block caspase activation, suppressing mitochondrial 
damage and nuclear fragmentation (Buzzard et. al., 1998). Hsp70 has also been 
suggested to have neutralising interactions with several pro-apoptotic effectors 
including Apafl, AIF and signalling molecules such as JNK-1, p53 or c-myc (Garrido 
et. al., 2001). 
1.5.4 Hsp70 in the lung. 
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Hsp70 has been studied extensively in lung inflammation. Hsp70 has been found 
increased in the lung epithelium in response to hyperoxia (Wong et. al., 1998), heavy 
metals (Timblin et. al., 1998; Gaubin et. al., 2000), asbestos (Timblin et. al., 1998), 
hydrogen peroxide (Timblin et. al., 1998) and cytokines (TNFa) (Ayad et al., 
1998). Hsp70 is induced by hyperoxia which can produce the generation of oxygen 
radicals such as superoxide (02'), hydrogen peroxide (H202) and the hydroxyl radical 
(*OH). These free radicals can cause cellular injury which can lead to mitochondrial. 
damage, ATP depletion, oxidation of membrane lipids and intracellular proteins and 
DNA damage (Wispe and Roberts, 1987). A study was carried out which investigated 
the effect of hyperoxia on A549 cells transfected with human Hsp70 cDNA. This 
showed that the cells with higher levels of Hsp70 had greater survival rates than 
untransfected A549 cells suggesting Hsp70 expression was protective (Wong et. al., 
1998). Rat lung epithelial cells were used to examine the effects of environmental 
agents which are known to cause oxidative injury (Timblin et. al., 1998). This study 
found that Hsp72/73 was not increased greatly by asbestos or H202, but was highly 
increased in response to cadmium. Another study, using cadmium found that in A549 
cells Hsp70 was produced in response to oxidative stress within the cell, as a result of 
the formation of active oxygen species and inhibition of peroxide detoxification 
(Gaubin et. al., 2000). Hsp70 is also known to inhibit the inflammatory response 
during lung injury. In A549 cells Hsp70 was found to inhibit the production of the 
chemokine RANTES (Ayad et. al., 1998). It was found that RANTES expression and 
secretion was dependent on NFKB activation and that Hsp70 prevented NFKB nuclear 
translocation by preventing phosphorylation of its inhibitor protein, IkB. It has since 
been found that Hsp70 prevents the activation of IrB kinase (Yoo et. al., 2000). 
1.6.0 Nuclear factor 1cB (NFYB) and its inhibitor (IKB). 
The transcription factor NFKB plays an important role in the inducible expression of 
many cellular genes particularly those involved in the immune system and 
inflammation. Activated NFKB can lead to the rapid induction of genes encoding 
defence or signalling proteins suggesting that NFicB has specialised during evolution 
as an immediate early mediator of immune and inflammatory responses. Human 
NFKB is composed of homo- or heterodimers of proteins belonging to the Rel family. 
In unstimulated cells NFKB is found in the cytoplasm in an inactive complex with its 
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inhibitor ficB. IicB is a term for a family of proteins which have the ability to interact 
with NFKB and prevent its activation thus keeping NFKB in the cell cytoplasm. 
1.6.1 Rel protein family 
The Rel protein family all share a very conserved region, the Rel homology domain, 
which contains sequences for the dimerisation, nuclear localisation and DNA binding 
of NFKB. The members of the Rel family include p5O, p52, p65/RelA, c-Rel, and 
RelB. The Rel proteins comprise two groups classified on their structure, function and 
mode of synthesis. Group I Rel proteins include p50 and p52 which are synthesised 
as precursor proteins of 105 (p 105) and I 00kDa (p 100) respectively. Group I mature 
proteins are characterised by the presence of the Rel homology domain which 
includes a DNA binding domain and nuclear localisation signal (NLS). Group 2 Rel 
proteins comprises p65, Rel or c-Rel , RelB. Group 2 mature proteins possess the Rel 
homology domain as well as one or more transcriptional activator domains (Sen and 
Packer, 1996). Dimerisation is functionally important since it allows DNA binding 
and then activation for transcription (Bauerele and Henkel, 1994). The differences 
between functions of the two groups of Rel proteins arise in the N-terminal DNA- 
binding domains where a sequence motif R(F/G)(R/K) YXCE determines the binding 
ability (Tolenado et. aL, 1993). Commonly the p5O-p65 dimer is known as NFKB. 
1.6.2 IicB protein family 
In unstimulated cells, NFKB DNA binding activity is not detectable in nuclear, 
cytosolic or membrane fractions. This is due to the factors known as inhibitors of 
NFKB (IKB). In mammalian cells the most common members of this family are 
IKB(x and IKBP. IKB functions by binding to NFKB masking the NLS and DNA 
binding activity of NFKB (Beg et. al., 1992). IKBa is composed of a central, 
protease-resistant domain containing five ankarin repeats and flanked by a surface 
exposed N-terminal extension and connected to the core by a flexible flanker (Jaffray 
et. al., 1995). IKBP is similar to IKBcc but has a larger molecular size and is thought to 
be the product of a different gene. The main differences between IKBa and IKBP are 
that IKB(x is specific for NFKB (p65, Ito et. al., 1995) while IKBP can also inhibit the 
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DNA binding of c-Rel. Another difference is that in vitro phosphatase treatment 
interfered with the inhibitory activity of IKBP but not IKBcc (reviewed by Grimm and 
Bacuerele, 1993). 
Upon cell stimulation IKB(x is phosphorlyatcd and degraded allowing active NFrB to 
translocate to the nucleus (Henkel et. al., 1993). Levels of IrB are found to increase 
due partly to an increase in mRNA transcription through the interaction of NFKB with 
NFKB-binding sites in the IKB promoter (Le Bail et. al., 1993; Sun el. al., 1993; 
Malck et. al., 1998). IrB has also been found in the nucleus as well as the cell 
cytoplasm. This is due to the accumulation of newly synthesised IrB localising to the 
nucleus to bind to the NFKB complexes. At this time a progressive reduction of both 
NFKB-DNA binding and NFKB-dependent transcription are found in the nucleus 
(Arenzana-Seisdedos et. al., 1995; Chiao et. al., 1994). It was then found that this was 
due to IKB binding with NFKB and exporting it out of the nucleus by use of nuclear 
export signal located in C-terminal domain Of IKB (Arenzana-Seisdedos et. al., 1997). 
1.6.3 Activation of NFicB. 
Activation of NFKB occurs in response to a wide range of stimuli including LPS, 
viruses, cytokines, physical and oxidative stress (reviewed by Wang et. aL, 2002). 
Activation of NFKB leads to the transcription of genes encoding cytokines, cell 
surface receptors, and acute phase proteins as well as transcription factors including 
IKB) p50 precursor and c-Rel. The signals that lead to modification of IKB(x 
presumably involve the generation of intracellular reactive oxygen species (ROS) 
(Schreck et. aL, 1991; Baeurele and Henkel, 1994). The main ROS involved are likely 
to be hydrogen peroxide and its derivatives (Reviewed by Sen and Packer, 1996). 
Antioxidants have been shown to inhibit the activation of NFKB confirming the 
involvement in the activation process (Reviewed by Sen and Packer, 1996). 
1.6.4 Role of activated NFKB in disease. 
As mentioned previously activation of NFKB can lead to the transcription of various 
cytokines. In particular NFKB activation is associated with increased production of 
the pro-inflammatory cytokines ILl, IL8, IL6, TNF(x and IFN-y. Over-activation of 
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NFKB can lead to the progression of inflammatory diseases such as rheumatoid 
arthritis, inflammatory bowel diseases, multiple sclerosis, psoriasis and asthma 
(reviewed by Hanada and Yoshmuri, 2002; Li and Verma, 2002). NFKB has also a 
role in the development of adaptive immunity by regulating lymphocyte development 
through effects on proliferation, protection from TNF-induced apoptosis and 
expression of anti-apoptotic genes (Li and Ven-na, 2002). NFKB has another effect on 
immunity through the rapid induction of acute phase proteins in response to microbial 
pathogens. 
1.6.4 NFicB activation in lung inflammation 
ROS have been implicated in the pathogenesis of a wide variety of lung diseases. It 
has been suggested that ROS may act as signal transduction messengers, inducing 
new gene expression in response to injury (Schreck et. al., 1991). The body is 
continually exposed to oxidants produced endogenously by metabolic reactions or 
exogenously by air pollutants, cigarette smoke and in the diet. NF1cB can also be 
activated by pro-inflammatory cytokines, bacterial and viral products in the lung 
(Reviewed by Fan et. al., 2001; Christman et. al., 2000). NFkB has been shown to be 
involved in the progression of lung inflammation associated with particulate air 
pollution. Several reports have indicated that various air pollution particles can induce 
the activation of NFKB which then lead to the production of pro-inflammatory 
cytokines such as IL6 and IL8. These studies have identified that NFKB activation 
was mediated by the generation of free-radicals by transition metals on the particle 
surface (Quay et. al., 1998; Kennedy et. al., 1998; Jiminez et. al., 2000; Shukla et. al., 
2000). One study (Jiminez et. al., 2000) identified NFKB activation in response to 
PM1 0 treatment occurred by a transition metal-mediated mechanism in the absence of 
IKB degradation. In these studies it was determined that ROS were responsible for 
NFKB activation by using antioxidant treatments which mop-up the ROS and prevent 
NFicB activation. Inhibition of NFkB activation can also occur during lung 
inflammation. One study showed that overexpression of IicBa in A549 cells 
prevented the nuclear translocation of NFicB (Park et. al., 2001). During lung 
inflammation neutrophils secrete a protein known as secretory leucocyte protease 
inhibitor (SLPI). This protein was also found to be expressed by pulmonary vascular 
epithelial cells during lung inflammation. SLPI was found to reduce the levels of 
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NFKB activation during the inflammatory process; this reduction was the result of 
increased IKB within the cell (Lentsch et. A, 1999). 
1.6.0 Particulate air pollution. 
Elevated levels of air pollution have been associated with adverse health effects for a 
long time. In London in 1952, smog covered the city for several days and led to an 
excess of 4000 deaths due to the high concentration of air pollution. Today particulate 
air pollution is still associated with increases in morbidity and mortality from 
respiratory and cardiovascular diseases (Pope et. al., 1992; Schwartz and Dockery, 
1992; Dockery et. al., 1993; Schwartz and Morris, 1995). The concentrations of 
particulate air pollution today are much lower in the UK than in the 1950s resulting 
from changes in the source of particles. During the 1950s the main source of air 
pollution particles was from coal burning which is not present now in UK cities, 
whereas the majority of particles today are generated from vehicle exhaust emissions. 
Particulate air pollution is also associated with asthma exacerbations, increased 
respiratory symptoms, decreased lung function and increased hospital admissions 
(discussed by Wilson and Spengler, 1996). 
Particulate air pollution is derived from many sources including industrial processes 
and vehicle exhausts. Particulate air pollution can be classified by its size in microns 
e. g. PM10 or PM2.5 etc., or by composition or source e. g. ROFA (residual oil fly 
ash), DEP (diesel exhaust particles) or mineral dusts. These particles can be collected 
on filters for chemical analysis and biological effects. Air pollution particles are a 
complex mixture of different components including aggregates of organic and 
elemental carbon, metals, sulphates, nitrates, course wind blown material, pollen and 
microbial contaminants. PMIO is composed of airborne particles which are less than 
or equal to 10 microns in size. The particles in a PM10 sample can also be sub- 
categorised by size into ultrafine, fine and course particles. The ultrafine particles 
have a mean aerodynamic diameter of 0.1 microns or less, and typically arise from 
combustion sources such as diesel engines. The fine particles have a diameter of 2.5 
microns or less and can arise from aggregation of ultrafine particles or can be 
produced by the combustion of fossil fuels. The course particles have a diameter 
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between 2.5 and 10 microns and arise from natural sources such as course wind blown 
material and pollen (Harrison et. A, 1997). The different components of PM10 result 
in differences in the composition of PM10 samples depending on the source e. g. rural 
PMIO samples will contain mainly biological particles whereas urban PMIO will 
contain mainly combustion derived particles. Many studies have found that 
particulates can cause not only localised inflammation but also systemic effects which 
may lead to the morbidity and mortality associated with episodes of air pollution. 
1.6.1 Effect of air pollution particles on the lung. 
Inhaled air pollution particles can be deposited in different areas of the lung 
depending on the size of the particle. Larger particles can be deposited in the mucous 
of the upper airways and are cleared by the ciliated epithelial cells. Smaller particles 
in the ultrafine range (diameter less than 100nm) can enter the alveoli of the lung 
where they are likely to undergo phagocytosis by AM. After phagocytosis the AM 
leave the lung on the mucocilliary escalator. However there tends to be very high 
numbers of these ultrafine particles and this process is not always efficient in 
removing them from the lung and this can lead to macrophage damage, known as 
particle overload (reviewed by Oberdorster, 1995). This leads to the presence of high 
numbers of ultrafine particles in the lung where they can cause damage and 
inflammation at sub-overload doses (Ferin et. al., 1992; Peters et. al., 1997). 
1.6.2 Particle induced inflammation 
Many studies have focused on the inflammatory potential of air pollution particles. 
Particles from many sources have been shown to induce the production of cytokines 
in human and rat lung cells. Several studies have shown that instillation of air 
pollution particles induces lung inflammation, one of these was carried out on the 
effects of PM10 from Utah valley, USA on human non-smoking volunteers (Ghio et. 
al., 2000; Ghio and Devlin, 2001) and another using a rat model was on the effects of 
PMIO from sites around the UK (Lightbody et. al., 2002). 
Other studies have been carried out on cellular models of inflammation. Several 
studies have identified the effect of particulate air pollution on macroPhagc and 
monocyte cells. These studies have found that these cells produced pro-inflammatory 
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cytokines and reactive oxygen species in response to particle treatments (Monn and 
Becker, 1999; Dorger and Krombach, 2000; Becker et. al., 1996; Schins et. al., 2002). 
One study showed that PM10 exposed macrophages could stimulate a pro- 
inflammatory response in lung epithelial cells via the production of TNFa (Jimenez 
et. al., 2002). 
Studies on the effects of particulate matter on epithelial cells have also been carried 
out. Cytokine production has been demonstrated with particulate matter treatment of 
human bronchial and alveolar epithelial cells (Fujii et. aL, 2001; Veronesi, et. aL, 
1999; Schins et. aL, 2002). Another study using human bronchial epithelial cells 
found that the cytokine production in response to ROFA particle treatment was metal 
dependent (Carteret. aL, 1997). 
1.6.3 Effect of particle derived oxidants on lung inflammation 
Oxidative stress has been shown to be involved in the pathogenesis of air pollution 
particles in the lung. This occurs when there is an imbalance between oxidising 
agents (ROS, NOS) and antioxidants. Production of oxidant species has been 
attributed to reactions on the surface of ultrafine particles with transition metals and 
surface radicals (reviewed by Donaldson, et. al., 1998; Donaldson and MacNee, 1998; 
Dorger and Krombach, 2000). Free radicals in the lung can also be produced by 
activated macrophages, auto-oxidation of small molecules, enzyme activity, 
mitochondrial electron transport and other intracellular mechanisms. 
Several studies have looked at the toxicity of particles with respect to free radical 
production. One study on the generation of free-radicals by PM2.5 (combustion 
derived particles) found that stable radicals were found on the particle surface but in a 
biological system redox cycling occurred resulting in the production of the DNA - 
damaging hydroxyl radical (Dellinger et. aL, 2001). Another study looked at the free- 
radical activity of PM10 in vivo and in vitro and found that lung and epithelial injury 
was the result of hydroxyl activity (Li et. aL, 1996). A study by Stone et. aL (1998) 
looked at the effect of carbon particles and their ability to produce free radicals and it 
was found that the ultrafine carbon particles produced greater oxidative stress than 
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larger carbon particles and once again the hydroxyl radical was generated by redox 
cycling. 
During oxidative stress there is an imbalance between oxidative and anti-oxidative 
agents. Several studies have looked at the effect of antioxidants in lung lining fluid on 
the particle induced oxidation. One of these studies looked at the oxidative 
interactions of synthetic epithelial lining fluid with ROFA and found that this particle 
could initiate oxidation of the lining fluid (Sun et. aL, 2001). Another study using 
synthetic lining fluid found that the antioxidants present in the fluid were able to 
reduce the effects of oxidative damage induced by PM10 and PM2.5 (Greenwell et. 
aL, 2002). 
1.7.0. Systemic effects of particulate inhalation. 
Particulate air pollution has been associated with systemic effects as well as localised 
inflammation. This is a result of the thin blood-gas barrier (less than 0.5 microns) in 
the lung to allow efficient gas exchange. The alveolar wall has a dense network of 
capillaries which are in close proximity to the alveolar epithelium (West, 1985). This 
allows the efficient movement of gas, and during inflammation the epithelium can 
have increased permeability allowing movement of proteins between the circulation 
and the lung. Systemic effects associated with inhaled particles include an increased 
incidence of cardiovascular diseases. It is believed that cytokines are responsible for 
the systemic response to inhaled particles (van Eeden et. A, 2001). Instillation of 
particles into the lung has been shown to cause increases in the number of circulation 
leukocytes arising from bone marrow stimulation (Mukae et. A, 2001). Increases in 
the number of circulating neutrophils and platelets were also found in response to 
inhalation of diesel exhaust particles (Salvi et. A, 1999). Other effects on the 
cardiovascular system associated with inhaled particles can include changes in heart 
rate variability and the autonomic nervous system (Utell et. A, 2002; Holguin et. A, 
2003). 
Increases in circulating inflammatory proteins are also found in response to inhalation 
of particulate matter. Several studies have found increases in the plasma level of 
fibrinogen, one in humans exposed to PMIO (Pekkanen et. al., 2000) and another in 
rats exposed to ROFA (Gardner, et. al., 2000). However one study (Seaton et. al., 
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1999) found that there was a decrease in fibrinogen levels in the blood associated with 
PM10 inhalation but there was an increase in the level of CRP. Increase in plasma 
CRP has also been associated with an acute phase reaction in response to particulate 
air pollution (Peters et. A, 2001). 
1.7.1 Epidemiological studies on effects of air pollution. 
Many epidemiological studies have been carried out on the effects of air pollution. 
Increases in air pollution levels have been associated with increased hospital 
admissions and mortality due to respiratory conditions (Fusco el. al., 2001). Even at 
very low levels of PM10 respiratory health has been shown to be decreased (reviewed 
by Brunekreef et. al., 1995). Many studies have found that exposure to air pollution 
can lead not only to respiratory disease but also cardiovascular disease. The level of 
risk for cardiovascular disease varies depending on the study carried out. One study 
found that air pollution increased the number of hospital admissions for 
cardiovascular admissions (Schwartz, 1999), while another found that air pollution 
increased mortality due to cardiovascular causes (Dockery et. al., 1993) in various 
areas in the USA. In Dublin it was found that a ban on coal burning reduced the levels 
of death due to respiratory causes by 15.5% and cardiovascular causes by 10.3% 
(Clancy et. al., 2002). The cardiovascular disease responsible for mortality or hospital 
admission in most of these studies is not determined. However the incidence of 
atherosclerosis (Suwa et. al., 2002) and myocardial ischernia (Pekarmen et. al., 2002) 
has been found to be increased by particulate air pollution. Many reviews also exist 
on the morbidity and mortality associated with particulate air pollution (Pope et. al., 
1995; Pope and Dockery, 1999; Hoek et. al., 2002; Brunekrecef and Holgate, 2002). 
1.7.2 Cardiovascular disease and particulate matter. 
It has been suggested that the systemic response to inhalation of particulate matter is 
responsible for the increase in cardiovascular disease. As discussed earlier the 
systemic effects are associated with increases in the levels of circulating proteins such 
as cytokines, CRP and fibrinogen. It has been suggested that the oxidative stress in the 
lung may also be able to reach the blood and have an effect on the systemic response 
(Donaldson et. aL, 2000). Several reviews exist which discuss the effect of exposure 
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to particulate air pollution on cardiovascular disease (Costa, 2000; Donaldson et. aL, 
2001; Donaldson and MacNee, 2001). 
1.8.0 Role of pro-inflammatory proteins in cardiovascular disease. 
Cardiovascular disease has been associated with systemic effects resulting from 
particle induced lung inflammation. The APR and oxidative stress have been 
implicated in the progression of cardiovascular disease. Therefore the effects of CRP, 
fibrinogen and Hsp70 on cardiovascular diseases will be discussed. 
1.8.1 CRP and cardiovascular disease 
A high level of expression of CRP in plasma has been found to be associated with an 
increased risk of heart disease, particularly atherosclerosis. This is due to heart and 
blood vessel inflammation in the damaged tissue. CRP has been found localised 
around altherosclerotic vessels and infarcted myocardium (Lagrand et. al., 1997). 
CRP binds to any damaged cells within the cardiovascular system. Monocytes can 
infiltrate the arterial wall at site of CRP deposition. The monocytes then differentiate 
into macrophages and, along with accumulation of lipids, foam cells are generated 
(Zwaka et. al., 2001). Further recruitment of inflammatory cells and cell proliferation 
leads to the development of altherosclerotic plaques. The level of CRP present in the 
plasma is thought to reflect the extent of inflammation in atherosclerosis and is also 
associated with increased risk of myocardial infarction and stroke (Ridker et. al., 
1998; Harris et. al., 1999; Cleland et. al., 2000; Danesh et. al., 2000; Blake and 
Ridker, 2001; Ferranti et. al., 2002, ). However several reports show that CRP only 
indicates the presence of cardiovascular disease and is unreliable as a marker of extent 
or severity (Azar et. al., 2000; Hunt et. al., 2000). IL6 and TNF (x play a central role 
in the amplification of the inflammatory cascade (Blake and Ridker, 2001) involved 
in atherosclerotic development and may induce further production of CRP. 
1.8.2 Fibrinogen and cardiovascular disease. 
Fibrinogen and many other clotting factors are associated with increased frequency of 
coronary heart disease (reviewed by Tracy, 1999). Increased levels of fibrinogen are 
associated with traditional cardiovascular risk factors such as age, diet and smoking. 
Fibrinogen can bind to the arterial wall and bind low density lipoproteins and this can 
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lead to atherogenesis. Raised levels of fibrinogen can increase the viscosity of the 
blood which results in reduced blood flow and increased platelet aggregation which 
are associated with atherogenesis, thrombogenesis and ischemia (reviewed by 
Montalescot et. al., 1998). These findings indicate that fibrinogen itself is a predictive 
marker of cardiovascular disease. 
1.8.3 Hsp70 in cardiovascular disease. 
Several heat shock proteins have been associated with increased incidence of 
cardiovascular diseases. Both Hsp70 and Hsp60 have been associated with increases 
in myocardial ischernia and atherosclerosis. Myocardial ischernia can induce a stress 
response with results in the production of Hsp70. Hsp70 has also been found 
increased in atrial tissue of patients with unstable angina (Yellon and Marber, 1994). 
It has been found that coronary artery bypass grafting can induce a rapid release of 
Hsp70 into the circulation followed by modulation of monocyte TLR2 and TLR4 
which then leads to an inflammatory response (Dybdahl et. A, 2002). During 
ischernia and reperfusion there is the generation of free radicals, hydrogen peroxide 
and cellular calcium overload in myocytes (Yellon and Marber, 1994) which is likely 
to induce the production of Hsp70. Hsp70 can also be produced by various tissues 
during inflammation and may contribute to high levels of Hsp70 in the circulation 
with a potential effect on cardiovascular disease. 
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Chapter 2 
Materials and Methods 
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2.0.0 Materials 
All reagents used were purchased from Sigma Aldrich Chemicals, London unless 
otherwise stated. Phosphate buffer saline solution (PBS) (1 tablet to 200ml dH20), 
acetone, 5% sheep serum from Scottish Antibody Production Unit (SAPU) in PBS. 
Primary antibodies in ascites fluid were used in these experiments : mouse anti-human 
fibrinogen, mouse anti-phycoerythrin (2M), mouse anti-human CD44, mouse anti- 
human C-reactive protein (CRP), and mouse anti-NF-KB (subunit p65) (Santa Cruz) 
(all diluted in sheep or donkey serum). Polyclonal antibodies: sheep anti-human 
Hsp70 (1/200 in 5% donkey serum), and rabbit anti-human IKB (both Santa-Cruz, and 
diluted 1/200 in 5% sheep serum). Secondary antibodies: biotinylated anti-mouse Ig, 
anti-rabbit Ig, anti sheep/goat Ig, anti-mouse Ig FITC and anti sheep- FITC 
conjugated antibody (diluted 1/100 in serum). The F1TC antibody is F(ab')2 AMIg- 
FITC. 
2.1.0 Cells and cell culture 
A549 cells (ECACC cell no. 86012804) are adherent carcinoma cells and were 
cultured in sterile RPMI-1640 medium supplemented with 10% heat inactivated foetal 
calf serum, penicillin (50gg/ml), streptomycin (50[tg/ml) and L-glutamate (2mM) 
(Gibco). The cells were kept at 37'C and in a 5% C02 concentration in humid 
conditions. Cell culture density was controlled by subculture (1/10) when confluence 
was reached. 
Before being used in any experiment the A549 cells were recovered from the tissue 
culture flask by addition of 1% trypsin- EDTA (Gibco) for 10 minutes to break 
adherence of the cells to the flask. The cells were washed twice in sterile medium. 
This was achieved by centrifuging at 500 xg for two minutes followed by removal of 
supernatant and re-suspension in RPMI-FCS. After completion of washing steps the 
cells were counted and assessed for viability using nigrosin dye and a Neubauer 
counting chamber. Adjustments were made to the cell suspension to produce a 
suspension of 2xI 05 cells/ml. 
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2.2.0 Cell treatments 
2.2.1 Cytokine treatment 
Cells grown at a density of 106 cells/ml were treated with Iml sterile medium 
containing cytokines which was added to each well in a 24 well plate, for 
immunofluoresence or in 25 cm 3 flasks for cell lysate preparation. Untreated controls 
were incubated with fresh medium. Cells were incubated at 370C (5% C02) overnight. 
Medium was removed and cells washed with PBS. 
2.2.2 Carbon black (CB) or ultrafine carbon black (ufCB) treatment 
Particle suspensions were prepared by addition of 1 ml culture medium to 5mg 
particles, and this solution was sonicated for 10 minutes prior to dilution, to 
100ýtg/ml, and addition to cells. Cells were treated for 0, ! /2,1,2,3,6, or 18 hours in 
conditions as for cytokine treatment. The fine carbon black used was of 320run 
diameter (Huber 900, H Haeffner, Chepstow, UK) and ultrafine carbon black l4nm 
diameter (Printex 90, Degussa, Germany). 
2.2.3 Metal salt treatment 
A solution of 100[tM FeC13 was prepared directly into culture medium and cells were 
treated for 0, V2,3,6 or 18 hrs. These time points were used to investigate the effects 
on fibrinogen, CRP, and Hsp70 expression. To investigate the effects of FeC13 on 
NFKB and IKB expression the time points 0,1/4, Y2,1,2, and 4 were used. 
2.2.4 PM10 treatment 
PM10 TEOM filters were place in Iml culture medium and sonicated for 10 minutes 
to remove particles from the filter. Turbidity assay of the resulting particle suspension 
was then carried out using known concentrations of CB. This allowed the 
determination of PMIO concentration removed from the filter. The PMIO suspension 
was then diluted to 80 [tg/ml before cell treatment. Cells were treated for 0, ! /2,3,6, 
18 hrs. 
2.2.5 Brefeldin A treatment. 
Brefeldin A was used to treat cells at a final concentration of 10ýtg/ml. This was 
prepared directly into cell culture medium and used to treat cells for 6 hours. 
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2.2.6 t-butyrl hydrogen peroxide (tBHP) treatment. 
Cells were treated with 5mM tHBP added directly into culture medium for 0, ! /2, and 6 
hours. 
2.2.7 Transcription factor inhibitor treatments. 
Cells were treated with 50ýtg/ml sn50 (Calbiochem), a peptide inhibitor of NFKB 
nuclear translocation. Sn50 was diluted directly into culture medium and treated 
simultaneously with ufCB. Cells were also treated with 50 ýLM Ag490 (Calbiochem) 
an inhibitor of the JAK/STAT transcription complex. Ag490 was diluted in DMSO 
prior to further dilution to working concentration in culture medium. Ag490 was used 
to treat cells 12 hours prior to ufCB treatment. 
2.2.8 Antioxidant treatments. 
Cells were treated with 200ýM Nacystelin (NAL) which was diluted directly into 
culture medium prior to treatment simultaneously with ufCB. Cells were also treated 
with 25ýM Trolox (Fluka) which was initially dissolved in DMSO prior to dilution in 
culture medium prior to treatment simultaneously with ufCB. 
2.2.9 Conditioned medium treatments. 
A549 conditioned medium was prepared by treating A549 cells overnight with ufCB. 
Medium was removed and particles were centrifuged out and the supernatant was 
used to treat MM6 cells. CRP-conditioned medium was prepared by diluting 
recombinant human CRP in culture medium to a final concentration of 4 ýLg/nil. 
Fibrinogen-conditioned medium was prepared by diluting recombinant human 
fibrinogen in culture medium to a final concentration of 2 ýtg/ml. 
2.3.0 Diff-Ouick stainin. 
A549 cells were gown in 24 well culture plates in which they were also treated. Cell 
culture medium was removed and cells washed in ice cold PBS. Cells were then 
stained using Diff-Quick staining kit. Cells were washed in distilled water and left to 
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dry. Cells were photographed in wells using a Zeiss inverted microscope and Sony 
digital camera. 
2.4.0 Immunofluoresent stainin2 
10mm. glass cover slips (Raymond Lamb) sterilised by immersion in 70% IMS were 
added to 24 well plates. The cell suspension was added to give 105 cells/well on the 
plate. Cells were left to incubate at 37*C (5% COD overnight to allow cells to adhere 
to cover slips. The next day the medium was removed and Iml of fresh medium 
containing treatment was added to each well in the 24 well plate while untreated 
controls were incubated with Iml of fresh medium. Cells were incubated at 37'C (5% 
COD overnight. Medium was removed and cells washed with PBS. 
2.4.1 Slide preparation and antibody staining. 
Cold acetone was added to each well to fix cells to the coverslip for 10 minutes on 
ice. Cells were then washed three times with PBS. Cells were blocked with 5% 
sheep serum (or 5% BSA for Hsp70) in PBS for 45 minutes at room temperature to 
prevent non-specific binding. Cells were then washed three times with PBS. Parafilm 
was stretched over an empty 24 well plate and 50gl of 5% sheep serum was added to 
the first wells of treated and untreated rows on the plate. Each well thereafter had 
50pl of primary antibody dispensed to appropriate wells (to correspond with original 
plate). Negative controls of 5% sheep serum and anti-2A4 antibody were set up to 
assess non-specific or irrelevant binding (2A4 binds to proteins found in red algae, 
which are not present in human cells). The positive control was set up to show the 
optimum fluorescence and reproducibility of the experiment. The positive control 
used was an antibody to CD44, the cell surface glycoprotein found on all human cells. 
Coverslips were then inverted onto antibody solutions and left to incubate in a humid 
chamber for 30 minutes at room temperature. Cover slips were retuned to 24 well 
plate and washed three times with PBS. Cells were incubated with secondary 
antibody, for 30 minutes in darkness, in a humid chamber. Three washes with PBS 
were carried out and coverslips mounted with Citifluor glycerol-PBS solution and 
examined using a UV microscope. Magnification of all images is X400 unless 
specified otherwise. 
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2.4.2 Analysis of photographs 
Photographs of cells were analysed using Metamorph software. The intensities of 100 
individual cells for each treatment were recorded and the mean intensity was 
calculated shown by Anderson (2003). 
2.4.3 Propidiurn iodide staining 
After cell treatment coverslips which were not acetone fixed were stained for 
immunofluoresence (2.4.1). Cells were then also stained using 10[tg/ml propidium 
iodide for 20 seconds. After the cells were washed as before the coverslips were 
mounted and viewed using LTV microscope. The percentage of cells which showed 
propidium iodide staining was then calculated. 
2.5.0 Cell saMDle Drenaration 
2.5.1 Lysate preparation 
A549 cells were seeded at a density of 2x 106 cells/ml in 25 CM2 culture flasks to 
allow adherence. The cells were then treated with 10 ng/ml cytokines for 18 hrs. The 
medium (supernatant) was then removed, aliquoted and stored at -80'C. The cells 
were then removed using trypsin, washed firstly in fresh medium and then twice in ice 
cold PBS. The resulting pellet of cells was solubilised in 200ul 0.5% PBS-NP40 
containing complete protease inhibitors (Roche) and incubated on ice for 30 minutes 
to allow lysis of the cells. The resulting lysate was centrifuged at 13,000 g for 20 
minutes at 4'C. The supernatant was then aliquoted and stored at -80'C. 
2.5.2 Protein concentration determination and equalisation 
Before sample preparation the protein concentration of the lysates was determined. 
This was achieved using the Bioinchonic acid (BCA) protein determination method 
using BCA and copper II sulphate and the absorbance was read at 550nm (Dynex 
sample reader). Bovine serum albumin was used as the standard to determine the 
protein concentration. 
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2.6.0 Fibrino2en / CRP ELISA 
Polyclonal anti-fibrinogen or anti-CRP (Sigma/Universal Biologicals, 1/100 in PBS) 
was added to wells of 96 well plate (Costar, high binding plate) and left overnight at 
5'C. Antibody was removed and the plate washed in PBS. Samples and standards 
were added to wells in triplicate and incubated at room temperature for 2 hours. The 
samples were removed and the plate washed in PBS-Tween (0.05%). Monoclonal 
anti-fibrinogen or anti-CRP was added to the wells and left for I hour at room 
temperature. Plate was washed in PBS-Tween before addition of biotinylated anti- 
mouse Ig to wells before incubation for a further hour at room temperature. The plate 
was washed again in PBS-Tween before addition of streptavidin-BRP and incubation 
for I hour. After further washing in PBS-Tween, substrate was added (R &D 
systems) and incubated in the dark for 15 mins. The reaction was stopped by addition 
of 1M sulphuric acid. The plate was read at 550nm in a Dynex sample reader. 
2.7.0 Western Blot - to detect HsD70. NF-icB or IicB 
2.7.1 Sodium dodecylsulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
Cell lysate and supernatant samples were run on a 10% acrylamide gel in Hoefer 
minigel equipment (Hoefer Scientific Instruments) using the Laemelli (1970) method. 
All buffers and gels were prepared as per manufacturer's instructions. The samples 
were run under reducing conditions by adding dithiothreitol (DTT) to give a final 
concentration of O. lM. Coloured and biotinylated (Biorad) standards were run as 
molecular weight markers. Gels were electrophoresed at 40mA for 45 minutes. 
2.7.2 Transfer of protein to nitrocellulose membrane 
Proteins separated by SDS-PAGE were transferred to a nitrocellulose membrane 
(Protran, SLS) prior to detection by antibody staining using the Towbin (1979) 
method. All transfer equipment was equilibrated in transfer buffer for 10 minutes. 
Transfer was then carried out using Biorad equipment as per manufacturer's 
instructions at IOOV for I hour. Resulting nitrocellulose blots were soaked in PBS- 
Marvel (5%)-Tween (0.1%)-NP40 (0.2%) overnight to block non-specific antibody 
binding sites. 
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2.7.3 Antibody detection of protein. 
Proteins were visualised on the nitrocellulose blots using sheep anti-human Hsp70, 
mouse anti-human NF-KB, or rabbit anti-human IKB diluted 1/200 in blocking buffer, 
biotinylated secondary antibody and streptavidin-HRP (both Amersham-Pharmacia, 
diluted 11500). Blots were then incubated with ECL Western Blotting detection 
substrate for 1 minute and exposed to radiographic film (Amersham-Phannacia). The 
film was developed using AGFA hand developing solutions. 
2.8.0 C-vtokine ELISAs. 
2.8.1 Interleukin-6 ELISA 
Interleukin-6 ELISA was carried out using a Biosource kit. The manufacturer's 
instructions were followed. ELISA was carried out by incubation of capture antibody 
in 96 well plate (Costar) overnight. The plate was then blocked in BSA for 2 hours 
prior to washing (0.01% PBS-Tween) and incubation of samples and detection 
antibody simultaneously. The plate was then washed and incubated with streptavidin- 
HRP. The enzyme substrate (R+D systems) was added to achieve colour change 
before addition of stop solution (IM H2SO4). The plate was read at 550nm in Dynex 
plate reader 
2.8.2 Interleukin-8 ELISA 
Interleukin-8 ELISA was carried out using a Cytoset kit. The manufacturer's 
instructions were carried out. The capture antibody was incubated overnight in 96 
well plate (Costar). The plate was blocked with BSA (1%) prior to washing (0.01% 
PBS-Tween) and addition of samples. The plate was washed and detection antibody 
was added. The plate was washed again and streptavidin-HRP was added and plate 
incubated in the dark. The plate was washed and enzyme substrate (R+D systems) 
was added to achieve colour change before addition of stop solution (IM H2SO4). The 
plate was read at 550nm in Dynex plate reader 
2.8.3 Tumour necrosis factor cc ELISA 
TNF(x ELISA was carried out using a Biosource kit. The manufacturer's instructions 
were carried out. The capture antibody was incubated overnight in 96 well plate 
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(Costar). The plate was blocked with BSA (1%) prior to washing (0.01% PBS-Tween) 
and addition of samples. The plate was washed and detection antibody was added. 
The plate was washed again and streptavidin-HRP was added and plate incubated in 
the dark. The plate was washed and enzyme substrate (R+D systems) was added to 
achieve colour change before addition of stop solution (lM H2SO4). The plate was 
read at 550nm in Dynex plate reader. 
2.9.0 Reverse TranscriDtase -Dolvmerase chain reaction (RT-PCR). 
2.9.1 Cell treatments. 
Cells were seeded at a density of 106 cell/ml and treated for 90 minutes in a 24 well 
plate. Medium was removed and cells washed in ice cold PBS before 300ýtl tri- 
reagent was added. Cells were then added to RNA free Eppendorf tubes and then 
either RNA extraction was carried out or samples were stored at -80'C until extraction 
at a later date. 
2.9.2 RNA extraction. 
If samples were frozen they were defrosted and left for 10 minutes. To cell/tri-reagent 
mixture 200 ýtl chloroform was added before vortexing and samples were left to stand 
for 10 minutes. Samples were centrifuged at 15,000g for 15 minutes at 4'C. The 
resulting upper phase was transferred to a fresh RNA free tube and 450ýLl isopropanol 
was added before centrifugation at 15,000g for 10 minutes. The supernatant was then 
removed and discarded and 50ýLl 70% ethanol was added to the remaining pellet prior 
to centrifugation at 75OOg for 5 minutes. The supernatant was removed and the pellet 
left to dry for 1 minute before the addition of 50 [tl nuclease free-water. 
2.9.3 RNA quantification. 
The amount of RNA in the samples was than quantified using absorbance readings at 
260nm. The absorbance reading of the RNA was then used to calculate the dilution 
required to equalise 10 ýd of RNA. 
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2.9.4 Polymerase chain reaction. 
Reaction mixtures were made up using Access kit (Promega) and primers for CRP 
(forward 5'TCG TAT GCC ACC AAG AGA CAA GAC A- 3', reverse 5'AAC ACT TCG CCT TCG 
ACT TCA TAC T- 3% fibrinogen (forward 5' GGG CAC NIT TGA AGA GGT GT-3', reverse 5' 
GCT ATC CCA GGG TGA TGA GA-3% Hsp70 (forward 5'ATC GAC CTG GGC ACC ACC TA- 
3', reverse 5' CAG CAC CAT GGA CGA GAT CT-3') and housekeeping gene GAPDH 
(forward 5' TCT AGA CGG CAG GTC AGG TCA ACC-3', reverse 5' CCA CCC ATG GCA ATT 
TCC ATG GCA -3') (all MWG Biotech). Samples for fibrinogen, Hsp70 and GAPDH 
were run for 25 cycles, and CRP was run for 35 cycles. 
2.9.5 Agarose gel electrophoresis. 
On completion of PCR reactions 6ýtl of product was added to 40[d BJ/OJ loading dye 
(Promega). A 1.5% agarose gel was prepared in 200 ml Ix TBE buffer (Promega) 
with 5[d ethidium. bromide added. This gel solution was poured into a horizontal 
Biorad GT electrophoresis tank and left to set for 1 hour. Once the gel was set 10ýd of 
sample was added to the gel with 10ýd molecular marker (2[tl DNA marker (Roche), 
2[il BJ/OJ dye and 6ml nuclease free water). The gel was then electrophoresed at 
1 OOV for 90 minutes. PCR products were visualised under UV light using Gene Snap 
software (Syngene). 
2.9.6 Quantification of product. 
Quantification of PCR product bands were carried out using Gene Snap and Gene 
tools software (Syngene). 
2.10.0 ATP Assay. 
2.10.1 Cell extraction. 
Cells were seeded at a density of 1.3 x 105 cells/well in a 24 well plate and treated for 
various time points (0, Y2 ,36 18 
hours). Medium was removed and cells were 
treated with 30ýtl 1% sulphosalycylic acid (SSA) for 5 minutes at room temperature. 
Cells were than removed from the plate and resuspended in the acid solution. Cells 
were centrifuged at 15,000 g for 3 minutes and stored at -80'C. 
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2.10.2 Measurement of samples. 
Reagent buffer was prepared (0.05M Tris, 2mM EDTA, 2mM M902,0.4g/IBSA) and 
2mM dithiothreitol (DTT), luciferase (lmg/ml) and luciferin (1.5mM) were added. 
The buffer was left at room temperature for 2 hours. ATP standards were made up in 
water (0,0.5,1,2.5,5, and I O[tM). In a polypropylene cuvette 200ýd reagent and 20ý11 
sample were mixed and luminescence was recorded immediately over a 30 second 
integral using a BioOrbit 1250 luminometer (Labsystems, UK). 
2.11.0 LDH Assav 
Samples were collected as supernatants from treated cells. Standards were made up of 
NADH in sodium pyruvate (0.75mM) to concentrations of 2000,1530,1040,640, 
280 and 0 U/ml. 60ýtl of each was added in triplicate to wells of 96 well plate. The 
rest of the plate was filled with 50ýd sodium pyruvate and the plate was incubated for 
5 minutes at 370C. 10pl of each sample was added to the plate before further 
incubation at 37'C for 30 minutes. 50pl of 2,4-dinitrophenylhydrazine was added and 
the plate was incubated at room temp for 20 minutes in dark. 50ýtl 4M sodium 
hydroxide was added and the plate was allowed to stand for 5 minutes at room 
temperature. The plate was read at 550 nin in Dynex plate reader. 
2.12.0 Data handling 
2.12.1 Experimental results 
All experiments were repeated three times giving n=3 for statistical analysis. All 
graphs are expressed as mean of all three experiments +/- SEM 
2.12.2 Statistical Analysis 
Normality test of the data was carried out using Kolmogorov-Smirnov test. Statistical 
significance of data was carried out using one way ANOVA and Tukey's multiple 
comparisons. 
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Chapter 3 
Effect of cytokine treatment on acute phase protein (APP) 
expression in lung epithelial cells. 
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3.1.0 Effect of cvtokine treatment on fibrino2en expression. 
3.1.1 Treatment of A549 cells with IL6, TNFa and IFNy. 
The aim of this experiment was to identify if A549 cells could express fibrinogen with 
cytokine treatment. It was expected that there would be expression of fibrinogen 
within these cells as shown by Simpson-Haidaris (1997) and Anderson (2003). 
Immuno fluorescent staining was used to show expression of fibrinogen in the treated 
cells (IOng/mI IL6, TNFa, or IFNy). This technique is used to show the localisation 
and intensity of protein expression within the cells. Photographs taken show that 
fibrinogen is expressed in a sub-population of the untreated cells (Fig la), localised in 
the cytoplasm, and that this can be dramatically increased by IL6 treatment (Figs. lb). 
Cells treated with TNF (x showed little increase in fibrinogen expression when 
compared to the untreated cells (Fig. 1c) which agrees with immuno fluorescence 
carried out previously (Anderson, 2003). 
The photographed cells were analysed using Metamorph software package to indicate 
the intensity of fluorescence in individual cells. One hundred cells from each 
treatment were analysed to indicate the levels of expression (n = 3). These results then 
enabled statistical analysis of any increase or decrease with treatment (Fig 2). The 
intensity analysis shows that there was a significant up-regulation of fibrinogen by 
IL6 (p<0.05). Although this method gives a semi-quantitative result for the 
immunofluorescence results it is limited by the fact that the expression of proteins in 
the cells is not uniform. This results in some under and over-estimation of the 
intensities and therefore can only be used as a guide to the actual level of fibrinogen 
in the cell at any given time. 
ELISA assays were performed to determine if there was any secretion of fibrinogen 
from the cells. This technique is more sensitive than the immunofluorescence 
intensites for indicating the level of protein expression within the cells. The cell 
supernatants (Fig 3) indicated that fibrinogen was being secreted from the cells with 
all treatments. TNF cc treated cells have a lower level of secreted fibrinogen than the 
untreated cells, however this was not statistically significant when n=3. This is due 
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to variation between the samples day-to day, although all assays showed the same 
trend. This reduction in the amount of secreted fibrinogen when cells are treated with 
TNF(x is similar to that found by Anderson (2003) where treatments were carried out 
in serum free conditions. 
3.1.2 Treatment of A549 cells with IL6, TNFoc and both cytokines simultaneously 
In the liver many cytokines are produced simultaneously during an APR and the 
combined effects of these control the levels of the acute phase proteins such as 
fibrinogen. Therefore the effect of more than one cytokine at a time was investigated. 
Cells were treated with lOng/ml of IL6, TNFoc, lOng/ml IL6 plus lOng/ml TNFoc, 
with untreated cells for comparison. Indirect immunofluorescence staining showed 
that IEL6 plus TNF(x treatment induced fibrinogen staining in the cytoplasm. The 
levels of staining were below the levels of EL6 treatment alone but above that of 
TNF(x alone (Fig 4). Intensity analysis (n--3) of the images was then carried out using 
Metamorph software, giving an indication of the levels of fibrinogen within the cells 
(Fig 5). This showed that IL6 increased the levels of fibrinogen 5-fold and the IL6 
plus TNFcc treatment increased the levels 4-fold, with both these treatments being 
statistically significant (p<0.001) over that untreated cells. 
ELISAs were then carried out on the cell supernatants to investigate whether 
fibrinogen was secreted from the cells. This showed that there was little secretion of 
fibrinogen from these cells (Fig 6). The IL6 plus TNFcc treatment showed some 
increase of secretion from the cells, however this was not significant, but all the other 
treatments were similar to the untreated cells. 
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3.1.3 Treatment of A549 cells with IL6 and IMP and both cytokines 
simultaneously. 
Cells were treated with I Ong/ml of IL6 or ILI P, or I Ong/ml IL6 plus I Ong/ml ELI 
with untreated cells for comparison. Immunofluorescence showed that IL6 increased 
the levels of fibrinogen above the untreated control (Fig 7). All the cells in the IL6 
treated cells showed cytoplasmic expression of fibrinogen but a small sub-population 
of cells in the other treatments showed low levels of fibrinogen expression. 
Intensity analysis of the images shows that indeed IL6 was the only cytokine 
treatment which increased the expression of fibrinogen (Fig 8). The level of CRP 
expression in the IL6 treated cells was statistically significant from the untreated cells 
(p<0.001). The immunofluorescence intensites also indicated that the IL6 plus 
ILI P treatment resulted in less expression of fibrinogen than the untreated cells. 
ELISAs were than carried out on both the cell supernatants. Analysis of the cell 
supernatant (Fig 9) indicated that all the cytokine treatments increased the expression 
of fibrinogen over that of the untreated cells. IL6 once again showed the greatest 
increase in expression with IL1P showing the next greatest increase with the 
combination of both cytokines being below the levels of either cytokine alone. Again 
there is no statistical significance between the treatments due to variations among the 
results. 
3.1.4 Treatment of A549 cells and with IL6 and IL8 simultaneously. 
Cells were treated with I Ong/ml of IL6 or IL8, or I Ong/ml IL6 plus I Ong/ml IL8, with 
untreated cells for comparison. Immunofluorescence shows that IL6 produces the 
greatest increase in fibrinogen, with IL6 plus EL8 showing an increase in expression 
over the untreated cells (Fig 10). Intensity analysis of the cells using Metamorph (Fig 
11) shows that the greatest increase in expression is in the IL6 plus IL8 treated cells 
(p>0.001), which is not evident when looking the pictures. IL6 treatment alone is also 
increased above that of the untreated cells (p<0.01) with EL8 being very similar to that 
of the untreated cells. 
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ELISAs were carried out on the cell supernatants. Analysis of the cell supernatant 
(Fig 12) indicated that all the cytokine treatments increased the expression of 
fibrinogen over that of the untreated cells. IL6 once again showed the greatest 
increase in expression with IL8 showing the next greatest increase with the 
combination of both cytokines being below the levels of either cytokine alone. 
Neither treatment showed any statistical significance compared to the untreated cells 
due to large variations between the samples but all showed the same trends. 
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Figure 1: Expression of fibrinogen in A549 cells treated with lOng/ml of each cytokine for 18 
hours as shown by indirect immunofluorescence 
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Figure 2: Immunofluorescent intensities of A459 cells stained for fibrinogen after 18 hours of 
treatment with lOng/ml of each cytokine. The average intensity is an arbitrary unit which is used 
in all figures. The results are the mean of triplicate results from 3 experiments ± SE. Asterisk 
denotes significant changes from untreated (control) cells, p< 0.05. 
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Figure 3: Concentration of fibrinogen in cell supernatant measured by ELISA after 18 hours of 
treatment with IOng/ml of each cytokine. Fibrinogen is expressed as a percentage of the 
concentration present in the untreated cells. The results are the mean of triplicate results from 3 
experiments ± SE. 
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Figure 4: Immunofluorescent photographs of A549 cells stained for fibrinogen. Cells were 
treated with IOng/ml of TNF(x or IL6 for 18 hours. 
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Figure 5: Immunofluorescent intensities of A459 cells stained for fibrinogen after 18 hours of 
10ng/ml TNFa or IL6 treatments. The results are the mean of triplicate results from 3 
experiments ± SE. Asterisks (***) denotes significant changes from untreated (control) cells, p< 
0.001. 
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Figure 6: Concentration of fibrinogen in cell supernatant measured by ELISA after 18 hours of 
1Ong/n-d TNFa or IL6 treatment. The results are the mean of triplicate results from 3 
experiments ± SE. Asterisks (**) denotes significant changes from untreated (control) cells, p< 
0.01. 
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Figure 7: Expression of fibrinogen in A549 cells treated with 10ug/mI IL6 or ILIP for 18 hours 
shown by indirect immunofluorescence. 
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Figure 8: Immunofluorescent intensities of A459 cells stained for fibrinogen after 18 hours of 
10ng/ml IL6 or ILIP treatments. The results are the mean of triplicate results from 3 
experiments ± SE. Asterisks (***) denotes significant changes from untreated (control) cells, p< 
0.001. 
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Figure 9: Concentration of fibrinogen in cell supernatant measured by ELISA after 18 hours of 
IOng/ml IL6 or ILIP treatment. The results are the mean of triplicate results from 3 experiments 
± SE. 
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Figure 10: Expression of fibrinogen in A549 cells treated with IOng/mI IL6 or IL8 for 18 hours as 
shown by indirect immunofluorescence. 
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Figure 11: Immunofluorescent intensities of A459 cells stained for fibrinogen after 18 hours of 
lOng/ml IL6 or IL8 treatments. The results are the mean of triplicate results from 3 experiments 
± SE. Asterisks denotes significant changes from untreated (control) cells, p< 0.01, 
p<0.001. 
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Figure 12: Concentration of fibrinogen in cell supernatant measured by ELISA after 18 hours of 
1Ong/mI IL6 or IL8 treatment. Fibrinogen is expressed as a percentage of the concentration 
present in the untreated cells. The results are the mean of triplicate results from 3 experiments 
SE. 
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3.2. Effect of cvtokine treatment on C-reactive protein (CRP) expression 
3.2.1 Treatment of A549 cells with IL6, TNFa and IFNy. 
Since fibrinogen was expressed in A549 cells an investigation into the expression of 
CRP, the prototypic human APP in the lung epithelium was carried out. IL6 is a major 
regulator of CRP expression in hepatocytes and it was investigated as to whether it 
would have a similar effect in A549 cells. 
Immunofluorescent staining was used to show CRP in the treated cells (I Ong/ml IL6, 
TNF a or IFN y). Photographs taken (Fig 13) show that there are very low levels of 
CRP in A549 cells, and this can be dramatically increased by treatment with IL6 and 
IFN y. There also appears to be a smaller increase of CRP expression with TNF a 
treatment. CRP is located within the cytoplasm which would be expected since in 
hepatocytes CRP is found in the cytoplasm attached to the endoplasmic reticulurn 
(Yue et. al., 1996). 
The photographed cells were also analysed using Metamorph software to indicate the 
intensity of fluorescence of the individual cells. One hundred cells from each 
treatment were analysed to indicate the level of expression from each treatment (n = 
3). These results then enabled statistical analysis of the increase in CRP within the 
cells (Fig. 14). Intensity analysis shows that there is a significant up-regulation of 
CRP by IL6 and IFN y (p<0.001) 
ELISA assays were carried out on the cell supernatant to determine if there was any 
secretion of CRP from the cells (Fig 15). It is clear from this figure that the CRP 
produced from the TNF cc treated cells is being secreted from the cells during the 18 
hour incubation. 
3.2.2 Treatment of A549 cells with IL6, TNFa and both cytokines 
simultaneously. 
As for fibrinogen the effect of several cytokines on the expression of CRP was 
investigated since more than one cytokine is likely to be found during inflammatory 
stimuli. 
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Cells were treated with lOng/ml of IL6, TNF(x, lOng/ml IL6 plus lOng/ml TNF(x, 
with untreated c ells for c omparison. I mmunofluorescence showed that the cytokine 
treatments produced staining in the cytoplasm, above the untreated levels. TNF (x 
showed the smallest increase, with the levels of IL6 treatment alone and in 
combination with TNFcc appearing similar (Fig 16). Intensity analysis (n=3) of the 
images was then carried out using Metamorph software, giving an indication of the 
levels of CRP within the cells (Fig 17). This showed that EL6 increased the levels of 
fibrinogen 6-fold and the IL6 plus TNF(x treatment increased the levels Mold, with 
both these treatments being statistically significant (p<0.01) over that untreated cells. 
ELISAs w ere then carried o ut on the c ell s upernatants toi nvestigate w hether CRP 
was secreted from the cells. This showed that there was little secretion of CRP from 
the untreated and IL6 treated cells (Fig 18). The TNF(x and IL6 plus TNF(x treatment 
showed an increase in secretion from the cells, however these results were not 
statistically significant. 
3.2.3 Treatment of A549 cells with IMP, IL6 and both cytokines simultaneously. 
It is known that ILI P and IL6 are required for the maximal synthesis of CRP in 
hepatocytes. Therefore the effect of several cytokines administered at the same time 
was investigated for CRP in lung epithelial cells. 
Cells were treated with 1 Ong/ml of either IL IP, IL6, or I Ong/ml IL 1P plus 1 Ong/ml 
IL6, with untreated cells for comparison. Immunofluoresence revealed that ILI p 
upregulated expression of CRP in A549 cells (Fig 19). The levels of EL6 induced CRP 
appear similar to that of the ILI P treated cells. The ILI P and IL6 treated cells have 
slightly higher levels than either of the cytokines on their own. The distribution of 
CRP within these cells is mainly in the cytoplasm but also with clear nuclear staining 
probably associated with snRNP binding. The nuclear staining is particularly 
prominent in the cells treated simultaneously with ILI P and IL6. Intensity analysis (n 
3) shows that there is increased CRP in the order ILI< IL6 <- ILI 0 plus IL-6- 
treated cells (Fig 20). Statistically this is significant (p< 0.01) in the ILI P plus EL6 
treated cells over the control (untreated cells). ELISAs were performed to indicate the 
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presence of secreted CRP with IL6 or ILlP (Fig 21). It was found that CRP was 
secreted from the cells with all treatments and there was a slight increase over 
untreated cells with the cytokines treatments however none of there treatments was 
statistically significant from the untreated cells. Individual assays show the same 
trend, however the concentrations of CRP secreted from the cells varied from day-to- 
day and were therefore not statistically significant. 
3.2.4 Treatment of A549 cells with IL6, IL8 and both cytokines simultaneously. 
The addition of ILIP with IIL6 had an increased effect on the expression of CRP, so 
simultaneous treatment with other cytokines and IL6 was investigated. This time the 
effect of IL8 was used to see if the effect was increased with addition of IL6. 
Cells were treated with lOng/mI of either IL6, IL8, or lOng/mI IL6 pluslOng/ml 
IL8, with untreated cells for comparison. The result of immunofluoresence analysis 
revealed that IL8 up-regulated the expression of CRP in A549 cells (Figs. 22). The 
levels of IL6 induced CRP appear higher than that of the IL8 treated cells. The IL6 
and IL8 treated cells have slightly higher levels than either of the cytokines on their 
own. The distribution of CRP within these cells appears mainly in the cytoplasm but 
also appeared to be expressed in the external cell membrane. 
Intensity analysis (n = 3) shows that there is increased CRP in the order IL8 > IL6 > 
IL6 plus IL8 treated cells (Fig 23). Statistically this is significant (p< 0.01) in the IL6 
plus EL8 treated cells over the control (untreated cells). 
ELISAs were performed to indicate the presence of secreted CRP (Fig 24). Statistical 
analysis shows that the EL6 plus IL8 treatment results induces a significant increase in 
the amount of CRP (p<0.05). 
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Figure 13: Expression of CRP in A549 cells treated with IOng/ml of each cytokine for 18 hours as 
shown by indirect immunofluorescence 
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Figure 14: Immunofluorescent intensities of A459 cells stained for CRP after 18 hours of 
treatment with 10ng/ml of each cytokine. The results are the mean of triplicate results from 3 
experiments ± SE. Asterisks (***) denotes significant changes from untreated (control) cells, p< 
0.001. 
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Figure 15: Concentration of CRP in cell supernatant measured by ELISA after 18 hours of 
treatment with 1Ong/mI of each cytokine. The results are the mean of triplicate results from 3 
experiments ± SE. Asterisk (*) denotes significant changes from untreated (control) cells, p< 0.05. 
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Figure 16: Expression of CRP in A549 cells treated with IOng/ml TNFOL or IL6 for 18 hours as 
shown by indirect immunofluorescence. 
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Figure 17: Immunofluorescent intensities of A459 cells stained for CRP after 18 hours of 
treatment with 1Ong/mI of TNFa or IL6. The results are the mean of triplicate results from 3 
experiments ± SE. Asterisks (**) denotes significant changes from untreated (control) cells, p< 
0.01. 
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Figure 18: Concentration of CRP in cell supernatant measured by ELISA after 18 hours of 
treatment with 10ng/ml TNFcc or IL6 treatment. The results are the mean of triplicate results 
from 3 experiments ± SE. 
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Figure 19: Expression of CRP in A549 cells treated with 10ng/ml IL6 or [LIP for 18 hours as 
shown by indirect immunofluorescence. X indicates nuclear localisation of CRP. 
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Figure 20: Immunofluorescent intensities of A459 cells stained for CRP after 18 hours of 
treatment with IOng/ml IL6 or IMP. The results are the mean of triplicate results from 3 
experiments ± SE. Asterisks denotes significant changes from untreated (control) cells, 
p< 0.01, P<0.001. 
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Figure 21: Concentration of CRP in cell supernatant measured by ELISA after 18 hours of 
treatment with 10ng/ml of IL6 or IMP treatment. CRP is expressed as a percentage of the 
concentration present in the untreated cells. The results are the mean of triplicate results from 3 
experiments ± SE. 
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Figure 22: Expression of CRP in A549 cells treated with IOng/ml IL6 or IL8 for 18 hours as 
shown by indirect immunofluoreseence. 
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Figure 23: Immunofluorescent intensities of A459 cells stained for CRP after 18 hours of 
treatment with IOng/ml of IL6 or IL8 treatments. The results are the mean of triplicate results 
from 3 experiments :k SE. Asterisks (**) denotes significant changes from untreated (control) 
cells, p< 0.01. 
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Figure 24: Concentration of CRP in cell supernatant measured by ELISA after 18 hours of 
treatment with lOng/mI IL6 or ILIP treatment. CRP is expressed as a percentage of the 
concentration present in the untreated cells, The results are the mean of triplicate results from 3 
experiments ± SE. Asterisks (*) denotes significant changes from untreated (control) cells, p< 
0.05. 
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Chapter 4 
Effect of air pollution particles, carbon black (CB) and 
ultrafine carbon black (ufCB), PMIO and the transition 
metal salt, FeC13, treatment on inflammatory protein 
expression in lung epithelial cells., 
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4.1.0 Effects on CRP eXDression. 
4.1.1 Treatment with CB over 18 hour period. 
Cells were treated with 100lig/ml CB for various time points over 18 hour period (0, 
V2 , 3,6,18 hours). Immunofluorescent staining showed that 
CRP was expressed in the 
cells from 3 hours and increased in a time-dependent manner (Fig. 25), with some 
nuclear localisation at 18 hours. Average intensity of the fluorescent cells for each 
time point was then calculated using Metamorph software (Fig 26). This shows that 
there is a significant increase in CRP over the untreated cells with CB treatment at 6 
hrs (p<0.05) and 18 hours (p<0.01). The levels of CRP in the untreated cells do not 
change greatly in culture over the 18 hour time period and in further experiments were 
assumed to be the same at the beginning as at the end of the 18 hour incubation. 
ELISAs were also carried out on the whole cell lysate and the cell culture supernatant. 
The cell lysate data (Fig 27) show that CRP increases time-dependently with a three 
. 
fold increase over the untreated cells after 18 hours. This increase is statistically 
significant (p< 0.05) from 6 hours. The cell supernatant data (Fig 27) show a similar 
trend to that of the cell lysate with a three fold increase after 18 hours of treatment, 
however high variability between replicates gives high standard deviations resulting 
in no statistical significance from untreated cells. 
4.1.2. Treatment with ufCB over 18 hour time period. 
Cells were treated with I 00[ig/ml ufCB for the same time points as the CB treatments. 
The effect of CB particle size (fine or ultrafine) was investigated to find if the smaller 
particles had an increased or decreased effect of CRP expression. Immunofluorescent 
staining was carried out to see the localisation of CRP within the cells (Fig 28). Like 
CB, ufCB induced a time-dependent increase in CRP. However, the localisation of 
CRP within the cell is different between the two treatments. The ufCB treatment 
produced a pattern which may indicate polarisation, since the CRP is located at either 
end of the cell, particularly after 18 hours of treatment. Average intensities of the cells 
were then calculated (Fig 29). Once again there is a statistical increase in CRP at 6 
and 18 hours (both p<0.01) of treatment. This shows a greater statistical significance 
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at the 6 hour time point with ufCB than the CB treatment (graphs of comparison 
between CB and ufCB in appendix 1). 
ELISA data indicated that there was an increase of CRP in both the whole cell lysate 
and the cell culture medium. The cell lysate (Fig 30) showed a statistically significant 
increase from 6 hours (p<0.05) which rose to 18 hours (p<0.001) with a 5- fold 
increase over the untreated cells. The cell supernatant (Fig 30) shows an increase from 
3 hours of treatment but once again this is not statistically significant compared to 
untreated cells (graphs of comparison between CB and ufCB in appendix 1). 
4.1.3. Treatment with PMIO over 18 hour time period. 
Cells were treated for up to 18 hours with 80[ig/ml PMIO (collected on TEOM filters 
from a roadside sampling site in Wolverhampton, UK). Immunofluorescent staining 
for CRP was carried out and showed that, like the surrogate air pollution particles, 
CRP could be produced in a time dependent manner (Fig 31). Between 6 and 18 
hours there appears to a slight reduction in the levels of CRP when looking at the 
pictures although this could be the result of differing staining patterns within the cells. 
At the 18 hour time point there appears to be some aggregation of CRP in the cell 
cytoplasm whereas at the 6 hour time point there appears to be a smoother appearance 
with some localisation around the nuclear membrane. Average intensities of the cells 
reveal that there is an increase in the levels of CRP during the first 3 hours of 
treatment and there after the levels remains constant until 18 hours (Fig 32). This is 
likely to be the result of differing staining patterns and the relative insensitivity of the 
software to differentiate between the different patterns. The levels of CRP in the cells 
was statistically significant at the 3,6 and 18 hour time points (p<0.01). 
ELISAs were carried out on the cell lysates and supernatants. The cell lysate showed 
that there was an increase in the levels of CRP in a time dependent manner (Fig 33). 
The levels of CRP are in agreement with the immunofluorescence results and the 
increase is statistically significant at the 18 hour time point (p<0.01). The cell 
supernatant was also analysed to look for secreted CRP (Fig 33). The appeared to be 
secretion of CRP from the cells; however, there were high variations between the 
different days in which the ELISA was carried out but it does appear that there is 
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indeed secretion at 18 hours although the results from the other time points are a little 
inconclusive. 
4.1.4. Treatment with FeC13 over 18 hour time period. 
Cells were treated with the transition metal salt, iron (111) chloride (FeC13), for up to 
IS hours at a concentration of I OOgM. Immunofluorescence staining was carried out 
and this showed that there was no effect on CRP expression in A549 cells. Intensity 
analysis was carried out and there was no change with treatment also there was no 
detectable CRP in either the cell lysate or cell supernatant, therefore data is not 
shown. 
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Figure 25: Expression of Greactive protein (CRP) in A549 cells treated with 100ýtg/ml CB, for 
various time points up to 18 hours shown by indirect immunofluorescence. X indicates nuclear 
localisation. For controls see Appendix 1. 
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Figure 26: Immunofluorescent intensities of A459 cells stained for CRP after 18 hours of 100 
gg/ml CB treatment. The results are the mean of triplicate results from 3 experiments ± SE. 
Asterisks (*, **) denotes significant changes from untreated (control) cells, p<0.05, p< 0.01. 
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Figure 27: Concentration of CRP in cell lysate and supernatant measured by ELISA after 18 
hours of treatment with 100[tg/nil CB. The results are the mean of triplicate results from 3 
experiments ± SE. Asterisk denotes significant changes from untreated (control) cells, p< 0.05, p< 0.01. 
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Figure 28: Expression of Greactive protein (CRP) in A549 cells treated with 100 ýLg/ml ufCB, 
for various time points up to 18 hours as shown by indirect immunofluorescence. X indicates 
nuclear localisation and V indicates polarisation of staining. For controls see Appendix 1. 
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Figure 29: Immunofluorescent intensities of A459 cells stained for CRP after 18 hours of 100 
gg/ml ufCB treatment. The results are the mean of triplicate results from 3 experiments ± SE. 
Asterisks (**) denotes significant changes from untreated (control) cells, p< 0.01. 
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Figure 30: Concentration of CRP in cell lysate and supernatant measured by ELISA after 18 
hours of treatment with 100tig/nil ufCB. The results are the mean of triplicate results from 3 
experiments ± SE. Asterisks denotes significant changes from untreated (control) cells, 
p< 0.05, P<0.001. 
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Figure 31: Expression of C-reactive protein (CRJP) in A549 cells treated with 80ý1g/ml PMIO, for 
various time points tip to 18 hours, as shown by indirect immunofluorescence. X indicates 
nuclear staining of CRP. For controls see Appendix 1. 
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Figure 32: Immunofluorescent intensities of A459 cells stained for CRP after 18 hours of 80 
gg/ml PM10 treatment. The results are the mean of triplicate results from 3 experiments ± SE. 
Asterisks (**) denotes significant changes from untreated (control) cells, p< 0.01. 
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Figure 33: Concentration of CRP in cell lysate and supernatant measured by ELISA after 18 
hours of treatment with 80pg/ml PM10. The results are the mean of triplicate results from 3 
experiments ± SE. Asterisks (**) denotes significant changes from untreated (control) cells, 
P<0.01. 
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4.2. Effect of CB and ufCB treatment on Fibrinol! en expression. 
4.2.1 Treatment with CB over 18 hour period. 
Immunofluorescent staining after treatment with CB showed a time-dependent 
increase in fibrinogen similar to that of CRP (Fig 34). After 3 hours of treatment the 
levels of fibrinogen appear to be increased compared to the untreated cells. 
Fibrinogen was found localised in the cell cytoplasm and distributed evenly 
throughout the cell. Intensity analysis (Fig 35) reveals that there is almost a linear 
relationship between time of treatment and amount of fibrinogen within the cells, with 
statistical significance at 18 hours (p<0.01). 
ELISAs carried out on the whole cell lysate and cell culture medium show similar 
results to CRP. In the whole cell lysate (Fig 36) the levels of fibrinogen increase with 
time showing statistical significance at 18 hours (p< 0.05). The analysis of the cell 
culture medium (Fig 36) indicates that there is also secretion of fibrinogen from the 
cells. There is an increase with time, but at the 6 hour time point there appears to be a 
decrease in the concentration of fibrinogen increasing to 18 hours. The decrease in 
fibrinogen levels at 6 hours is unexpected and is likely to be the result of experimental 
errors. 
4.2.2. Treatment with ufCB over 18 hour time period. 
The effect of treatment with ufCB on fibrinogen expression was then investigated. 
Cells were treated as described earlier for CRP. Immunofluorescent staining (Fig 37) 
shows that there is an increase in expression of fibrinogen with time. The levels of 
fibrinogen start to increase from 3 hours but are greatly increased from 6 hours. The 
staining at the 6 and 18 hour time points show distinct polarisation of the fibrinogen 
in the cells, which was not present in the CB treated cells. Intensity analysis was 
carried out (Fig 38) and this showed that there was little change in the intensity in the 
first three hours. After 6 hours of treatment there is statistical significance compared 
to untreated cells (p< 0.01) rising to 18 hours (p<0.001). 
ELISAs were carried out on the whole cell lysate and the cell culture medium. The 
whole cell lysates (Fig 39) showed an increase with time and a statistical significance 
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at 18 hours after treatment. The cell culture medium (Fig 39) showed that there is 
some secretion of fibrinogen although it never increases enough to be statistically 
significant. This could be due to adsorption of fibrinogen on to the particle surface 
which would result in an underestimation of the amount of secreted fibrinogen (see 
appendix II). 
4.2.3. Treatment with PM10 over 18 hour time period. 
Treatment with 80mg/ml PMIO from a roadside TEOM sampler in Wolverhampton, 
UK, was carried out over 18 hours. Immunofluorescent staining was carried out at 
various time points and showed that fibrinogen was produced in a time dependent 
manner (Fig 40). Fibrinogen was found to be present in the cytoplasm of the cells 
with fairly high density of fibrinogen localised around the cell nucleus. Intensity 
analysis showed that there was an increase in fibrinogen but this was not statistically 
significant (Fig 41). 
ELISAs were carried out on the cell lysates and cell supernatants of the PMIO treated 
cells. The cell lysates (Fig 42) showed that there was an increase in the levels of 
fibrinogen with time of PMIO treatment. The cell supernatants showed that there was 
some secretion of fibrinogen from the cells (Fig 42). Although the levels of fibrinogen 
are only increased above the control cell level at the 18 hour time point and even then 
there are high variations. 
4.2.4. Treatment with FeC13 over 18 hour time period. 
Cells were treated with 100ýM of the transition metal salt FeC13 for various time 
points up to 18 hours. Immunofluorescent staining was carried out for fibrinogen at 
each time point and this revealed that fibrinogen was stimulated in a time dependent 
manner (Fig 43). At all the time points fibrinogen is found in the cytoplasm of the 
cells and at the latter time points there is fibrinogen expressed at high levels in a 
higher proportion of the cells. Intensity analysis of the cells showed that there is an 
increase in the levels of fibrinogen with FeC13 treatment over the time course and that 
at 18 hours this increase is statistically significant (p<0.01)(Fig 44). 
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ELISAs were carried out in the cell lysate revealed that fibrinogen expression was 
increased over the time course; however, the errors between treatments were high (Fig 
45). The high deviation between the samples means that it is difficult to tell if the 
values actually represent what is happening within the cells and the errors are too 
great to achieve statistical significance. Analysis of the cell supernatant indicates that 
there may be an increase in fibrinogen after 18 hours (Fig 45) however at this time 
point there are is a high degree of error between the samples resulting in no statistical 
significance. Both the cell lysate and supernatants were repeated 5 tirjqes and this did 
not affect the results. 
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Figure 34: Expression )f fibrinogen in A549 cells treated with 100lig/ml CB, for various time 
points up to 18 hours as shown by indirect immunofluorescence. For controls see Appendix 1. 
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Figure 35: Immunofluorescent intensities of A459 cells stained for fibrinogen after 18 hours of 
100 jig/n-d CB treatment. The results are the mean of triplicate results from 3 experiments ± SE. 
Asterisks (**) denotes significant changes from untreated (control) cells, p< 0.01. 
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Figure 36: Concentration of fibrinogen in cell lysate and supernatant measured by ELISA after 
18 hours of treatment with 100[ig/ml CB. The results are the mean of triplicate results from 3 
experiments ± SE. Asterisk (*) denotes significant changes from untreated (control) cells, p< 0.05. 
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Figure 37: Expression of fibrinogen in A549 cells treated with 100 jig/ml ufCB, for various time 
points up to 18 hours as shown by indirect immunofluorescence. X indicates polarisation of 
fibrinogen. For controls see Appendix 1. 
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Figure 38: Immunofluorescent intensities of A459 cells stained for fibrinogen after 18 hours of 
100 gg/ml ufCB treatment. The results are the mean of triplicate results from 3 experiments ± 
SE. Asterisks denotes significant changes from untreated (control) cells, p< 0.01, 
p<0.001. 
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Figure 39: Concentration of fibrinogen in cell lysate and supernatant measured by ELISA after 
18 hours of 100 jig/ml ufCB treatment. The results are the mean of triplicate results from 3 
experiments ± SE. Asterisk (*) denotes significant changes from untreated (control) cells, p< 0.05. 
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Figure 40: Expression of fibrinogen in A549 cells treated with 80ýLg/ml PMIO, for various time 
points tip to 18 hours as shown by indirect immunofluorescence. For controls see Appendix 1. 
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Figure 41: Immunofluorescent intensities of A459 cells stained for fibrinogen after 18 hours of 80 
pg/ml PM10 treatment. The results are the mean of triplicate results from 3 experiments ± SE. 
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Figure 42: Concentration of fibrinogen in cell lysate and supernatant measured by ELISA after 
18 hours of 80pg/ml PM10 treatment. The results are the mean of triplicate results from 3 
experiments ± SE. Asterisk (*) denotes significant changes from untreated (control) cells, p< 0.05. 
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Figure 43: Expression of fibrinogen in A549 cells treated withIOOmM FeC13, for various thine 
points tip to 18 hours as sbown by indirect iminunofluorescenee. For controls see Appendix 1. 
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Figure 44: Immunofluorescent intensities of A459 cells stained for fibrinogen after 18 hours of 
IOOpM FeCl3treatment. The results are the mean of triplicate results from 3 experiments ± SE. 
Asterisks (**) denotes significant changes from untreated (control) cells, p< 0.01 
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Figure 45: Concentration of fibrinogen in cell lysate and supernatant measured by ELISA after 
18 hours of 100mM FeC13 treatment. The results are the mean of triplicate results from 3 
experiments ± SE. 
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4.3. Effect of CB and ufCB treatment on HsD70 exvression. 
4.3.1 Treatment with CB over 18 hour period. 
Incubation of cells with CB for up to 18 hours showed that Hsp70 expression could be 
stimulated in a time dependent manner. Immunofluorescence microscopy (Fig 46) 
showed that low levels of Hsp70 were present in the cell cytoplasm for the first 3 
hours of treatment. After 6 hours of treatment there were high levels of Hsp70 
present, much of which was located around the nucleus of the cells with some nuclear 
localisation present. The nuclear localisation of Hsp70 gives a punctuated staining 
pattern. At 18 hours of treatment there are very high levels of Hsp70 in the cytoplasm 
which may be masking nuclear localisation although there appears to be a faint 
punctuated pattern. Intensity analysis of the inummofluorescence photographs (Fig 
47) shows that there is indeed a high increase in intensity of Hsp70 after 3 hours of 
treatment which is statistically significant from the untreated cells (p<0.001 at 6 and 
18 hours). 
Western blots of the cell lysate and cell supernatant were carried out (Fig 48). ELISAs 
were not available for this protein and therefore this was the most sensitive technique 
available. This revealed that in the cell lysate detectable levels of Hsp70 were present 
from 3 hours in the cell lysate. In the cell supernatants there also appeared to be an 
increase in Hsp70 after 18 hours of treatment (Fig 49) 
4.3.2 Treatment with ufCB over 18 hour period. 
Incubation of cells with ufCB for up to 18 hours showed that Hsp70 expression was 
induced by ufCB after 6 hours, similarly to that with CB treatment. 
Immunofluorescent microscopy (Fig 50) showed that very low levels of Hsp70 were 
present during the first 3 hours of treatment, but after 6 hours there were very high 
levels of Hsp70. At 6 hours of treatment Hsp70 is localised mainly in the nucleus of 
the cells with some cytoplasmic staining, and at 18 hours there is high levels of 
staining in both the cytoplasm and the nucleus. Intensity analysis (Fig 5 1) revealed 
that there is a statistically significant increase in Hsp70 after 6 hours of treatment 
(p<0.001). 
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Western blots were carried out on the cell lysate and cell supernatant of the treated 
cells. This revealed that once again high levels of Hsp70 were present in the cell 
lysate after 3 hours as indicated by the bands on the blot (Fig 52). Analysis of the cell 
supernatant showed that there were high increases in the level of Hsp70 after half an 
hour of treatment (Fig 53). 
4.3.3 Treatment with PMIO over 18 hour period. 
Cells were treated with 80ýLg/ml PM10 from Wolverhampton for various time points 
before immunofluorescent staining for Hsp70. The results (Fig 54) show that Hsp70 
was expressed in the cells in a time-dependent manner. At the 6 and 18 hour time 
points there appears to be Hsp70 present in the nucleus of the cells; however, the 
staining pattern is continuous and not the punctuated appearance that the CB and 
ufCB treated cells have. This may be due to a later stage of nuclear localisation than 
the CB and ufCB particles or possibly PMlO is inducing Hsp70 nuclear localisation 
by a different mechanism. Average immunofluorescent intensities were calculated 
(Fig 55) and show that Hsp70 levels are statistically significant after 3 hours (p<0.05) 
and also at 6 and 18 hours (p<0.001). 
Western blots were carried out on the cells lysates and cell supernatants. Cell lysate 
Western blots show that Hsp70 is increased with time in particular at the 18 hour time 
point (Fig 56). The cell supernatants show that there is some secretion of Hsp70 from 
the untreated cells with a slight increase with time of treatment (Fig 57), high levels in 
the untreated cells may be due to some stressing of the cells prior to treatment. 
4.3.4 Treatment with FeC13 over 18 hour period. 
Cells were treated with 100liM FeC13 over the 18 hour time period. 
Immunofluorescence staining revealed that there was some Hsp70 staining in the 
untreated cells and that this was increased during the first three hours of treatment 
(Fig 58). The average immunofluorescent intensities of the cells revealed that the 
level of Hsp70 in the cells peaks at 3 hours with statistical significance (P<0.01), 
before decreasing (Fig 59). This may be the result of Hsp70 preventing any cellular 
damage and reducing transcription events. However, a mild stress response may have 
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occurred when the cells were in contact with the iron solution and this could have 
been quickly resolved. 
Western blots were carried out on the cell lysates and cell supernatants of the cells. 
The cell lysate Western blots revealed that Hsp70 was present at high levels in the 
cells at all time points and that little increase was seen over the already high level in 
the untreated cells (Fig 60). Once again it would appear that the cells are stressed 
before the treatment. This may be due to stressing of the cells during the lysis 
procedure. Western blots carried out for the cell supernatants reveals that small 
amounts of Hsp, 70 were being secreted from the cells before and after treatment (Fig 
61). There was little increase in the levels of Hsp, 70 being secreted before or during 
treatment. This strengthens the evidence that the cells may have been stressed during 
the lysis procedure since the cell supernatant was removed prior to lysis and little 
secreted Hsp70 was present indicating the stress occurred after the supernatant was 
removed. 
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Figure 46: Expression of Hsp70 in A549 cells treated with 100lig/ml CB, for various time points 
up to 18 hours as shown by indirect immunofluorescence. X indicates nuclear and peri-nuclear 
localisation. For controls see Appendix 1. 
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Figure 47: Immunofluorescent intensities of A459 cells stained for Hsp70 after 18 hours of 100 
gg/ml CB treatment. The results are the mean of triplicate results from 3 experiments ± SE. 
Asterisks (***) denotes significant changes from untreated (control) cells, p< 0.001 
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Figure 48: Level of Hsp70 expression in cell lysate measured by Western blot after 18 hours of 
lOOgg/ml CB treatment. 
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Figure 49: Level of Hsp70 expression in cell supernatant measured by Western blot after 18 
hours of IOOpg/n-d CB treatment. 
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Figure 50: Expression of Hsp70 in A549 cells treated with 100ýig/ml ufCB, for various time points 
up to 18 hours as shown by indirect immunofluorescence. X indicates nuclear localisation. For 
controls see Appendix 1. 
83 
18 hours untreated 
b) ', hour treatnicnt 
c) IS hour treatnwii, 
140 
120 
100 
c '3' 80 
60 cn 
40 
20 
0 
Figure 51: Immunofluorescent intensities of A459 cells stained for Hsp70 after 18 hours of 
100gg/nil ufCB treatment. The results are the mean of triplicate results from 3 experiments ± SE. 
Asterisks (***) denotes significant changes from untreated (control) cells, p< 0.001 
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Figure 52: Level of Hsp70 expression in cell lysate measured by Western blot after 18 hours of 
100lig/nil ufCB treatment. 
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Figure 53: Level of Hsp70 expression in cell supernatant measured by Western blot after 18 
hours of 100jig/ml ufCB treatment. 
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Figure 54: Expression of Hsp70 in A549 cells treated with 80lig/mI PMIO, for various time points 
up to 18 hours as shown by indirect immunofluorescence. For controls see Appendix 1. 
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Figure 55: Immunofluorescent intensities of A459 cells stained for Hsp70 after 18 hours of 
80Rg/ml PM10 treatment. The results are the mean of triplicate results from 3 experiments ± SE. 
Asterisks (*, ***) denotes significant changes from untreated (control) cells, p<0.05, p< 0.001. 
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Figure 56: Level of Hsp70 expression in cell lysate measured by Western blot after 18 hours of 
80pg/ml PMIO treatment. 
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Figure 57: Level of Hsp70 expression in cell supernatant measured by Western blot after 18 
hours of 80pg/ml PMIO treatment 
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Figure 58: Expression of Hsp70 in A549 cells treated with IOOmM FeC13. for various time points 
up to 18 hours as shown by indirect immunonuorescence. For controls see Appendix 1. 
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Figure 59: Immunofluorescent intensities of A459 cells stained for Hsp70 after 18 hours of 
100mM FeC13 treatment. The results are the mean of triplicate results from 3 experiments ± SE. 
Asterisks (**) denotes significant changes from untreated (control) cells, p< 0.01. 
Figure 60: Level of Hsp70 expression in cell lysate measured by Western blot after 18 hours of 
100mM FeC13 treatment. 
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Figure 61: Level of Hsp70 expression in cell supernatant measured by Western blot after 18 
hours of 100mM FeC13 treatment. 
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4.4.0 Effect of CB and ufCB treatment on NFicB expression. 
4.4.1 Treatment with CB over 18 hour period. 
After incubation of cells with CB for up to 18 hours immunofluorescence microscopy 
showed that NFKB expression could be stimulated in two phases, early and late (Fig 
62). The early phase occurred in the flrst hour peaking at 30 minutes before a decrease 
at around 3 hours. A fin-ther increase occurred at around 6 hours which continues to 
increase up to 18 hours. The staining pattern is predominantly cytoplasmic although 
there is some evidence to suggest that NFYB is localised around the nuclear 
membrane at 18 hours. Immunofluorescent intensities were analysed and showed that 
there were indeed two phases of expression of NFKB (Fig 63). 
Western blots were carried out on the cell lysate of untreated and treated cells (Fig 
64). The Western blots showed that there was an increase in NFKB within the first 
hour similar to that shown by the immunofluorescence results before returning to a 
level similar to the untreated cells. However unlike the immunofluorescence data 
there was no increase detected after the initial rise and fall. 
4.4.2 Treatment with ufCB over 18 hour period. 
Cells were treated for up to 18 hours with 100ýtg/ml ufCB prior to immunofluorescent 
staining. Photographs taken reveal that NFKB was activated in the first 30 minutes 
(Fig 65) causing nuclear localisation of NFKB which persists for the first hour before 
the levels of NFKB are reduced by 3 hours of treatment. At the 6 and 18 hour time 
points the levels of NFKB are increased again and there appears to be mainly 
cytoplasmic staining with some localisation around the nuclear membrane. Intensity 
analysis (Fig 66) showed that there were peaks at V2 and at 6-18 hours of treatment 
with a decrease between I and 4 hours of treatment, however these could be a result 
of variation in the data since neither of these peaks are statistically signiflcant. 
Western blots were carried out for the cell lysate of untreated and treated cells (Fig 
67). These indicate that the levels of NFKB within the cells vary over the time course 
with a reduction within the first hour, followed by and increase at 2 hours, a decrease 
at 4 hours followed by and increase at 6 and 18 hours. 
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4.4.3 Treatment with PM10 over 18 hour period. 
Cells were treated for up to 18 hours with 80ýtg/ml PM10 from Wolverhampton. 
Immunofluorescence microscopy showed that NFxB was present in the untreated 
cells in the cytoplasm and by 30 minutes of PM10 treatment NFrB had entered the 
nucleus of the cells (Fig 68). The nuclear localisation of NFKB persisted until 2 hours 
before being detectable only in the cytoplasm at 3 hours of treatment. After 3 hours 
the levels of NFKB would appear to decrease back to the levels of the untreated cells 
by 18 hours. Average immunofluorescence intensities show that there is a decrease in 
the intensity at the 30 minute time point this is due to the nuclear localisation of 
NFKB when little protein is found in the cytoplasm of the cells (Fig 69). Cytoplasmic 
staining tends to give high intensities whereas nuclear staining tends to be punctated 
which leads to underestimation of the intensity values. Once more cytoplasmic 
staining is present at I hour, the intensities increase up to about 3 hours until 
decreasing at 6 and 18 hours when the NFKB levels return to the untreated levels. 
Western blots were carried out on the cell lysates of the cells (Fig 70). This shows that 
there are higher levels of NFKB in the cell at 30 minutes and 4 hours. The higher level 
at 30 minutes is likely to be due to increased availability of NFKB binding sites for 
antibody binding when NFKB isn't bound to IKB. At 4 hours the high levels are more 
likely to be the result of high cytoplasmic levels of NFKB before returning to the 
untreated level of NFKB at 6 hours. 
4.4.4 Treatment with FeC13 over 4 hour period. 
Cells were treated with FeC13 over the 4 hour time period. This time period was 
chosen instead of the 18 hour time course since most effects on NFKB occur early in 
the time series of the other treatments and since FeC13 is soluble in the culture 
medium it might be expected to have a quicker effect on the cells than non-soluble, 
particulate, treatments. Immunofluorescence staining revealed that there was NFKB 
staining in the cytoplasm of the untreated cells as expected; however, the levels 
remained fairly constant over the four hour time course, with no nuclear localisation 
occurring, suggesting that no activation of NFKB occurred (Fig 71). The average 
immunofluorescence intensities of the cells revealed that the level of NFKB increased 
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after V2 an hour of treatment which it may be the result of a minor stress response or 
may be a normal factor in the cell cycle (Fig 72). 
Western blots were carried out on the cells lysates of the cells over 18 hours of 
treatment. The cell lysate Western blot revealed that NFKB was present at high levels 
in the cells at all time points and that little increase was seen with the exception of the 
6 hour time point where no NFKB was present (Fig 73). This may be the result of 
NFKB entering the nucleus at this time point, but it seems to occur at a later time point 
than expected and no evidence of this was seen in preliminary experiments to identify 
the best time series. 
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Figure 62: Expression of NFKB in A549 cells treated with 100gg/ml CB, for various time points 
up to 18 hours as shown by indirect immunofluorescence. For controls see Appendix 1. 
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Figure 63: Immunofluorescent intensities of cells stained for NFKB (p65) after 18 hours of 
lOOVg/mI CB treatment. The results are the mean of triplicate results from 3 experiments ± SE. 
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Figure 64: Level of NFKB (p65) expression in cell lysate measured by Western blot after 18 hours 
of 100gg/ml CB treatment. 
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Figure 65: Expression of NFKB in A549 cells treated with 100l. Lg/ml ufCB, for various time points 
up to 18 hours as shown by indirect immunofluorescence. X indicates nuclear localisation of 
NFKB. For controls see Appendix 1. 
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Figure 66: Immunofluorescent intensities of A459 cells stained for NFKB after 18 hours of 
100gg/ml ufCB treatment. The results are the mean of triplicate results from 3 experiments ± SE. 
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Figure 67: Level of NFKB (p65) expression in cell lysate measured by Western blot after 18 hours 
of 100 ýLg/ml ufCB treatment. 
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Figure 68: Expression of NFKB in A549 cells treated with 80lig/ml PMIO, for various time points 
up to 18 hours as shown by indirect immunofluorescence. X indicates nuclear localisation of 
NFKB. For controls see Appendix 1. 
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Figure 69: Immunofluoreseent intensities of A459 cells stained for NFKB after 18 hours of 
80gg/ml PM 10 treatment. The results are the mean of triplicate results from 3 experiments ± SE. 
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Figure 70: Level of NFKB (p65) expression in cell lysate measured by Western blot after 18 hours 
of 80gg/n-d PMIO treatment. 
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Figure 71: Expression of NFKB in A549 cells treated with IOOmM FeC13. for various time points 
up to 4 hours as shown by indirect immunofluorescence. For controls see Appendix 1. 
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Figure 72: Immunofluorescent intensities of A459 cells stained for NFKB after 18 hours of 
I 00mM FeC13 treatment. The results are the mean of triplicate results from 3 experiments ± SE. 
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Figure 73: Level of NFxB (p65) expression in cell lysate measured by Western blot after 18 
hours of IOOmM FeC13 treatment. 
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4.5.0 Effect of CB and ufCB treatment on JxB expression. 
4.5.1 Treatment with CB over 18 hour period. 
Cells were treated for up tol8 hours with 100lig/ml CB and then stained for IKB (the 
inhibitor of NFKB), using indirect immunofluorescence (Fig 74). This revealed that 
there were constitutive expression of IKB in the cell cytoplasm and after 30 minutes of 
treatment this was reduced until after 3 hours of treatment. This suggests that IKB 
may be degraded in the cell in response to CB treatment. At 6 hours of treatment there 
appears to be high levels of nuclear localisation of IKB which is reduced to mainly 
cytoplasmic staining around the nucleus of the cells at 18 hours. Immunofluorescence 
intensities were calculated (Fig 75) and this showed that there was a low level of IKB 
in the cells during the flrst 4 hours prior to an increase between 4 and 6 hours of 
treatment. 
Western blots were carried out on the cell lysates of the untreated and treated cells 
(Fig 76). The Westerns blots also indicated that ther e is ai decrease in the levels of IKB 
in the cells during the first four hours of treatment. The increase and decrease in IKB 
appear to be less pronounced in the Western blots than'the immuno fluorescence and 
this is likely to be the result of different sensitivities of the techniques. 
4.5.2 Treatment with ufCB over 18 hour period. 
Cells were treated with 100 gg/ml ufCB for various time points and analysed by 
indirect immunofluorescence (Fig 77). The flndings show that there is a decrease in 
the levels of licB after 30 minutes of treatment followed by high levels of IKB in the 
cell nucleus after I hour which persists until 3 hours of treatment. This suggests that 
there is degradation of IKB in the cell followed by an increase of IKB which 
translocates to the nucleus. This is indicative of a typical stress response where IKB is 
degraded in the cytoplasm allowing NFxB to enter the nucleus (see Fig 78) and bind 
to the DNA signalling the production of pro-inflammatory molecules including IKB. 
The newly synthesised IKB can then enter the nucleus and bind to NFKB and inhibit 
DNA binding resulting in the translocation of the licB-NFKB complex back into the 
cell cytoplasm. Intensity analysis of the fluorescence images shows- that- there is a 
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peak in IKB levels at I hour of treatment and that this decreases until 3 hours before 
increasing to IS hours of treatment. 
Western blots of the cell lysate revealed that IKB was present at high concentrations in 
the untreated cells and this level was decreased after 30 minutes of treatment an that 
the level of IKB rose thereafter (Fig 79). 
4.5.3 Treatment with PM10 over 18 hour period. 
Cells were treated for up to 18 hours with PMIO from Wolverhampton. 
Immunofluorescence microscopy showed that IKB was present in the untreated cells 
in the cytoplasm (Fig 80). There appeared to be no nuclear localisation of IKB even 
though NFKB was present in the nucleus from V2 -2 hours of treatment. Average 
immunofluoresence intensities show that there is some fluctuation in the levels of IKB 
over the time course but at no time are the levels significant from the untreated cells 
(Fig 81). 
Western blots were carried out on the cell lysates of the cells (Fig 82). This shows that 
t 
the levels of IKB in the cell fluctuate over the time course similarly to what was 
shown in the immunofluorescence results. 
4.5.4 Treatment with FeC13 over 4 hour period. 
Cells were treated with FeC13 over the 4 hour time period. This time period was 
chosen instead of the 18 hour time course since this was the time point chosen for 
NFKB. Immuno fluorescence staining revealed that there was staining in the cytoplasm 
of the untreated cells, as expected however the levels remained fairly constant of the 
four hour time course with no nuclear localisation, suggesting no activation was 
occurring (Fig 83). There was a decrease in the levels of IKB at 1/2 an hour of 
treatment, this may be due to degradation of IKB due to activation however, no NFKB 
nuclear localisation occurred for this treatment making degradation unlikely. The 
average immuno fluorescence intensities of the cells revealed that the level of IKB in 
the cells decreases after half an hour of treatment before rising slightly with time (Fig 
84). 
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Western blots were carried out on the cell lysates of the cells over 18 hours of 
treatment. The cell lysate Western blots revealed that IKB was present at high levels 
of the cells at all time points and that little change occurred with the exception of a 
decrease the half hour time point (Fig 85), which supports the immunofluorescence 
results. 
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Figure 74: Expression of IKB in A549 cells treated with 100l. Lg/ml CB, for various time points up 
to 18 hours as shown by indirect immunofluorescence. X indicates nuclear localisation of IKB. 
For controls see Appendix 1. 
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Figure 75: Immunofluorescent intensities of A459 cells stained for IKB after 18 hours of I 00gg/ml 
CB treatment. The results are the mean of triplicate results from 3 experiments ± SE. 
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Figure 76: Level of 11c. 13 expression in cell lysate measured by Western blot after 18 hours of 
lOOgg/n-d CB treatment. 
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Figure 77: Expression Of IKB in A549 cells treated with 100jig/ml ufCB, for various time points 
up to 18 hours as shown by indirect immunofluorescence. X indicates nuclear localisation of fic-B. 
For controls see Appendix 1. 
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Figure 78: Immunofluorescent intensities of A459 cells stained for IKB after 18 hours of 100 
gg/ml ufCB treatment. The results are the mean of triplicate results from 3 experiments ± SE. 
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I. ig/ml ufCB treatment. 
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Figure 80: Expression of IKB in A549 cells treated with 80ýig/ml PMIO, for various time points up 15 
to 18 hours as shown by indirect immunofluorescence. For controls see Appendix 1. 
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Figure 81: Immunofluorescent intensities of A459 cells stained for IKB after 18 hours of 80gg/ml 
PMIO treatment. The results are the mean of triplicate results from 3 experiments ± SE. 
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Figure 82: Level of IKB expression in cell lysate measured by Western blot after 18 hours of 
80ýLg/ml PM 10 treatment. 
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Figure 83: Expression of IKB in A549 cells treated with 100ýM FeC13. for various time points up 
to 18 hours as shown by indirect immunofluorescence. For controls see Appendix 1. 
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Figure 84: Immunofluorescent intensities of A459 cells stained for IxB after 18 hours of 100ýLM 
FeC13 treatment. The results are the mean of triplicate results from 3 experiments ± SE. 
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Figure 85: Level of IKB expression in cell lysate measured by Western blot after 18 hours of 
I 00ýLM FeC13 treatment. 
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Chapter 5 
Possible mechanisms of inflammatory protein expression 
and secretion in lung epithelial cells in response to particle 
treatments. 
ill 
5.1.0 Are inflammatorv proteins actively secreted from the cells into the culture 
SUDernatant or released as a result of membrane damap-e? 
5.1.1. Is the cell membrane damaged during cell treatment? 
To determine if CRP, fibrinogen and Hsp, 70 present in the cell supernatant were 
present in the cell supernatant as a result of membrane damage during cell treatment 
dye exclusion studies were carried out. Due to the limited availability of 
Wolverhampton PM10, investigations of particle mechanisms were carried out using 
ufCB which showed similar results to the PM10 treatments in previous experiments. 
Cells were gown on glass coverslips and treated with ufCB as shown previously 
before incubation with propidium iodide. If the cell membrane was damaged due to 
particle exposure the propidium. iodide would be able to enter the cell and stain the 
cell nuclei. Cells were viewed under the UV microscope and the percentage viability 
was calculated (Fig 88). This showed that for ufCB that there was only a small 
decrease in cell viability which was not statistically significant suggesting that the 
cells remained viable after treatment. 
5.1.2 Treatment of A549 cells with particles and Brefeldin A. 
To identify if CRP, fibrinogen and Hsp70 present in the cell supernatant were as a 
result of active secretion from the cell via the Golgi, cells were co-treated with either 
CB or ufCB with Brefeldin A. Brefeldin A is an antiviral antibiotic which can inhibit 
the transport of newly synthesised proteins from the endoplasmic reticulum to the 
Golgi complex (Misumi el. aL, 1986). ELISAs were carried out for CRP and 
fibrinogen and Western blots were carried out for Hsp70 on the cell supernatants with 
particle and Brefeldin A co-treatments and for particle treatments alone. Levels of 
CRP in the supernatants was found to be decreased for all treatments (untreated 
control, 100gg/ml CB and 100gg/ml ufCB) when Brefeldin A was present (Fig 87). 
Both the particle treatments with Brefeldin A showed a decrease in CRP in the 
supernatant which was statistically significant (p<0.05) from the particle treatment 
alone, suggesting that secretion was responsible for CRP being present in the 
supernatant. 
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The concentration of fibrinogen in the supernatants were analysed using ELISA for 
the Brefeldin A treatment. Fibrinogen secretion was found to be prevented for all 
treatments (untreated control, lOOpg/ml CB and 100lig/ml ufCB) when Brefeldin A 
was present (Fig 88). In the untreated control cells, there was a large decrease in the 
amount of fibrinogen present; however, this result was not statistically significant. 
Both the particle treatments showed a decrease with Brefeldin A treatment with only 
ufCB being statistically significant (p<0.05) from the particle treatment alone. This 
suggests that secretion was responsible for fibrinogen being present in the supernatant 
for ufCB treatment and that it is likely to be responsible for CB. 
The amount of Hsp70 secreted from the cells with particle and Brefeldin A treatment 
was determined using Western blotting. Secretion of Hsp70 was found to be 
prevented for all treatments (untreated control, 100[tg/ml CB and 100ýtg/ml ufCB) 
when Brefeldin A was present (Fig 89). This indicates that Hsp70 is actively secreted 
from A549 cells in response to both CB and ufCB exposure. 
113 
95 
90 
85 
80 
- 75 0 
70 
Figure 86: Percentage of propidium iodide dye exclusion in A549 cells with 100[ig/ml ufCB 
treatment. The results are the mean of triplicate results from 3 experiments ± SE. 
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Figure 87: Concentration of CRP in cell supernatant measured by ELISA after 6 hours of 
Brefeldin A (10lig/ml) and particle treatment (100pg/ml) of A549 cells. The results are the mean 
of triplicate results from 3 experiments ± SE. Asterisk (*) denotes significant changes from 
particle only treatments, p< 0.05. 
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Figure 88: Concentration of fibrinogen in cell supernatant measured by ELISA after 6 hours of 
Brefeldin A (10pg/ml) and particle treatment (100 pg/ml) of A549 cells. The results are the mean 
of triplicate results from 3 experiments ± SE. Asterisk (*) denotes significant changes from 
particle only treatments, p< 0.05. 
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a) Western blot of particle and Brefeldin A treatments, stained for Hsp70. Where 1) untreated, 2) 
untreated + Brefeldin A, 3) CB treated, 4) CB + Brefeldin A treated, 5) ufCB treated, and 6) ufCB and 
Brefeldin A treated. 
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Figure 89: Level of Hsp70 in cell supernatant measured by Western blot band intensities using 
Metamorph software after 6 hours of Brefeldin A and particle treatment of A549 cells. The 
results are the mean of triplicate results from 3 experiments ± SE. Asterisk (*) denotes significant 
changes from untreated control cells, p< 0.05 and S denotes significant changes from particle 
oniv treatments, p< 0.05. 
115 
5.2 How do particles induce the expression of CRP, Fibrinoeen and Hsp70? 
5.2.1 Effect of transcription complexes on CRP expression and secretion. 
The expression of CRP is known to be under the transcriptional control of NFKB in 
hepatocytes. It is also known that particles can produce oxidative stress in the lung 
epithelium which results in the degradation of IKB which in turn results in the 
activation and nuclear translocation of NFKB. In chapter 2 NFKB was found to 
translocate to the nucleus of A549 cells after treatment with CB, ufCB and PM10. To 
determine if NFKB was able to signal the production of CRP in response to particle 
treatments, cells were treated with ufCB (100ýtg/ml) in the presence of sn50 
(50ýtg/ml) an inhibitor of NFKB nuclear translocation. Cells were also treated with 
another inhibitor Ag490 (50ýM), which inhibits the Jak family tyrosine kinase, 
preventing its phosphorylation. This inhibitor was used since it was shown to inhibit 
the Jak/STAT transcription complex involved in the production of Hsp70 in response 
to oxidative stress. Potentially this pathway may be generally involved in oxidative 
mechanisms of inflammatory protein production. Cells were treated for 6 hours with 
ufCB in the presence and absence of these inhibitors. ELISAs carried out on the cell 
lysates (Fig 90) showed that there was a statistically significant increase (p<0.05) in 
CRP with ufCB treatment and that both inhibitors reduced the level of CRP in the 
cells. The reduction in CRP with inhibitors was not statistically significant from the 
ufCB treated cells. ELISAs carried out on the cell supernatants (Fig 91) showed that 
ufCB resulted in a statistically significant (p<0.05) increase in CRP secretion. 
Treatment in the presence of the inhibitors reduced the levels of secreted CRP to the 
level of the untreated cells and this reduction was also statistically significant 
(p<0.05). 
5.2.2 Effect of transcription complexes on fibrinogen expression and secretion. 
To investigate the effect of transcription events of fibrinogen production A549 cells 
were treated with ufCB (100[tg/ml) and the transcription inhibitors sn50 (50[tg/ml) 
and Ag490 (50ýM), as shown for the effects on CRP production. ELISAs carried out 
for fibrinogen showed that ufCB induced a statistically significant increase (P<0.05) 
in the levels of fibrinogen in the cells compared to untreated cells (Fig 92). The cells 
treated with ufCB in the presence of Ag490 appeared to have no inhibitory effects of 
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the expression of fibrinogen induced by ufCB. ELISAs carried out on the cell 
supernatants (Fig 93) showed that there was an increase in fibrinogen secretion with 
ufCB and the levels of secretion were reduced by both inhibitors. The cells treated 
with sn50 (the inhibitor of NFKB nuclear translocation) showed a reduction in 
fibrinogen secretion which was lower than the levels of secretion in untreated cells; 
however, this reduction was not statistically significant from the ufCB treated cells. 
5.2.3 Effect of transcription complexes on Hsp70 expression and secretion. 
To investigate the effect of transcription events of the expression of Hsp70 with ufCB 
exposure the same inhibitors were used as for CRP and fibrinogen. 
Immunofluorescence microscopy was carried out on the treated cells and the average 
intensities of the cells carried out (Fig 94). This shows that ufCB (100gg/ml) 
increased the levels of Hsp70 in the cells and that Ag490 reduced the level of Hsp70 
while sn50 had little effect. Western blots were carried out on the cell supernatants 
(Fig 95). This showed that ufCB induced an increase in secreted Hsp70. The Western 
blots also showed that the inhibitors reduced the amount of secreted Hsp70, 
particularly in the Ag490 treated cells. 
117 
7 
6 
5 
E 
1 
0 
Ag490 sn50 
Figure 90: Concentration of CRP in cell lysate measured by ELISA after 6 hours of ufCB 
(100pg/ml) and transcription inhibitor treatment of A549 cells. Cells were treated with 50PM 
Ag490 and 50pg/ml sn50. Where Ag490 is the inhibitor of the JAK/STAT transcription events 
and sn50 is an inhibitor of NFKB nuclear translocation. The results are the mean of triplicate 
results from 3 experiments ± SE. Asterisk (*) denotes significant changes from untreated cells, p< 
0.05. 
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Figure 91: Concentration of CRP in cell supernatant measured by ELISA after 6 hours of ufCB 
(100pg/ml) and transcription inhibitor treatment of A549 cells. Cells were treated with 50PM 
Ag490 and 50pg/ml sn50. Where Ag490 is the inhibitor of the JAK/STAT transcription events 
and sn50 is an inhibitor of NFKB nuclear translocation. The results are the mean of triplicate 
results from 3 experiments ± SE. Asterisk (*) denotes significant changes from untreated cells, p< 
0.05 and S denotes significant decrease from ufCB treated cells. 
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Figure 92: Concentration of fibrinogen in cell lysate measured by ELISA after 6 hours of ufCB 
(100tig/ml) and transcription inhibitor treatment of A549 cells. Cells were treated with 50ým 
Ag490 and 50pg/ml sn50. Where Ag490 is the inhibitor of the JAK/STAT transcription events 
and sn5O is an inhibitor of NFO nuclear translocation. The results are the mean of triplicate 
results from 3 experiments ± SE. Asterisk (*) denotes significant changes from untreated cells, 
p< 0.05. 
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Figure 93: Concentration of fibrinogen in cell supernatant measured by ELISA after 6 hours of 
ufCB (100gg/ml) and transcription inhibitor treatment of A549 cells. Cells were treated with 
50jiM Ag490 and 50pg/ml sn50. Where Ag490 is the inhibitor of the JAVJSTAT transcription 
events and sn50 is an inhibitor of NFKB nuclear translocation. The results are the mean of 
triplicate results from 3 experiments ± SE. 
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Figure 94: Immunofluorescent intensities of A459 cells stained for Hsp70 after 6 hours of ufCB 
(100pg/ml) and transcription inhibitor treatment of A549 cells. Cells were treated with 50PM 
Ag490 and 50pg/mi sn50. Where Ag490 is the inhibitor of the JAK/STAT transcription events 
and sn50 is an inhibitor of NFKB nuclear translocation. The results are the mean of triplicate 
results from 3 experiments ± SE. 
Figure 95: Western blot of A459 cells stained for Hsp70 after 6 hours of ufCB (100ýLg/ml) and 
transcription inhibitor treatment of A549 cells. Where lane I is untreated cells, 2 is ufCB 
treated, 3 is cells treated with 5OgM Ag490 and ufCB and lane 4 is cells treated with 50gg/ml 
sn5O and ufCB. Where Ag490 is the inhibitor of the JAK/STAT transcription events and sn5O is 
an inhibitor of NFKB nuclear translocation. The results are the mean of triplicate results from 3 
experiments ± SE. 
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5.3.0 Are CRP, Fibrino2en and Hsp70 produced in response to oxidative stress? 
5.3.1 Effect of t-butyrI hydroperoxide (tBHP) treatment on CRP expression. 
To investigate if CRP was produced as a direct result of oxidative mechanisms cells 
were treated with tBHP to induce oxidative stress. Cells were treated with 5ýLM tBHP 
for various time points up to 6 hours. Immunofluorescent staining showed that there 
was an increase in CRP with time (Fig 96). Analysis of the cell supernatants, by 
ELISA, showed that there was an increase in secreted CRP with tBHP over the time 
course (Fig 97). The levels of CRP secretion was found to be statistically significant 
after 6 hours of treatment (p<0.05). 
5.3.2 Effect of t-butyrI hydroperoxide (tBHP) treatment on fibrinogen 
expression. 
Cells were treated with tBHP similarly to that for CRP expression. 
Immunofluorescence staining showed that fibrinogen expression was increased over 
the time course (Fig 98). The staining pattern at the 6 hour time point shows some 
polarised localisation of fibrinogen. This staining pattern is very similar to that seen in 
cells treated with ufCB for 6 and 18 hours. This may suggest that a similar mechanism 
is responsible for the polarisation of fibrinogen for these treatments. Analysis of the 
cell supernatants, by ELISA, shows that there is an increase in the secretion of 
fibrinogen with time but differences between the experimental results are too great to 
achieve any statistical significance (Fig 99). 
5.3.3 Effect of t-butyrI hydroperoxide (tBHP) treatment on Hsp70 expression. 
Cells treated with tBHP for up to 6 hours showed that there was an increase in the 
levels of Hsp70. Immunofluorescence analysis shows that there is some nuclear 
localisation of Hsp70 by 30 minutes of treatment (Fig 100). At the 6 hour time point 
there are several different staining patterns present including nuclear and peri-nuclear 
staining patterns. Some of the cells would appear to be activated and producing 
projections which have some Hsp70 staining. Hsp70 may be distributed evenly along 
the cytoplasm or there may be membrane staining. The perinuclear staining shows a 
slight polarised effect which may suggest morphological changes in the cells. 
Analysis of the cell supernatants was carried out using Western blotting (Fig 101). 
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This shows that there is a large increase in Hsp70 by half an hour of treatment and 
this continues to be increased up to the 6 hour time point. 
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Figure 96: Expression of C-reactive protein (CRP) in A549 cells treated with 5ýLM tBHP, for 
various time points up to 6 hours as shown by indirect immunolluorescence. 
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Figure 97: Concentration of CRP in cell supernatant measured by ELISA after 6 hours of 5PM 
tBHP treatment of A549 cells. The results are the mean of triplicate results from 3 experiments 
SE. Asterisk (*) denotes significant changes from untreated cells, p< 0.05. 
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Figure 98: Expression of fibrinogen in A549 cells treated with 5l. LM tBHP, for various time points 
up to 6 hours as shown by indirect immunofluorescence. 
1 
0.9 
0.8 
E 0.7 
0.6 
0.5 
CD 0 r 
0.4 
. I- jn 0.3 
" 0.2 
0.1 
0 
8 
Time (hours) 
Figure 99: Concentration of fibrinogen in cell supernatant measured by ELISA after 6 hours of 
51M tl3HP treatment of A549 cells. The results are the mean of triplicate results from 3 
experiments ± SE. 
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Figure 100: Expression of Hsp70 in A549 cells treated with 5j. LM tBHP, for various time points up el 
to 6 hours as shown by indirect immunofluorescence. 
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Figure 101: Level of Hsp70 secretion measured by western blot after 6 hours of 5liM tBHP 
treatment of A549 cells. 
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5.3.4 Effect of antioxidants on NFKB expression with ufCB treatment. 
To investigate if the increase in cellular NFKB and its nuclear translocation was a 
result of oxidative stress cells were treated with ufCB in the presence of antioxidants. 
The antioxidants used were Nacystelin (NAL) and Trolox. Antioxidants have been 
shown to prevent the nuclear translocation of NFKB by mopping up free radicals, thus 
reducing the signalling and degradation of IKB. Cells treated with ufCB show some 
nuclear localisation of NFKB after 6 hours of treatment. Immunofluorescent staining 
for NFKB shows that the level of nuclear staining is decreased in cells with 
antioxidants simultaneously with ufCB treatment (Fig 102). The amount of nuclear 
staining is not completely eliminated with antioxidant treatment although it is greatly 
reduced. 
5.3.5 Effect of antioxidants on CRP expression with ufCB treatment. 
After establishing that CRP expression is NFKB dependent, and antioxidants reduce 
the translocation of NFKB, the effect of antioxidants on CRP expression was carried 
out. Cells were treated for 6 hours in the presence of ufCB and antioxidants. ELISAs 
were carried out (Fig 103) on the cell lysates of treated cells. This showed that ufCB 
increased the level of CRP and this increase was statistically significant from 
untreated cells. Treatments with both the antioxidants in the presence of uf'CB showed 
a reduction in the concentration of CRP in the cell lysates. Although this result is not 
significant from ufCB, it is no longer different from the control cells. Analysis of the 
cells supernatants by ELISA (Fig 104) showed that once again ufCB induced a 
statistically significant increase in the amount of secreted CRP (p<0.05). When cells 
were treated with ufCB and antioxidants the level of secreted CRP was reduced to the 
level in the untreated cells for both NAL and Trolox and this reduction was 
statistically significant for both (p<0.05). 
5.3.6 Effect of antioxidants on fibrinogen expression with ufCB treatment. 
The effect of antioxidants on the expression of fibrinogen in A549 cells with ufCB 
was carried out as for CRP. ELISAs of the cell lysate showed that ufCB induced an 
increase in fibrinogen which was statistically significant (p<0.05) from untreated cells 
(Fig 105). The cells treated with antioxidants simultaneously with ufCB showed a 
small decrease in the level of fibrinogen however when the degree of error is taken 
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into consideration this decrease is small. Analysis of the cell supernatants using 
ELISAs (Fig 106) showed that ufCB increased the level of secreted fibrinogen in a 
statistically significant manner (p<0.05). The cells treated with ufCB and antioxidants 
simultaneously showed a decrease to the level in the untreated cells and this decrease 
was statistically significant (p<0.05). 
5.3.7 Effect of antioxidants on Hsp70 expression with ufCB treatment. 
Treatment of A549 cells with antioxidants and ufCB was carried out to identify the 
effects on the expression of Hsp70. Immunofluorescence staining of the cells for 
Hsp70 was carried out and the average fluorescent intensity of the cells was 
calculated (Fig 107). This showed that ufCB increased the level of Hsp70 in the cells 
and this was reduced by simultaneous treatment of ufCB with antioxidants. With the 
ufCB and NAL treatment inducing a decrease which is statistically significant 
(p<0.05). Western blots were carried out on the cell supernatants (Fig 108). This 
showed that ufCB increased the level of Hsp70 secreted from the cells. Treatment in 
the presence of antioxidants reduced the levels of secreted Hsp70 induced by ufCB. 
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Figure 102: Expression of NFKB in A549 cells treated with the antioxidants Nacystalin (NAL, 
200ýM) or Trolox (25[tM) for 6 hours as shown by indirect immunofluorescence. 
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Figure 103: Concentration of CRP in cell lysate measured by ELISA after 6 hours of ufCB 
(100pg/ml) and antioxidant treatment of A549 cells. Cells were treated with the antioxidants 
Nacystalin (NAL, 200pM) or Trolox (25ý1M). The results are the mean of triplicate results from 3 
experiments ± SE. Asterisk (*) denotes significant changes from untreated cells, p< 0.05. 
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Figure 104: Concentration of CRP in cell supernatant measured by ELISA after 6 hours of ufCB 
(100pg/ml) and antioxidant treatment of A549 cells. Cells were treated with the antioxidants 
Nacystalin (NAL, 200pM) or Trolox (251M). The results are the mean of triplicate results from 3 
experiments ± SE. Asterisk (*) denotes significant changes from untreated cells, p< 0.05 and $ 
denotes significant decrease from ufCB treated cells, p<0.05. 
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Figure 105: Concentration of fibrinogen in cell lysate measured by ELISA after 6 hours of ufCB 
(100gg/ml) and antioxidant treatment of A549 cells. Cells were treated with the antioxidants 
Nacystalin (NAL, 200pM) or Trolox (25[tM). The results are the mean of triplicate results from 3 
experiments ± SE. Asterisk (*) denotes significant changes from untreated cells, p< 0.05. 
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Figure 106: Concentration of fibrinogen in cell supernatant measured by ELISA after 6 hours of 
ufCB (100ýLg/ml) and antioxidant treatment of A549 cells. Cells were treated with the 
antioxidants Nacystalin (NAL, 200ýM) or Trolox (25tiM). The results are the mean of triplicate 
results from 3 experiments ± SE. Asterisk (*) denotes significant changes from untreated cells, p< 
0.05 and $ denotes significant changes from ufCB treated cells, p<0.05. 
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Figure 107: Level of Hsp70 expression measured by immunofluorescence after 6 hours of ufCB 
(100jig/ml) and antioxidant treatment of A549 cells. Cells were treated with the antioxidants 
Nacystalin (NAL, 200gM) or Trolox (25gM). The results are the mean of triplicate results from 3 
experiments ± SE. Asterisk (*) denotes significant changes from untreated cells, p< 0.05. 
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Figure 108: Level of Hsp70 secretion measured by western blot after 6 hours of ufCB (100lig/n-d) 
and antioxidant treatment of A549 cells. Cells were treated with the antioxidants Nacystalin 
(NAL, 200ýM) or Trolox (25gM). Where lane I is untreated cells, 2 is ufCB treated, 3 is NAL 
treated and 4 is Trolox treated cells. The results are the mean of triplicate results from 3 
experiments ± SE. 
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5.3.8. Morphological changes in A549 cells with particle changes. 
The immunofluorescent images of particle treated cells showed several different 
staining patterns. The polarised expression of CRP and fibrinogen with ufCB and 
tBHP suggest that morphological changes of the cells may be occurring. A review on 
oxidative stress showed that morphological change in cells was a common indication 
that oxidative stress was occurring (Bellomo and Mirabelli, 1992). To investigate if 
morphological changes in the cells did indeed occur with particle treatments cells 
were treated and stained using Diff-Quick. This is a qualitative technique which 
shows what is happening to the cells however, this gives no quantitative results 
although the images shown represent what was occurring over repeated measures. 
Cells treated with 5gM tBHP would be expected to be under going oxidative stress 
and when the Diff-Quick stained slides were analysed there did appear to be some 
morphological changes over the first 6 hours of treatment (Fig 109). By one hour of 
treatment there was elongation of the cells and after two hours there appeared to be 
some cell debris present probably due to apoptotic or necrotic events associated with 
the stress response. By three hours of treatment there appears to be some cellular 
adaptation with cells of almost normal appearance and with more characteristic 
spherical cell shape associated with A549 cells. This may be the result of a large heat 
shock response as shown by the immunofluorescence pictures of cells stained for 
Hsp70 after 6 hours of treatment. Treatment of cells with 80JIg/mI PMIO showed that 
like the tBHP treatment, morphological changes occurred over the time course (Fig 
110). The PM 10 treatment started to show morphological changes around the 3 hour 
time point and the changes increased with time. This is unlike the tBHP treatment 
where the cells appeared to recover with time. The PMIO treatment appears to be 
activating the cells with increased cell projections present, particularly after 18 hours 
of treatment. Treatment with 100ýtg/ml ufCB showed morphological changes from 
half an hour of treatment (Fig I 11). These changes appeared to be greater than those 
produced by either tBHP or PMIO in the first few hour of treatment, although ufCB 
showed similar changes as PM10 at the 6 and 18 hour time points. Cells exposed to 
100ýtg/ml CB showed some morphological changes at the 6 and 18 hour time points 
although they were not as great as the changes shown with PM10 of ufCB treatment 
(Fig 112). Cells exposed to 100mM FeC13 showed very few morphological changes 
over the 18 hour time course (Fig 113). 
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Figure 109: Diff-Quick staining of cells treated with 5ýLM tBHP for up to 4 hours to show changes 
in cell morphology. Pictures shown are representative images of repeated experiments (n=3). 
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Figure 110: Diff-Quick staining of cells treated with 80gg/ml, for up to PM 10 18 hours to show 
changes in cell morphology. Pictures shown are representative images of repeated experiments 
(n=3). 
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Figure I 11: Diff-Quick staining of cells treated with I 00ýLg/ml ufCB for up to 18 hours to show 
changes in cell morphology. Pictures shown are representative images of repeated experiments 
(n=3). 
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Figure 112: Diff-Quick staining of cells treated with 100pg/ml CB for up to 18 hours to show 
changes in cell morphology. Pictures shown are representative images of repeated experiments 
(n=3). 
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Figure 113: Diff-Quick staining of cells treated with 100 pM FeC13 for up to 18 hours to show 
changes in cell morphology. Pictures shown are representative images of repeated experiments 
(n=3). 
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5.3.9. Intracellular ATP levels over 18 hour time course of treatments. 
A review on cytoskeletal changes in response to oxidative stress (Belomo and 
Mirabelli, 1992) suggests that cytoskeletal. changes often arise simultaneously with 
ATP depletion when cells are challenged with oxidants. To investigate if there were 
any changes in intracellular ATP, cells were treated with either ufCB, tBHP, CB or 
tBHP and the ATP levels measured using the luciferase assay. The levels of 
intracellular ATP show that decreases occur with CB, ufCB and tBHP but not with 
FeC13 (Fig 114). The results for FeC13 were not unexpected since very little 
inflammatory protein expression was induced by this treatment and also there were 
few morphological changes. PMIO and ufCB produced similar decreases in 
intracellular ATP with tBHP producing a slightly larger decrease which was also not 
unexpected since both exposures induced morphological in cells. Surprisingly, the CB 
treatment showed a sharp decrease in ATP early on before the level of ATP increased 
to that of the untreated cells after 18 hours. This was unexpected but was present in all 
replicates of the treatment. 
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Figure 114: Level of intracellular ATP in A549 cells measured by luciferase assay. Cell 
treatments are 100mM FeC6 100pg/ml CB, 100pg/nd ufCB and 5PM tBHP. The results are the 
mean of triplicate results from 3 experiments ± SE. 
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5.4. Is expression of CRP, flbrino2en and HsV70 a result of newIV synthesised 
protein or the release of stored protein? 
5.4.1 RT-PCR for CRP with particle treatments. 
To determine if the expression of CRP in cells after particle treatments was a result of 
de novo protein synthesis after transcriptional activation of the CRP gene, RT-PCR 
was carried out on the cells. CRP is known to be present in the cell cytoplasm bound 
to the endoplasmic reticulum in an inactive state ready to undergo post transcriptional 
modifications so that it can be released quickly in response to inflammatory stimuli 
(Yue et. A 1996). RT-PCR was carried out to examine mechanisms responsible for 
CRP expression. Cells were exposed for 90 minutes to CB, ufCB, FeC13, tBHP or 
TNFa, before RNA extraction. UfCB was found to produce the highest levels of 
mRNA expression (Fig 115) and this was statistically significant from the untreated 
cells (p<0.001). Small increases in mRNA were also found for tBHP and TNFa and 
this may be due to the fact that they are both soluble in the culture medium and may 
induce a faster response than the particle treatments which results in the mRNA being 
produced before this time point. The increase in mRNA with the treatments indicates 
that CRP is being produced by the cells in response to a transcription signal being 
induced by the cell treatments. 
5.4.2 RT-PCR for flbrinogen with particle treatments. 
To find out if fibrinogen was being produced in the cells as a result of transcriptional 
activation RT-PCR was carried out. UfCB and tBHP treatments showed the greatest 
increases in fibrinogen mRNA expression (Fig 116); however, this did not show any 
statistical significance due to high variation among the replicates although increases 
were found in each. There were also very small increases with the CB and FeC13 
treatments. There was no increase in the levels of RNA with TNF (x treatment which 
would be expected since TNFa has been shown to reduce or prevent fibrinogen 
expression (Zhang and Fuller, 2000; Nguyen and Simpson-Haidaris, 2000). 
5.4.3 RT-PCR for Hsp70 with particle treatments. 
To identify if Hsp70 was being produced in the cells as a result of transcriptional 
activation RT-PCR was carried out. UfCB, tBHP and FeC13 treatments all showed an 
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increase in the levels of Hsp70 mRNA expression (Fig 118). Once again there was no 
statistical significance of these treatments over the untreated cells due to variation 
between the replicates. Interestingly the CB treatment showed a decrease in the level 
of RNA which was unexpected. However, it would appear that Hsp70 was being 
produced in the cells as a result of transcriptional activation. 
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Figure 115: Level of CRP mRNA in A549 cells measured by RT-PCR. Cells were treated with 
100lig/nd CB, 100ýtg/ml ufCB 5ýM tBHP, 100mM FeC13 and IOng/ml TNF(x for 90 minutes. The 
results are the mean of triplicate results from 3 experiments ± SE. Asterisks (***) denote 
statistical significance from untreated cells p<0.001. 
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Figure 116: Level of fibrinogen mRNA in A549 cells measured by RT-PCR. Cells were treated 
with 100gg/ml CB, 100lig/ml ufCB 5pM tBHP, 100mM FeC13 and IOng/mI TNFcc for 90 minutes. 
The results are the mean of triplicate results from 3 experiments ± SE. 
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Figure 117: Level of Hsp70 mRNA in A549 cells measured by RT-PCR. Cells were treated with 
1OOpg/n-d CB, 100gg/ml ufCB 51M tBHP, 100mM FeC13 and IOng/n-d TNFcc for 90 minutes. The 
results are the mean of triplicate results from 3 experiments ± SE. 
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Chapter 6 
Investigation into functions of secreted pro-inflammatory 
proteins. 
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6.1.0 Effect of CRP and Fibrinogen treatment on Monomac 6 (MM6) cells. 
6.1.1 Effect of CRP treatment on MM6 cell line 
To determine the effect of secreted CRP on other cells, monocyte-like NM6 cells 
were treated with recombinant CRP. The concentration of CRP used was determined 
by the amount of CRP present in the cell supernatants of particle treated cells. MM6 
cells were treated with 4gg/ml of recombinant CRP for up to 4 hours. Cells were then 
used for indirect immunofluoresence and examined for CRP, fibrinogen, Hsp70 and 
NFY, B expression. This showed that CRP treatment induced the expression of CRP 
and NFKB within the cells but very little fibrinogen and Hsp70 expression was 
induced (Figure 118). In the NFKB stained cells there was some nuclear staining 
present which may be responsible for CRP expression. However, there is no increase 
in fibrinogen expression which indicates that the presence of CRP may arise due to 
activation of stored CRP and not NFKB induced transcription of CRP. Fibrinogen 
expression may arise in response to conditioned media (CM) treatments at a later time 
point. 
6.1.2 Effect of fibrinogen treatment on MM6 cell line 
To deterinine the effect of secreted fibrinogen on NM6 cells, the cells were treated 
with recombinant human fibrinogen. The concentration used was similar to the 
amount of fibrinogen secreted from the cells treated with particles. MM6 cells were 
treated with 2[ig/ml fibrinogen for 4 hours. Cells were then examined using indirect 
immunofluoresence for CRP, fibrinogen, Hsp70 and NFKB expression. This shows 
that fibrinogen treatments induced the expression of all proteins except CRP after 4 
hours of treatment (Fig 119). Once again, as for the CRP treatment, there is some 
nuclear staining of NFKB with fibrinogen treatment. The expression of Hsp70 may 
suggest that the cells are stressed by the fibrinogen treatment. 
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Figure 118: Expression of inflammatory protein expression in MM6 cells treated with, 4mg/ml 
recombinant human CRP after 4 hours of treatment. Negative controls show little background 
staining which is at a similar level to the cells stained for Hsp70. X indicates nuclear localisation 
of NFKB. 
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Figure 119: Expression of inflammatory protein expression ill MM6 cells treated with 2mg/ml 
recombinant human fibrinogen after 4 hours of treatment. Negative controls show little 
background staining which is at a similar level to the cells stained for CRP. X indicates nuclear 
localisation of NFKB. 
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6.2.0 Effect of A549 conditioned media on pro-inflammatory protein expression 
and secretion MM6 cells. 
The effect of CM from A549 cells, treated with lOOgg/ml ufCB for 18 hours, was 
examined using MM6 cells. There is likely to be high concentrations of many proteins 
in the CM including cytokines, CRP, fibrinogen and Hsp70, which may have various 
effects on the MM6 cells. MM6 cells were treated with the CM for 4 hours and 
indirect immunofluoresence was carried on the cells (Fig 120). This showed an 
increase in CRP, fibrinogen, Hsp70 and nuclear and cytoplasmic expression of NFKB. 
ELISAs were than carried out to find out what proteins were present in the medium 
and to see if MM6 were producing pro-inflammatory proteins in response to this 
treatment. This shows that the acute phase protein fibrinogen was increased after CM 
treatment suggesting that fibrinogen was being secreted from the MM6 cells (Fig 
121). However there was little secretion of CRP by N4M6 after CM treatment 
although there was CRP present in the A549 CM. 
ELISAs for the cytokines IL6, IL8 and TNF(x were carried out (Fig 122). This 
showed that there was an increase in production of IL6 and TNF(x by MM6 treatment 
after CM treatment. There was however a large increase in the amount of IL8, present 
in the supernatant after treatment with the A549 CM which is statistically significant 
(p<0.001) from the untreated MM6 cells and the A549 CM. This may be the result of 
cellular damage since IL8 is known to be involved in the recruitment of circulating 
neutrophils to tissue damage 
6.3.0 Does A549 CM have damaging effects on MM6 cells? 
The production of the pro-inflammatory protein expression suggested that MM6 cells 
may be maintaining an inflammatory response and this may be associated with cell 
damage. Therefore the cells were examined for morphological changes associated 
with cellular stresses. This was carried out as before by staining the treated cells with 
Diff-Quick staining solutions (Fig 123). This shows that there is a dramatic response 
of the cells at V2hour of CM treatment shown by nuclear condensation of the cells 
with some signs of necrosis shown by loss of normal cellular morphology and cellular 
disintegration. By I hour of treatment the cells still show nuclear condensation but 
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there are far fewer cells present and many more necrotic cells. At 1 hour there also 
appears to be some apoptotic cells displaying nuclear fragmentation. By 2 hours of 
treatment most of the cells appear to be recovering with some necrotic cells present 
and also some phagocytic activity by some of the cells. At 3 hours of treatment the 
cells appear to be more non-nal in shape and by 4 hours of treatment the cells look as 
healthy as the untreated cells. This suggests that the CM is inducing a huge 
inflammatory/stress response in these cells. 
A LDH assay was than carried out to find if the cells were indeed becoming damaged 
by the treatment as would appear by looking at the morphological changes. LDH is 
released by the cells during membrane damage which can occur as cells become 
necrotic. The assay (Fig 124) showed that there was an increase in the amount of 
LDH release by the cells with CM treatment which is statistically significant 
(p<0.05). There was little production by the untreated cells and the A549 cells which 
were treated by the ufCB particles. This also suggests that the ufCB treated A549 
cells were producing something which was causing a huge stress response in MM6 
cells. 
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Figure 120: Expression of inflammatory protein expression in MM6 cells treated with ufCB 
treated A549 conditioned medium for 4 hours. Negative controls show little background staining. 
X indicates nuclear localisation of NFKB. 
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Figure 121: Acute phase protein concentration in cell supernatants with A549 CM. The results 
are the mean of triplicate results from 3 experiments ± SE. 
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Figure 122: Cytokine concentration in cell supernatants with A549 CM. The results are the mean 
of triplicate results from 3 experiments ± SE. Asterisks (***, **) denote significant changes from 
untreated MM6 cells and $ denotes significant change in ILS present in MM6 supernatant over 
A549 supernatant. 
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Figure 123: Diff-Quick staining of MM6 cells treated with A549 CM. X- necrotic cells, Y- 
apoptotic cells, Z- phagocytosis. 
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Figure 124: LDH assay for CM treated MM6 cells. The results are the mean of triplicate results 
from 3 experiments ± SE. Asterisk (*) denotes significant changes from untreated MM6 cells and A549 supernatant. 
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Discussion and Conclusions. 
7.1.0 Expression of acute phase proteins in A549 cells after evtokine treatment. 
7.1.1 Fibrinogen expression after cytokine treatment. 
Fibrinogen has been shown to be produced in the lung during inflammatory events. It 
has been shown that fibrinogen can be produced in the lung epithelial cells in 
response to IL6 (Simpson-Haidaris, 1997), parasitic infections (Simpson-Haidaris et. 
al., 1998), and PM10 exposure (Anderson et. al., 2002). Hepatic expression of 
fibrinogen is known to arise from stimulation by IL6. It has also been shown that IL6 
induced fibrinogen production can be inhibited by the presence of ILlp (Zhang and 
Fuller, 2000). Therefore the effect of cytokines on fibrinogen expression in the lung 
epithelium was investigated in A549 cells. 
In agreement with studies mentioned above, fibrinogen expression was found to be 
stimulated in A549 cells with IL6 treatment. Treatment with TNFoc and IFNy 
produced little increase in fibrinogen expression as shown by indirect 
immunofluoresence and ELISAs. When the effect of simultaneous cytokine treatment 
was tested it was found that IL6 and TNF(x together could stimulate the production of 
fibrinogen above the level of TNFcc alone as shown by immunofluoresence. The 
decrease in fibrinogen production with simultaneous treatment with IL6 and TNF(x 
has been found previously in human hepatoma cell lines (Mackiewicz et. al., 1991) 
and in A549 cells in serum free condition (Anderson, 2003). However, analysis of the 
cell supernatant showed that the simultaneous treatment with IL6 and TNFcc induced 
the greatest amount of fibrinogen secreted from the cells. This indicates that IL6 and 
TNFoc induce the production of fibrinogen by different mechanisms and that in 
combination they can induce optimal secretion of fibrinogen from the cells in the 
presence of fetal calf serum. The lower intracellular levels of fibrinogen in the 
simultaneous treatment may be the result of faster secretion than is seen with IL6 
treatment alone. 
Simultaneous treatment was also carried out with IL6 and ILlP. This showed that 
fibrinogen could be found expressed in the cytoplasm of the cytokine treated cells and 
simultaneous treatment of IL1P with IL6 had no evident additional effect from IL6 
only-treated cells. A study by Zhang and Fuller (2000) found a large decrease in 
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fibrinogen expression with IL6 and ILI P co-treatments which was not found in this 
study. This may indicate that fibrinogen expression in human lung epithelial cells may 
occur in a different manner to that in the rat liver. Activation of fibrinogen by IL6 can 
occur by signalling via two transcription pathways (Fuller and Zhang, 2001; 
Siebenlist et. al., 1994). The first of these is by CCAAT enhancer binding proteins 
(C/EBP) and the other is by the STAT pathway, whereas ILI P activates NFKB. In rat 
liver, NFKB associates with the STAT3 binding site preventing IL6 activating the 
fibrinogen gene but in the human lung there may be a greater distance between the 
binding sites of these transcription factors. 
Simultaneous treatment was also carried out with IL6 and IL8. IL8 is produced during 
inflammation as a result of signalling from TNF(x and ILI P. It was found that IL8 
induced a small increase in fibrinogen but IL6, and the simultaneous treatment of IL6 
with IL8, produced a greater response. This indicates that fibrinogen can be produced 
in the lung epithelial cells in response to several cytokine stimuli and most of these 
can increase the level of expression over and above the effect produced by IL6 alone 
(results summarised in Table 1). 
7.1.2 CRP expression after cytokine treatment. 
The results from this study indicate that CRP can be produced in the human alveolar 
epithelial cell line, A549. This occurred when the cells were exposed to various 
cytokines on their own or in combination with other cytokines. Of particular interest 
is the finding that TNF(x induced the greatest amount of secreted CRP whereas there 
were relatively low levels of CRP expressed in the cytoplasm of the cells. This 
suggests that TNFcc induced CRP in a different way to that of the other cytokines 
resulting in the early secretion of CRP. In hepatocytes, CRP is synthesised at a low 
rate in normal cells and is found bound to the endoplasmic reticulum by two 
carboxylesterases (gp60a and gp60b, Yue et. al., 1996). This allows CRP to be 
quickly released from the cells during an acute phase response, which may occur with 
TNFa treatment. However, treatment with the other cytokines may be having a 
transcriptional effect on CRP expression which takes longer for the production of 
CRP. IFNy was shown to stimulate the production of IL6 in A549 cells after 24 hours 
(Crestani et. al., 1994). The IL6 produced by the IFNy may then be able to induce the 
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expression of CRP intracellularly at this time point but not the secretion of CRP 
(results summarised in Tablel). 
The induction of high levels of cytoplasmic CRP and nuclear localisation in the 
combined treatment of the cytokines IL6 and IL1 P suggests that within the lung there 
is the potential for high levels of expression of CRP in epithelial cells and that CRP 
may have a cytoprotective role. Other proteins with nuclear localisation sequences 
include transcription factors, heat shock proteins, and nucleoplasmin all of which are 
involved in protecting the cell from cellular stress (Malek et. al., 1998; Benjamin et. 
al., 1998; Santoro, 1999). Transcription factors enter the nucleus during inflarnmation 
to signal the production of important inflammatory mediators. HSPs are known to 
enter the nucleus to protect nuclear material from various stresses including thermal, 
oxidative and radiation effects. Studies by Du Clos (1989,1990,1991) have found 
CRP associated with histones, snRNPs (Jewell et. al., 1993) and chromatin which 
suggests that CRP may be involved in protecting the nucleus during an inflammatory 
response. 
Table 1: Summary of the effect of cytokine treatments on CRP and fibrinogen 
expression. 
CRP Fibrinogen 
IL6 Highly increas ed expression. Highly increased expression. 
TNFa Increased level of secretion Little effect on expression or 
from cells secretion. 
IL6 + TNFa Expression and secretion Expression and secretion 
increased. Expression is similar increased. Expression is similar 
to that of IL6 treatments alone, to that of IL6 treatment alone 
while secretion is similar to but secretion is increased over 
treatment with TNFcc alone. the levels of either IL6 or TNFcc 
alone. 
IFNy Increased expression and Little effect on expression or 
secretion. secretion. 
ILlP Increased expression and Increased expression and 
secretion. With nuclear secretion. 
localisation. 
IL6 + ILI P Highly increased expression Slightly decreased expression 
and secretion, above that of and secretion when compared to 
either IL6 or ILI P alone. With effect of IL6 but above effect of 
nuclear localisation. ILI P or control cells. 
IL8 Little effect on expression or Little effect on expression or 
secretion. secretion. 
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IL6 + IL8 Highly increased expression Highly increased expression 
over either IL6 or IL8 treatment over either IL6 or IL8 treatment 
alone. Little effect on secretion. alone. Little effect on secretion. 
7.1.3 Effects of acute phase proteins (APP) in the lung. 
The present studies show the ability of lung epithelial cells to mount and acute phase 
response. Another APP known as haptoglobin (Hp) has also been found to be 
expressed in alveolar macrophages and airway epithelial cells (Yang et. al., 2000). 
This suggests that this family of inflammatory proteins may have important 
consequences on pulmonary inflammatory events. All three APP mentioned are not 
present in the normal lung yet appear to be present in high quantities during infection 
and injury. 
Both CRP and Hp have been shown to reduce the movement of lymphocytes and 
neutrophils towards stimuli (Oh et. al., 1990; Kew et. al., 1990; Shepherd et. al., 
1992; Heuertz et. al., 1993; Heuertz et. al., 1994; Heuertz et. al., 1996; Zhong et. al., 
1998). Fibrinogen degradation products (FDP) have been associated with increased 
chemotaxis of lymphocytes and neutrophils (Altier et. al., 1993; Leavell et. al., 1996; 
Gross et. al., 1997; Forsythe et. al., 2001; Rubel et. al., 2001). This suggests that each 
APP in ay h ave s pecific roles int he recruitment of I ymphocytes and n eutrophils to 
sites of inflammation and therefore this may be the reason for differing effects in 
response to specific cytokines. 
Other effects of APP proteins in the lung during inflammation can involve interaction 
between exogenous A PP p roduced I ocally or sy stemically from t he c irculation a nd 
leucocytes and neutrophils. CRP has been shown to induce the expression and 
production of the cytokines ILIct, IL10 and TNFa from alveolar macrophages 
(Galve-de Rochemonteix et. al., 1993) and monocyte chemotatic protein-1 (MCP-1) 
from human monocytes (Zhou et. al., 1995). Monocytes, macrophages and 
neutrophils express surface receptors for both CRP and fibrinogen suggesting that 
these proteins can be bound to the cell surfaces. CRP is often found associated with 
neutrophils at sites of inflammation (Du Clos, 1981). CRP acts as an opsonin and 
there are receptors on monocytes and leucocytes for CRP to assist in phagocytosis of 
pathogens and damaged cells (James et. al., 1981a, b; Mold et. al., 1982; Bharadwaj 
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et. al., 1999; Mold et. al., 2001). Fibrinogen also has the ability to bind to 
macrophages and monocytes, stimulating NFKB activation and chemokine secretion 
(Sitrin et. al., 1998; Smiley et. al., 2001). Both CRP and fibrinogen may also have the 
ability to exert effects on the lung epithelium. One study has found that fibrinogen can 
be phagocytosed by A549 cells (Ordjilin et. al., 2001). CRP has been found to have 
direct pro-inflammatory effect on vascular endothelial cells (Pasceri et. al., 2000). 
These all suggest that the expression and secretion of CRP and fibrinogen during 
inflammatory stimuli from epithelial cells may have important effects on the 
progression of lung inflammation. 
7.2.0 Effect of air pollution particles on pro-inflammatory protein expression. 
In chapter 4 the effect of inflammogenic-air pollution particles (PM10) on lung 
epithelial cells was investigated. This was carried out using roadside PMIO, a 
heterogenous air pollution particle, which is composed of a mixture of organic and 
elemental carbon, transition metals, acid salts, organic pollutants (polyaromatic 
hydrocarbons, nitroaromatic hydrocarbons, etc. ) and biological components such as 
bacterial products and pollen spores. The cells were also treated with fine and 
ultrafine carbon black (CB and ufCB) and FeC13, a transition metal salt. This allowed 
a comparison between the inflammatory potential of PM10 and some of the 
components which make up PM 10. 
7.2.1 Effect of air pollution particles on CRP expression. 
When the cells were treated with PMlO, CB or ufCB there was an increase in the 
levels of CRP expression within the cells. This was determined using indirect 
immunofluoresence of the treated cells and by ELISA. It was also determined by 
ELISA that CRP could be secreted from the cells in response to these three particle 
treatments. The treatments were carried out over an eighteen hour time course and the 
production of CRP was found to be time dependent. However the treatment with the 
iron salt produced no increase in intracellular or secreted CRP. 
Air pollution particles are known to be associated with oxidative stress in the lung. It 
is thought that this is a result of high surface area of the smaller (ultrafine) particles 
153 
where chemical reactions can occur. This surface chemistry occurs between species 
on the surface such as the transition metals (Li et. al., 1996; Dellinger et. al., 2001; 
and reviewed in Donaldson et. al., 1998; MacNee and Donaldson, 1999). There is also 
evidence that free radical production can occur on the surface of ufCB particles 
(Stone et. al., 1998). This oxidative stress is known to be involved in the progression 
of inflammatory events and has been shown to be associated with cytokine production 
on alveolar macrophages and epithelial cells (Becker et. al., 1996; Carter et. al., 
1997). Therefore, it would be expected that PM10 and ufCB treatments would 
produce more CRP due to their greater inflammatory potential. 
When examined it was found that there was little difference between the intracellular 
levels of CRP with particle treatments. The intracellular levels of CRP were increased 
by around lmg/mI as shown by ELISA. The main difference between the treatments 
was in the ability to induce secretion of CRP. Using ELISAs, CB induced a maximal 
concentration of 1.5 mg/ml (+/-0.1), ufCB a concentration of lmg/mI (+/- 0.1) and 
PMIO with a concentration of 8mg/mI (+/- 1). This suggests that adsorption of the 
protein onto the particle surface was occurring and this was found to be the case. 
Since ufCB has a larger surface area than CB more protein adsorption is able to occur 
therefore underestimating the amount of secreted protein. 
When examining the effects of the particle treatments on the intracellular CRP by 
indirect immunofluoresence other differences in the effects of the treatments become 
apparent. All three treatments are able to induce the nuclear localisation of CRP. As 
discussed above this is important in establishing that the particles are stimulating an 
inflammatory response and that this may be harmful to the cells. Both carbon particles 
induced nuclear localisation only after 18 hours of treatment while nuclear 
localisation occurs after 3 hours with PMIO treatment. This indicates that the PM10 is 
able to induce a greater response in the cells than the carbon particles alone and this 
would not be unexpected. This is due to the fact that the components of PM10 are 
known to interact with each other and this can cause synergism of the biological 
effects (Wilson et. al., 2002). Cells were also treated with FeC13 which produced no 
effect on CRP expression and secretion however metals contribute to induction CRP 
expression but only when present in PM 10. 
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Also s hown int he u fCB t reatment isana Iteration int he c ell m orphology after 18 
hours of treatment. This gives the impression of a polarised staining pattern. This may 
be the result of oxidative stress. Free radicals produced can cause depletion of 
intracellular ATP in cells. This can result in the depolymerisation of actin and 
breakdown of the acto-myosin network which are responsible for maintaining cell 
shape (Bellorno and Mirabelli, 1992). Interestingly there does not appear to be any 
changes in cell morphology in the PM10 treatment after 18 hours, although there is 
some evidence to suggest that minor alterations may be occurring at the 3 and 6 hour 
time points. 
Table 2: Summary of the effects of air pollution particles on CRP expression 
Effect on CRP 
CB Increased expression and secretion in a time-dependent manner. 
Nuclear localisation at 18 hours. 
ufCB Increased expression and secretion in a time-dependent manner. 
Nuclear localisation and polarisation of cytoplasmic staining at 
18 hours. 
PM10 Increased expression and secretion in a time-dependent manner. 
Nuclear localisation at 3,6 and18 hours. 
FeC13 No effect on either expression or secretion. 
7.2.2 Effect of air pollution particles on fibrinogen expression. 
The effect of environmental air pollution was investigated for fibrinogen as for CRP. 
However unlike CRP, fibrinogen expression was stimulated by all treatments 
including the FeC13 treatment. The treatment of the cells was carried out over an 18 
hour time course and the cells analysed by indirect immunofluorescence and ELISA. 
The expression of fibrinogen was found to be highest for the PM 10 treatment with an 
increase of 3 mg/ml (+/- 0.5), followed by ufCB with an increase of lmg/ml (+/- 0.1), 
CB with an increase of 0.5 mg/ml (+/- 0.1) and FeC13 with an increase of 0.2mg/ml 
(+/- 0.1) over untreated cells. This suggests that oxidative stress may have a role in 
the effects on intracellular levels of fibrinogen. 
Analysis of the cell supernatants for fibrinogen secretion shows that all four 
treatments were capable of stimulating the secretion of fibrinogen. Treatment of the 
cells with CB and ufCB appeared to show an increase in secreted fibrinogen in the 
first few hours of treatment but after 3 hours the levels decrease. This may be due to 
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absorption of fibrinogen onto the particle surface. However the treatment with PM10 
does not appear to show this phenomenon. This may be due to the fact that there is a 
relatively low level of fibrinogen present during the first 6 hours of treatment and this 
may be due to absorption of the protein onto the particle surface (Kim et. aL, 2003); 
this may only be overcome when the levels of fibrinogen saturate the particle surface 
at 18 hours and this may explain the high degree of deviation among the three 
experiments. Another explanation for these results may be due to enclocytosis of 
fibrinogen (OdrIjin et. al., 2001) by binding to the integrin receptor ccvP3. This would 
result in the degradation of fibrinogen within the cells and it has been hypothesised 
that this may be involved in the process of alveolar tissue repair and matrix 
remodelling. Fibrinogen m ay a Iso bed egraded byt he cells orp roteins int he c ell 
supernatant giving arise to fibrinogen degradation products (FDP) which are not 
detectable in the ELISA assay (degradation of fibrinogen reviewed by Herrick et. al., 
1999). 
When examining the intracellular localisation of fibrinogen it can be seen that 
fibrinogen is localised in the cell cytoplasm in the peri-nucelar region. This is the 
same for treated and untreated cells. The only difference between the treatments is 
seen in the ufCB treated cells. The ufCB treated cells show some of the 
morphological changes shown in the cells stained for CRP: there is elongation and in 
the majority of the cells fibrinogen is localised densely at only one end of the cell. 
This may have consequences on fibrinogen secretion which occurs basolateraly due to 
the arrangement of the cell microtubules. However, disruption of the microtubules 
results in the inhibition of fibrinogen secretion (Guadiz et. al., 1997). This may also 
contribute to the variable results for fibrinogen secretion shown by ELISA. 
Table 3: Summary of the effects of air pollution particles on fibrinogen expression. 
Effect on fibrinogen 
CB Highly increased expression and secretion in a time-dependent 
manner. 
uf'CB Highly increased expression and secretion in a time-dependent 
manner. Polarisation of cytoplasmic staining at 6 and 18 hours. 
PMIO Highly increased expression and secretion in a time-dependent 
manner. 
FeC13 Increased expression and secretion in a time-dependent manner 
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7.2.3 Effect of air pollution particles on Hsp70 expression. 
The effect of PM10, CB, ufCB and FeC13 on Hsp70 expression in A549 cells was 
investigated. All four treatments stimulated an increase in the expression of Hsp70. 
The particle treatments all were able to stimulate Hsp70 expression in a time 
dependent manner but the FeC13 treatment produced a different response. Indirect 
immuofluorescence showed that the particle treatments not only generated an increase 
in intracellular Hsp70 but also produced nuclear localisation of Hsp70 after around 6 
hours of treatment. Nuclear localisation of Hsp70 is known to result from exposure to 
stresses including oxidative stress. This is thought to be cytoprotective since Hsp70 
bound to the DNA can protect against radical-induced genotoxicity (reviewed by 
Jacquier-Sarlin et. al., 1994). Another function of Hsp70 in the nucleus during stress 
is to associate with the peri-ribosomal granular region of the nucleolus and assist in 
maintaining ribosome assembly and translocation (Welch and S uhan, 1986). In the 
nucleus Hsp70 can also bind to the DNA at HSF1 sites and inhibit the HSP gene 
transcription w hen h igh levels ofH SP a re p resent int he c ells toc ontrol t he s tress 
response (Shi et. al., 1998). 
Indirect immunofluorescence of the FeC13 treated cells shows a different Hsp70 
response from the particle treatments. It can be seen that there is a fast response to the 
iron treatment and this is resolved quickly leaving the cells with a lower level of 
Hsp70 than was present in the untreated cells. This may be due to stressing of the 
cells prior to treatment, since there is more Hsp70 present in the cells than was shown 
for the particle treatments. Another explanation could be that a quick response to the 
treatment occurred, since the iron is soluble in the culture medium, and that this was 
quickly resolved, therefore explaining the lack of CRP production to this treatment. 
Hsp70 has been shown to inhibit inflammatory responses by inhibiting the activation 
of the transcription factor, NFicB (Guzhova et. al., 1997; Ayad et. al., 1998; Yoo, et. 
al., 2000; Stuhlheimer, 2000; reviewed by Santoro, 2000; Malhotra and Wong, 2002). 
Other studies have examined the effects of other transition metals on Hsp70 
production. It has been found that Hsp70 can be induced in various cell types in 
response to treatments with zinc and cadmium salts (Timblin et. al., 1998; Wagner et. 
al. 1999; Gaubin et. al., 2000; Croute et. al., 2000). HSPs have also been found to be 
stimulated in alveolar macrophages by quartz coated with cadmium or vanadium 
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(Radloff et. al., 1998). Other metals have been shown to induce HSP production in 
cells including copper, cobalt, nickel, mercury and arsenic (reviewed by Hall, 1994). 
Analysis of the cell supernatants showed that there was some secretion of Hsp70 from 
the cells. There is little in the literature on secretion of Hsp70 from cells suggesting 
this may be one of the first studies to report this. Hsp70 is known to be present in the 
circulation during infection and inflarnmation (reviewed by Wallin et. al., 2002). The 
presence of Hsp70 has normally been attributed to release from apoptotic and necrotic 
cells and from bacterial sources. Hsp70 has been found to be released after coronary 
bypass surgery (Dybdahl et. al., 2002) although the cells responsible for producing 
Hsp70 were not identified. The presence of extracellular Hsp70 was presumed to be a 
result of necrosis. Although most of the Hsp70 present would appear to be the result 
of secretion some may also arise from apoptosis or necrosis from the treatment 
however concentrations used were subtoxic. Extracellular Hsp70 has been associated 
with the stimulation of an immune response through the generation of fusion proteins. 
These HSP fusion proteins can induce cytotoxic T-lymphocytc-mediatcd immune 
responses, protective anti-viral immunity, and stimulate classical and/or alternative 
MHC class I pathways (reviewed by Wallin et. al., 2002). Extracellular Hsp70 has 
been associated with the generation of an inflammatory response through the 
production of cytokines in blood monocytes, peritoneal macrophages and various 
monocyte-like cell lines through the Toll like receptors TLR2 and TLR4 (Asea et. al., 
2002; Dybdahl et. al., 2002). 
Table 4: Summary of the effect of air pollution particles on Hsp70 expression. 
Effect on Hsp70 
CB Highly increased expression and secretion in a time-dependent 
manner. Nuclear and peri-nuclear localisation at 6 and 18 hours. 
ufCB Highly increased expression and secretion in a time-dependent 
manner. Nuclear and peri-nuclear localisation at 6 and 18 hours. 
PM10 Highly increased expression and secretion in a time-dependent 
manner. Some morphological changes. 
FeC13 Rapid increase in expression and secretion which is reduced to 
I control levels after 3 hours of treatment 
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7.2.4 Effect of air pollution particles on NFrB and licB expression. 
Treatment of A549 cells with CB, and ufCB produced the degradation of IKB 
followed by the activation of NFKB as shown by immunofluoresence. The PM10 
treatment induced NFKB activation without any apparent IKB degradation, while 
FeC13 treatment failed to stimulate the degradation of IKB or the activation of NFKB 
in an IKB-independent manner (Jimenez et. al., 2000). IKB degradation in the CB and 
ufCB treatments occurred within 30 minutes of particle treatment. The expression of 
IKB was increased between 3 and 6 hours for CB and after 1 hour of ufCB treatment. 
This was followed by nuclear localisation of IKB. During this time NFKB was found 
to have entered the nucleus of the cells at around 3 hours for CB treatment and Y2 an 
hour for ufCB treatment. This suggests that the degradation of IKB led to the nuclear 
localisation of NFKB which in turn bound to the DNA to induce the expression of 
pro-inflammatory proteins including IKB (Le Bail et. al., 1993; Cheng et. al., 1994; 
reviewed by Baeuerle and Henkel, 1994; Baldwin et. al., 1996; Christman, et. al., 
2000; Karin and Ben-Neriah, 2000). Once the newly formed IKB was present in the 
cell it was able to translocate to the nucleus and bind to the NFKB and remove the 
NFxB-IkB complex back into the cytoplasm of the cells where it is retained (Beg et. 
al., 1992; Arenzana-Sesdedos et. al., 1997; reviewed by Bachelerie et. al., 1998), as 
shown by immunofluoresence at the 6 and 18 hour time points. The PM10 treatment 
did not appear to induce the degradation of IKB although NFKB was found in the 
nucleus of the cells at the ! /2 hours and 1 hour time points. This has been found 
previously in this cell line and the explanation for this phenomenon was attributed to 
the effects of transition metals, notably iron (Jiminez et. al., 2000). It was suggested 
that oxidant-induced activation of NFicB occurred via a proteosome-independent 
pathway. 
The treatment of cells with FeC13 appeared to generate no activation of NFKB or have 
any effect on the expression of IKB. This may have been expected since this treatment 
had little effect on the expression of any of the other proteins studied. This indicates 
that iron has no effect on the lung on its own but on the surface of PMIO it can 
interact with the other components and create redox cycling resulting in the 
generation of free radicals and oxidative stress (Wilson et. A, 2002). 
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Table 5: Summary of the effect of air pollution particles on NFrB and IrB 
expression. 
Effect on NFKB Effect on IKB 
CB Slightly increased expression Nuclear localisation at 6 hours. 
during time course. Little difference from untreated 
cells at other time points. 
ufCB Highly increased expression Increased expression after I hour 
nuclear localisation at ! /2 -I hour. with nuclear localisation at I and 
Decrease in levels at 4 hours 3 hours. 
followed by increase at 6 hours 
with more nuclear localisation. 
PM10 Increased expression with nuclear Little effect. 
localisation at Y2 hour. 
FeC13 Little effect. Slight increase in cytoplasmic 
levels in treated cells. 
7.2.5 Effect of air pollution particles on inflammatory response in lung epithelial 
cells. 
The results from this chapter indicate that CB, ufCB and PM 10 have the potential to 
elicit an inflammatory response in this cell line. Many of the results would indicate 
that oxidative stress may be generated, particularly in the ufCB and PM10 treated 
cells, and this is what is driving the inflammatory response. Oxidative stress and free 
radicals have been attributed to the activation of transcription factors including NFKB 
(Schreck et. al., 1991; Barchowsky et. al., 1995; reviewed by Baeza-Squiban et. al., 
1999). The oxidative stress and free radicals would also result in the production of 
Hsp70. The response time for the induction of the proteins would appear to occur at 
around the same time with NFKB apparently being activated just before Hsp70. The 
production of Hsp70 after NFKB would explain why an inflammatory response to the 
particle occurs in the cells when Hsp70 has been shown to inhibit NFKB activation 
(Guzhova et. al., 1997; Ayad et. al., 1998; Yoo, et. al., 2000; Stuh1heimer, 2000; 
reviewed by Santoro, 2000; Malhotra and Wong, 2002). 
The activation and nuclear localisation of NFKB would be expected to induce the 
expression of important pro-inflammatory proteins. These proteins would include 
IKB, CRP and fibrinogen as well as cytokines. The results indicate that all three of 
these proteins were produced after the nuclear localisation of NFKB suggesting that 
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this may be the case. Indeed a recent study has indicated that the over expression of 
NFY, B can result in the production of CRP (Agrawal et. al., 2003). 
7.3.0 Investigation into mechanisms of pro-inflammatorv protein production. 
In chapter 5 the possible mechanisms of pro-inflammatory protein expression and 
secretion are discussed. Firstly the secretion of CRP, fibrinogen and Hsp70 was 
investigated to ensure that the proteins were indeed being secreted from the cells and 
not present in the cell supernatant as a result of cellular damage caused by the cell 
treatments. Then the effect of transcription inhibitors used in the presence of ufCB 
treatment was investigated to identify the transcription pathways being stimulated by 
the particle treatments which were responsible for the pro-inflammatory protein 
production. This chapter also discusses the effect of oxidative stress on the cells using 
tBHP and antioxidant treatments to investigate if the particles were able to stimulate 
the production of the pro-inflammatory proteins via oxidative stress. After 
establishing that oxidative stress would appear to induce pro-inflarnmatory protein 
production the effects of oxidative stress on cell was investigated looking at cell 
morphology and intracellular ATP levels. Finally this chapter identifies that these 
treatments are stimulating de novo synthesis of these inflammatory proteins and not 
the release of stored inactive protein subunits. 
7.3.1 Is presence of CRP, fibrinogen and Hsp70 in supernatant a result of active 
secretion from the cell? 
Firstly the cells were stained with propidium iodide after ufCB treatment to determine 
if the cell membrane was intact. If the treatment was damaging to the cell the 
membrane would be disrupted and the dye would enter the nucleus and would be 
visible under the UV microscope. The cells were counted after treatment with ufCB 
for various time points and it was found that there was a small decrease in cell 
viability over the time course but this is unlikely to be responsible for the amounts of 
each protein found in the supernatant. 
Secretion of CRP and fibrinogen occurs through the conventional secretory pathway 
(Kushner and Feldmann, 1978; Hartwig and Danishefsky, 1991; reviewed by Redman 
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and Xia, 2001) via the rough endoplasmic reticulum, smooth endoplasmic reticulum 
and the Golgi apparatus before packaging into secretory vesicles to exit the cell by 
exocytosis (Lodish et. al., 1995). The cells were treated with ufCB in the presence of 
Brefeldin A which has b een shown to block the intracellular transport of secretory 
proteins. Brefeldin A impedes the transport of proteins from the endoplasmic 
reticulum to the Golgi complex therefore preventing the secretion of the proteins 
(Misumi et. al., 1986). Treatment of ufCB simultaneously with Brefeldin A was 
shown to greatly reduce the levels of CRP, fibrinogen and Hsp70 in the cell 
supernatants. This indicates that these proteins are being actively secreted from the 
cells. 
The actively secreted pro-inflammatory proteins could have consequences on the lung 
as a whole as discussed previously. After particle inhalation or during lung 
inflammation the released proteins may also enter the circulation. The presence of 
cytokines produced during inflammation such as TNFa, ILlp, and IFNy have been 
shown to increase vascular permeability which allows the infiltration of proteins and 
cells across the lung-blood barrier (Sedgewick et. al., 2002). 
7.3.2. Effect of transcription complexes on particle induced pro-inflammatory 
protein production. 
To investigate the effects of transcriptional events on the expression of CRP, 
fibrinogen and Hsp70 inhibitors of transcription complexes were used in combination 
with ufCB treatment. Previous studies suggest that NFKB is involved in the signalling 
of CRP and fibrinogen expression in cells during inflammatory stimuli (Agrawal et. 
al., 2003; Siebenlist et. al., 1994). Hsp70 has been shown to be under the 
transcriptional control of the JAK/STAT complex during oxidative stress (Stephanou 
et. al., 1999; Madamanchi et. al., 2001) while STAT3 (also known as APRF, acute 
phase response factor) has been associated with the induction of fibrinogen and CRP 
expression (Siebenlist et. al., 1994; Zhang et. al., 1996; Agrawal et. al., 2001; 
Agrawal et. al., 2003). 
These transcription factors can be activated by various stimuli including stress 
(oxidative, chemical, UV), pro-inflammatory cytokines, and pathogens including 
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bacterial LPS via Toll-like receptors. NFKB as mentioned previously is particularly 
redox sensitive and is readily activated by free radicals (Schreck et. al., 1991; Meyer, 
et al., 1994; Barchowosky et. al., 1995; and reviewed by Haddad, 2002; Rahman, 
2002). The JAK/STAT pathway can also be activated in response to intracellular ROS 
(Simon et. al., 1998) and endogenous hydrogen peroxide (Carabello et. al., 1999). 
These two transcription factors can also be activated by a wide variety of cytokines 
including TNFa, IL1 P for NFKB, and IL2, IL3, IL4, IL5, IL6, ILI. 1, IL12, IFNy, and 
GM-CSF for JAK/STAT (reviewed by Hanada and Yoshimura, 2002; Heim, 1996; 
Boscoe et. al., 1996). 
Inhibitors of these transcription complexes were found and treated with ufCB to 
determine if the production of CRP, fibrinogen and Hsp70 were dependent on the 
activation of these transcription complexes. The inhibitor for NFKB was a cell 
permeable peptide known as sn50. Sn50 contains the NFKB nuclear translocation 
signal sequence allowing it to enter the nucleus and bind to the DNA mimicking and 
preventing the binding of NFKB (Lin et. al., 1995). The inhibitor used for the 
JAK/STAT activation was a tyrosine kinase blocker known as Ag490. Ag490 is a 
member of tyrosine kinase inhibitors known as tyrophostins (Gazit et. al., 1991). 
Ag490 works by blocking the constitutive activation of STAT3 (Nielsen et. al., 1997). 
Treatment with ufCB and these inhibitors indicated that intracellular levels of CRP 
were dependent on NFKB and not by JAK/STAT and that secretion of CRP required 
both transcription complexes. The dependence of CRP expression and secretion on 
NFKB activation is not surprising since CRP is known to be activated by NFKB 
during inflammatory events. JAK/STAT inhibition however shows only reduced 
levels of CRP in the cytoplasm compared to ufCB treated cells but there does appear 
to be the requirement for the JAK/STAT pathway in the secretion of CRP. The lack of 
CRP inhibition with Ag490 treatment indicates that either the treatment does not 
activate the JAK/STAT pathway or that the use of this inhibitor was not able to inhibit 
the pathway efficiently. However, the inhibition of secreted CRP indicates that the 
inhibitor may be having a small effect on the production of CRP which is more 
evident at a later stage in the production and secretion of CRP. The use of this 
inhibitor may be having a small effect on the synthesis of CRP which may have an 
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effect on the normal synthesis and secretion pathway for example the rate limiting 
step in CRP secretion is the time of exit from the RER, so if the inhibitor had an effect 
on the RER this would result in reduced secretion of CRP from the cells. CRP 
secretion efficiency has also been shown to be related to the intracellular 
concentration of CRP so if there was a slight decrease in this concentration it may 
have a larger consequence on the amount of secreted CRP (Hu et. al., 1988). 
The effect of transcription inhibitors of fibrinogen expression is very similar to the 
effects on CRP expression with NFKB apparently being responsible for the expression 
and secretion of fibrinogen from the cells in response to ufCB treatment. A small 
decrease was also shown for treatment with Ag490 indicating that the JAK/STAT 
pathway may have a small effect but not as much as NFKB. The effect on Hsp70 
expression indicated that NFKB had little effect on Hsp70 expression but was capable 
of inhibiting the secretion of Hsp70. The treatments with Ag490 indicated that Hsp70 
expression and secretion was dependent on the JAK/STAT pathway. 
7.3.3. Effect of oxidative stress on particle induced pro-inflammatory protein 
production. 
The results of the particle treatments and the use of transcription inhibitors suggested 
that oxidative stress may play a role in the expression of these pro-inflammatory 
proteins. Therefore the effect of oxidative stress on the expression of these proteins 
was carried out using treatment with tBHP. Treatment with tBHP showed similar 
responses to the particle treatments on CRP, fibrinogen and Hsp70 expression and 
secretion. Since tBHP was soluble in the culture medium a shorter time series was 
used but a time dependent increase in expression occurred for all three proteins. 
Nuclear localisation of CRP and Hsp70 occurred at the later time points and there was 
some evidence of changes in cell morphology as was found in the ufCB and PM10 
treatments. 
7.3.4. Effect of antioxidant treatment on particle induced pro-inflammatory 
protein production. 
In the lung environment epithelial cells cope with oxidative stress by producing 
antioxidants which scavenge free radicals. The epithelium is covered by lining fluid 
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which contains many antioxidants produced by the cells including mucin, uric acid, 
protein (albumin), ascorbic acid (Vitamin C) and reduced glutathione (Cross et. al., 
1994). Several studies have found that synthetic lung lining fluid can reduce oxidative 
damage in cells treated with particles (Sun et. al., 2001; Greenwell et. al., 2002). 
Many studies have also treated cells with PM10 in the presence of other antioxidants 
and found that these antioxidants scavenged the free radicals preventing NFic]B 
activation. Many studies have used N-acetyl cysteine (NAC) which has been shown to 
increase intracellular levels of the antioxidant glutathione and deplete the oxidative 
effects associated with P M10 and DEP (Quay et. al., 1998; Kennedy et. al., 1998; 
Stringer et. al., 1998; Gaubin et. al., 2000; Omara et. al., 2000; Harper et. al., 2001; 
Whitekus et. al., 2002). Studies carried out using Vitamin E analogues such as Trolox 
and oc-tocopherol have shown that these compounds can reduce oxidative effects in 
cells. Trolox is a water soluble derivative of vitamin E and can penetrate 
biomembranes and protect the cells. Trolox has been shown to prevent hydroxyl 
radical formation, H202 formation, lipid peroxidation, and intracellular plasmid 
degradation in cultured epithelial cells (Menzel, 1992; Luo, X et. al., 1999; Luo, X. 
et. al., 2003). 
To further investigate the effects of oxidative stress on the expression and secretion of 
CRP, fibrinogen and Hsp70, treatment of the cells with ufCB was carried out in the 
presence of antioxidants. The antioxidants used were either a N-acetylcysteine 
analogue, Nacystalin (NAL) or Trolox. Firstly, the antioxidant and ufCB treated cells 
were examined using indirect immunofluoresence for NFKB to show that the 
concentration of antioxidants were capable of mopping-up any free radicals, thereby 
preventing the activation and nuclear transclocation of NFKB. This showed that both 
antioxidants prevented the nuclear localisation of NFKB. Similar results have also 
been found in human blood monocytes using ufCB and these antioxidants (Brown et. 
aL, 2003). As for the use of the transcription inhibitors there was a reduction in the 
levels of intracellular expression of CRP, fibrinogen and Hsp70 although this was not 
statistically significant for any of these proteins. Similarly to the transcription factor 
inhibitors there was a huge reduction in the levels of secreted proteins from the cells 
for CRP and fibrinogen showing statistically significant reductions for both 
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antioxidants compared to the ufCB treated cells. This indicated that oxidative stress 
was capable of inducing the transcription factors responsible for the production of 
these proteins. Interestingly both antioxidants were able to produce similar effects on 
protein expression although these antioxidants work by different mechanisms. Many 
antioxidants have been shown to reduce lipid and protein peroxidation during 
oxidative stress however thiol antioxidants such as NAL are the only antioxidants 
which decrease the intracellular GSH: GSSH ratio during oxidative conditions 
(Whitekus et. al., 2002). Trolox works by preventing increased hydroxyl radical and 
hydrogen peroxide formation. This reduction in hydrogen peroxide in culture medium 
can prevent programmed cell death by apoptosis which occurs when the levels of 
intracellular thiols are depleted (Luo et. al., 1999). Therefore the protection of 
intracellular thiols by different means (NAL by maintaining intracellular GSH: GSSH 
ratio and T rolox bym opping-up radicals inc ulture rn edium) may h elp explain t he 
similar results for both antioxidants. 
7.3.5. Morphological changes in A549 cells with particle treatments. 
To investigate further the apparent morphological changes occurring with particle 
treatment the cells were treated and Diff-Quick staining of the cells was carried out. 
This enabled identification of any changes in morphology and revealed any 
indications of cell apoptosis or necrosis associated with the treatments. Treatment 
with FeC13 showed little morphological changes over the time course which was not 
unexpected since there was no previous evidence to indicate free radicals and 
oxidative stress were having a role in the effects of this treatment. However, tBHP 
and all the particle treatments (PMIO, ufCB, CB) induced huge morphological 
changes occurring during the first few hours of treatment which increased with time. 
This suggests that oxidative stress may be causing these changes in the cells which if 
this occurred in vivo would result in increased epithelial permeability and movement 
of cells and proteins across the epithelial blood barrier with resulting inflammation 
(Bellomo and Miarbelli, 1992; Morrison et. aL, 1999, reviewed by Rahman and 
MacNee, 2000). 
Morphological changes are thought to occur during oxidative stress as a result of ATP 
depletion. The depletion of intracellular ATP causes depolymerisation of actin 
resulting in an elongated cell shape which has been shown by immunofluoresence and 
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the Diff-Quick staining. Intracellular levels of ATP were measured using a luciferase 
assay after CB, ufCB, tBHP and FeC13 treatments. It would be expected that tBHP 
would induce oxidative stress which would induce a large reduction in ATP levels 
(Nowak et. al., 1998; Min et. al., 2000) and the FeC13 treatment would have little 
effect. When carried out this was indeed the case. The ufCB treatment showed a very 
similar response to the tBBIP treatment indicating that free radical production is likely 
to contribute to the effects of ufCB on the activation of NFkB and subsequent pro- 
inflammatory protein production. Surprisingly, the CB treatment showed a sharp 
decrease in the levels of ATP in the first few hours of treatment and the levels 
recovered between 3 and 18 hours. This was unexpected and was reproducible when 
repeated on a number of occasions. This may indicate that free radical production is 
associated with this treatment and is responsible for the effects found for CB 
treatment. 
7.3.6. RT-PCR for particle treated cells 
To ensure that the CRP, fibrinogen and Hsp70 levels detected in the cell cytoplasm 
and supernatant are the result of protein synthesis arising from the cell treatments RT- 
PCR w as c arried o ut. One t ime p oint w as chosen f or C B, u fCB, t BHP, FeC13 and 
TNFcc treatments. However, not all these treatments are likely to induce optimal RNA 
synthesis at the time point since CB and ufCB are particulate and tBHP, FeC13, and 
TNF are soluble in the culture medium. However, the results suggest that all these 
treatments are having an effect in the first few hours. After 90 minutes of treatment 
increased mRNA expression was found after ufCB, and tBHP exposures indicating 
that the treatments were indeed inducing the synthesis of these proteins presumably as 
a result of transcriptional activation by free radicals. 
7.4.0 Effect of A549 cell supernatants on the monocyte-like cell line MM6. 
After establishing that CRP and fibrinogen can be secreted from A549 cells the effect 
of these proteins on surrounding cell populations which occur in the lung was 
investigated. Plasma CRP and fibrinogen are both known to interact with various cell 
types including blood monocytes and tissue macrophages during an inflammatory 
response (Galve-de Rochmontiex et. al., 1993; Pue et. al., 1996; Sitrin et. al., 1998; 
Smiley et. al., 2001). Several studies have focused on the interactions among lung 
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cell populations using cell lines. One study examined the cross talk of cytokines 
during inflammatory stimuli between pulmonary epithelial cells and peripheral blood 
mononuclear cells (Krakauer, 2002). Another study examined the effect of PM10- 
exposed macrophages on lung epithelial cells (Jimenez et. al., 2002). Both these 
studies indicate the communication between cells by secreted proteins, namely 
cytokines, during inflammatory stimuli. 
7.4.1 Effect of CRP and fibrinogen on pro-inflammatory protein expression in 
MM6 cells. 
Treatment was firstly carried out using exposure of MM6 cells to recombinant CRP or 
fibrinogen. Immunofluoresence showed very low levels of CRP, fibrinogen, NFicB 
and Hsp70 in untreated cells. However CRP treatment induced CRP and NFKB 
expression while fibrinogen induced Hsp70, fibrinogen and NFKB expression. This 
indicates that CRP and fibrinogen both can stimulate a response in MM6 cell but each 
protein would appear to induce different responses. The expression of CRP in MM6 
cells with CRP treatment could arise from phagocytosis or uptake of CRP molecules 
by the cells (Mold et. al., 2001) or by the release of stored CRP subunits (Yue et. al., 
1996). While fibrinogen treatment induced the expression of fibrinogen in the MM6 
cells which may arise from the phagocytosis of fibrinogen molecules, it is more likely 
to be the result of NFKB dependent production. Fibrinogen treatment was also able to 
induce the expression of Hsp70 in the MM6 cells and this may occur through Toll- 
like receptor 4 (TLR4). Fibrinogen has been shown to activate chemokine expression 
in macrophages through TLR4, and Hsp70 expression can be activated by binding to 
TLR4 on the surface of monocytes (Smiley et. al., 2001; Dybdahl et. al., 2002). The 
synthesis of Hsp70 by macrophages has been shown in response to TNFcc (Heimbach 
et. al., 2001; Wantanabe et. al., 1997; Wantanabe et. al., 1998) which could result 
from TLR4 binding or by activation of NFKB. Interestingly, both CRP and fibrinogen 
treatments were able to induce the expression and nuclear localisation of NFKB. 
NFKB activation in monocytes by fibrinogen has been shown previously (Sitrin et. al., 
1998) but the same has not been found for CRP. 
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7.4.2 Effect of A549 CM on protein expression in NIN16 cells 
The effect of CM from A549 cells treated with ufCB (100gg/ml for 18 hours) on 
protein expression in MM6 cells was investigated. This indicated that CM exposure 
induced the expression of CRP, fibrinogen, Hsp70 with activation and nuclear 
localisation of NFKB. To identify if there was also secretion of CRP and fibrinogen 
from the cells ELISAs were carried out. This showed that MM6 cells were capable of 
secreting CRP and fibrinogen constitutively without treatment. ELISAs for CRP and 
fibrinogen in the supernatants of the A549 treated cells were carried out to confirm 
the levels present in the CM used to treat the MM6 cells with. This showed that there 
was constitutive secretion of both proteins in untreated MM6 cells and there was CRP 
and fibrinogen present in the CM prior to treatment. That there was less CRP present 
after MM6 treatment than expected may be due to phagocytosis of CRP or 
degradation of CRP by MM6 cells (Robey et. al., 1997; Mortensen and Zhong 2000). 
The secretion of fibrinogen from MM6 cells was higher than either the untreated 
MM6 cells or the A549 conditioned media treated MM6 cells as expected and 
indicates the secretion of fibrinogen. 
The cell supernatants were also analysed for cytokine production by MM6 which may 
be a result of the NFkB activation induced by the CM treatment. This indicated that 
IL8 could be produced by MM6 cells in response to the CM treatment. There was also 
a small increase in the levels of TNFoc and IL6. The high levels of ILS indicate that 
there is an inflammatory response occurring which may be associated with cell 
damage. IL8 is often produced during tissue injury and is involved in the recruitment 
and activation of circulating and tissue neutrophils (Luscinskas et. al., 1992). 
Oxidative stress has been shown to induce NOS production in many cell types 
including e pithelial cells and N OS production is often a ssociated with c oncomitant 
formation of superoxide and hydrogen peroxide (Adcock et. al., 1994). The presence 
of these species in the CM as well as the presence of pro-inflammatory proteins and 
cytokines p rovides a further m echanism f or t he activation ofN FkB in MM6 c ells. 
Other mechanisms which may trigger the secretion of cytokines from MM6 cells with 
A549 CM treatment could include ICAM-1 expression in response to Hsp70 secreted 
from the A549 cells (Galdiero et. al., 1997). Increased ICAM 1 expression can lead to 
169 
cytokine production (in particular ILS), reactive oxygen species production and cell 
proliferation (Hubbard and Rothlein, 2000) 
7.4.3 Investigation into damaging effects of A549 CM on MM6 cells 
The high levels of IL8 produced by MM6 cells after treatment with ufCB treated 
A549 culture medium indicated cell damage. The increased expression of NFKB and 
Hsp70 in the cells also indicated that the treatment was inducing stress (presumably 
oxidative stress) in the MM6 cells. Diff-Quick staining of the cells at various time 
points of treatment shows that a huge stress response occurred in the first 30 minutes 
of treatment which induced cell apoptosis and necrosis. The remaining cells were 
shown to phagocytose the damaged cells and after 3 hours the cells remaining viable 
appear to be of normal cell morphology. This indicated that the A549 cells are 
producing species associated with oxidative stress for example NOS and/or ROS 
(Adcock et. al., 1994) and this is then having and effect on the MM6 cells. 
To further investigate the damaging effects of the A549 CM on MM6 cells a lactate 
dehydrogenase (LDH) assay was carried out. LDH is released from cells during 
membrane d amage a nd isag ood i ndicator oft oxicity. T his s howed t hat t here w as 
little LDH present in the untreated MM6 cell and the A549 CM. However, after 
treatment of MM6 with CM for 4 hours there were increased levels of LDH present in 
the cell supernatant which is likely to be produced by the necrotic cells found after 1 
hour of treatment with the CM. 
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7.5.0 Conclusions. 
The results discussed above indicate the importance of CRP, fibrinogen and Hsp70 
expression and secretion in the progression and pathology of inflammatory lung 
conditions In this thesis the main focus of the work was on the expression of these 
proteins in A549 lung epithelial cells in response to inflammatory stimuli such as 
cytokines and particulate air pollution (see overview in Figure 125). The production 
of these proteins in the lung could provide insight into inflammatory effects 
associated with infection (microbial, viral and parasitic) in the lung and also in other 
organs. Both CRP and fibrinogen production have been associated with infection 
locally and systemically (Simpson-Haidaris et. al., 1998; Szalai et. al., 1999; Gould 
and Weiser, 2001; Horan et. al., 2001; Du Clos and Mold, 2001; O'Grady et. al., 
2001). 
The expression of all the proteins studied with respect to environmental air pollution 
particle exposure also indicates the powerful effects of oxidative stress on the 
progression of lung inflammation. PM10 exposure has been associated with adverse 
health effects (Donaldson and MacNee, 1998; Salvi et. al,. 1999; MacNee et. al., 
2000). Many of these effects include morbidity and mortality due to not only 
respiratory but also cardiovascular diseases (Dockery et. al., 1993; Seaton et. al., 
1995; Schwarz, 1999; Donaldson et. al., 2001). The secretion of CRP, fibrinogen and 
Hsp70 from the lung epithelium would appear to have important consequences on the 
localised inflammatory response. This study indicates that the secretions from 
epithelial A549 cells in response to particulates is capable of having a huge response 
on monocytic cells. Several studies have shown inability of alveolar macrophages 
(AM) to cope with the clearance of inhaled particulates (discussed by Renwick et. al., 
2001) and this may arise due to impaired function of the AM arising from epithelial 
cell secretory products as well as the association with particle overload. 
Other studies have indicated that CRP, fibrinogen and Hsp70 have effects on the cells 
present in the lung during inflammation. For example CRP is involved in the influx 
and impairment of neutrophils which are recruited to the lung during inflammation 
(Buchta et. al., 1988; Shepherd et. al., 1992; Heuertz et. al, 1993,1994,1996,1999; 
Kew et. al., 1990; Heurtz and Webster 1997; Zouki et. al., 1997; Zhong et. al., 1998). 
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In the rabbit lung the effects of CRP in the circulation has been associated with 
decreased vascular permeability (Abernathy et. al., 1996). Fibrinogen has also been 
shown to have effects on the function of neutrophils and monocytes. Fibrinogen 
unlike CRP, has been shown to promote neutrophil activation (Altier, et. al., 1993; 
Walzog et. al., 1999; Rubel, et. al., 2001; Forsyth et. al., 2001) and activate 
monocytes (Sitrin et. al., 1998) all via signalling through integrin (CDllb/CD18) 
binding. The effects of Hsp70 during inflammation generally occur intracellularly. 
However, there has been evidence recently that Hsp70 can also be secreted from cells 
and extracellular Hsp70 can be involved in the signalling of pro-inflammatory 
cytokines by monocytes (Asea et. al., 2002). Until this time the circulatory pool of 
Hsp70 was thought to arise from necrotic cells or was assumed to be bacterial in 
origin (Hall, 1994). Hsp70 also has been associated with endothelial cells, particularly 
in and around the heart where it is associated with increased risk of myocardial 
ischemia (Yellon et. al., 1994). 
The results shown here may be useful in understanding the signalling events arising in 
response to oxidative stress and the production of CRP, fibrinogen and Hsp70 during 
inflammation. The expression of CRP and fibrinogen has been shown to be similar to 
that in hepatocytes by being inducible by cytokines which stimulate the activation and 
nuclear localisation of NFKB. The expression and secretion of Hsp70 in response to 
oxidative stress via the JAK/STAT pathway in the lung epithelium also provides 
another mechanism by which inhaled particles can mediate their effects. 
The secretion of CRP, fibrinogen and Hsp70 from the cells also provides a 
mechanism by which particles can exert extrapulmonary effects. Evidence here 
indicates that particle-induced oxidative effects can cause morphological changes in 
epithelial cells which, if this occurs in vivo, may contribute to the increased 
permeability of the lung during inflammation. The permeabilised lung then could 
allow not only the extravasion of inflammatory cells and proteins from the circulation 
but allow the movement of secreted proteins from the lung, including CRP, fibrinogen 
and Hsp70, contributing to the systemic inflammatory response. Increased levels of 
environmental particles have been associated with increased cardiovascular disease 
and morbidity (Costa et. A, 2000; Donaldon et. A, 2001; Donaldson and MacNee, 
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2001). Since CRP, fibrinogen and Hsp70 are all well recognised risk factors for 
cardiovascular disease there may be a link between the secretion of these proteins 
from the lung epithelium and the increased risk of cardiovascular events. 
Many studies on the effect of PMlO on systemic immune responses have found 
increased plasma levels of CRP and fibrinogen. Increased levels of plasma CRP have 
been found with exposure to PMlO in several studies (Seaton et. al., 1999; Peters et. 
al., 2001). Increased plasma levels of fibrinogen have also been found in response to 
PM10 and this has been associated with increased plasma viscosity (Pekkanen et. al., 
2000; Gardner et. al., 2000; reviewed by Donaldson et. al., 2001). While Hsp70 has 
not previously been found to be present in the circulation during particulate air 
pollution episodes these results indicate that it should be investigated further in 
exposure studies. 
These results may provide useful information for further studies on inflammation in 
the lung in particular particle-induced inflammation. This study indicates the potential 
for further investigation into cellular mechanisms of pro-inflammatory protein 
production and signalling through the JAK/STAT pathway. Further investigation into 
the secretion of proteins into the lung alveolus and fate of secreted proteins would 
also provide insight into the proposed mechanism by which cardiovascular disease is 
associated with inhalation of environmental particles. 
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Figure 125: Overview of potential mechanisms by which inflammatory proteins are 
produced in lung in response to particle exposure. 1. Particles enter lung and come 
into contact with AM. AM phagocytose particles and generate cytokines and ROS. 2. 
Direct contact of particles and ROS with epithelial cells. 3. Activation of transcription 
and production inflammatory proteins. 4. Secretion of proteins into alveolus. 5. 
Possible secretion of proteins into circulation during inflammation/membrane 
permeability. 6. Interaction between secreted inflammatory proteins and AM and 
potential exacerbation of inflammatory response. 
7.6.0 Ideas for future work 
Further work based on this project could focus on the in vivo production of CRP, 
fibrinogen and Hsp70. Studies on human volunteer and animal exposure to PMIO 
inhalation could be carried out to assess whether the production of these proteins still 
occurs in vivo. Analysis of human lung secretory products could also be carried out to 
analyse the secretion of these proteins during inflammatory conditions. To examine if 
these proteins can enter the circulation from the lung, labelled proteins could be 
administered in to the lungs of animals and the blood analysed for the labelled 
proteins. 
Futher in vitro experiments could also be carried out on primary epithelial cells to 
determine if they behave similarly to that of the A549 cell line. Analysis using 
174 
confocal microscopy could help determine the exact location of the proteins within 
the cells and help to study the nuclear translocation of proteins. Multiple staining of 
the cells could also be carried out to find if the proteins are localised in the same areas 
of the cells at the same time e. g. the acute phase proteins CRP and fibrinogen or 
NFY, B and IrB. Further analysis of the effects of particles on NFKB activation could 
be carried out. This could include detailed examination of cytosolic and nuclear 
fractions of the cells to determine when NFKB was in each fraction and this could be 
measured by a more sensitive technique than the western blot such as EMSA or 
ELISA. 
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Appendix 1: Controls for immunofluorescence of A459 cells shown in Chapter 4. 
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Appendix 11: Comparison between effects of CB and ufCB on pro-inflammatory 
protein production. 
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Fig a) Concentration of CRP in cell lysate, measured by ELISA. 
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Fig b) Concentration of CRP in cell supernatant, measured by ELISA. 
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Fig c) Concentration of fibrinogen in cell lysate, measured by ELISA. 
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Fig d) Concentration of fibrinogen in cell supernatant, measured by ELISA. 
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Appendix III: Adsorption of protein on to particle surface. 
A known concentration of either CRP or fibrinogen was incubated with CB or ufCB 
for various time points. The particles were spun out of the suspension and the 
concentration of CRP or fibrinogen was determined by ELISA. 
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Appendix IV: Controls for immunofluorescence of A549 cells shown in Chapter 5. 
Controls t'or 
ii. Controls for figure 102. 
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Appendix V: Controls for i mm un o fluorescence of MM6 cells shown in Chapter 6 
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